# Global Salvage Report
## ./migrations/README_021.md
```text
# Migration 021: Common Medications Flag

## Status: ‚úÖ Ready for Execution

### What This Migration Does
Adds an `is_common` boolean column to the `ref_medications` table and marks the 12 most clinically relevant medications for display in the Protocol Builder's "Most Common" section.

### Selected Medications (Top 12)
Based on clinical prevalence in psychedelic therapy patient populations:

**SSRIs (3)**
- Sertraline (Zoloft) - Most prescribed antidepressant
- Escitalopram (Lexapro) - Very common
- Fluoxetine (Prozac) - Classic antidepressant

```

## ./archive/README.md
```text
# üì¶ **ARCHIVED PROTOCOL BUILDER VERSIONS**

**Archive Date:** 2026-02-10  
**Decision By:** User (PPN Portal Team)  
**Canonical Version:** `ProtocolBuilder.tsx` (Original)

---

## üìã **ARCHIVED FILES**

### **1. ProtocolBuilderRedesign.tsx**
- **Size:** 80KB
- **Archived:** 2026-02-10 12:05 PM
- **Reason:** User chose original ProtocolBuilder.tsx as canonical version
- **Features:** 
```

## ./CHANGELOG.md
```text
# Changelog

All notable changes to the PPN Research Portal will be documented in this file.

The format is based on [Keep a Changelog](https://keepachangelog.com/en/1.0.0/),
and this project adheres to [Semantic Versioning](https://semver.org/spec/v2.0.0.html).

## [1.0.1] - 2026-02-12

### Added
- **Accessibility Protocols** - Mandatory "Identity Headers" and "Sidebar Naming" for all agent responses.
- **Agent Configuration** - Updated `agent.yaml` to enforce accessibility rules in system prompt.
- **Documentation** - Updated `TEAM_HANDOFF_PROTOCOLS.md` with Section 5 (Accessibility Standards).

## [1.0.0] - 2026-02-10
```

## ./backend/README.md
```text
# PPN Research Portal - Backend API

FastAPI-based backend for the PPN Research Portal. Provides REST API endpoints for clinical research data management with Supabase integration.

## üöÄ Quick Start

### 1. Install Dependencies

```bash
cd backend
python3 -m venv venv
source venv/bin/activate  # On Windows: venv\Scripts\activate
pip install -r requirements.txt
```

```

## ./backend/venv/lib/python3.14/site-packages/idna-3.11.dist-info/licenses/LICENSE.md
```text
BSD 3-Clause License

Copyright (c) 2013-2025, Kim Davies and contributors.
All rights reserved.

Redistribution and use in source and binary forms, with or without
modification, are permitted provided that the following conditions are
met:

1. Redistributions of source code must retain the above copyright
   notice, this list of conditions and the following disclaimer.

2. Redistributions in binary form must reproduce the above copyright
   notice, this list of conditions and the following disclaimer in the
   documentation and/or other materials provided with the distribution.
```

## ./backend/venv/lib/python3.14/site-packages/starlette-0.52.1.dist-info/licenses/LICENSE.md
```text
Copyright ¬© 2018, [Encode OSS Ltd](https://www.encode.io/).
All rights reserved.

Redistribution and use in source and binary forms, with or without
modification, are permitted provided that the following conditions are met:

* Redistributions of source code must retain the above copyright notice, this
  list of conditions and the following disclaimer.

* Redistributions in binary form must reproduce the above copyright notice,
  this list of conditions and the following disclaimer in the documentation
  and/or other materials provided with the distribution.

* Neither the name of the copyright holder nor the names of its
  contributors may be used to endorse or promote products derived from
```

## ./backend/venv/lib/python3.14/site-packages/httpcore-1.0.9.dist-info/licenses/LICENSE.md
```text
Copyright ¬© 2020, [Encode OSS Ltd](https://www.encode.io/).
All rights reserved.

Redistribution and use in source and binary forms, with or without
modification, are permitted provided that the following conditions are met:

* Redistributions of source code must retain the above copyright notice, this
  list of conditions and the following disclaimer.

* Redistributions in binary form must reproduce the above copyright notice,
  this list of conditions and the following disclaimer in the documentation
  and/or other materials provided with the distribution.

* Neither the name of the copyright holder nor the names of its
  contributors may be used to endorse or promote products derived from
```

## ./backend/venv/lib/python3.14/site-packages/pip/_vendor/idna/LICENSE.md
```text
BSD 3-Clause License

Copyright (c) 2013-2024, Kim Davies and contributors.
All rights reserved.

Redistribution and use in source and binary forms, with or without
modification, are permitted provided that the following conditions are
met:

1. Redistributions of source code must retain the above copyright
   notice, this list of conditions and the following disclaimer.

2. Redistributions in binary form must reproduce the above copyright
   notice, this list of conditions and the following disclaimer in the
   documentation and/or other materials provided with the distribution.
```

## ./backend/venv/lib/python3.14/site-packages/uvicorn-0.40.0.dist-info/licenses/LICENSE.md
```text
Copyright ¬© 2017-present, [Encode OSS Ltd](https://www.encode.io/).
All rights reserved.

Redistribution and use in source and binary forms, with or without
modification, are permitted provided that the following conditions are met:

* Redistributions of source code must retain the above copyright notice, this
  list of conditions and the following disclaimer.

* Redistributions in binary form must reproduce the above copyright notice,
  this list of conditions and the following disclaimer in the documentation
  and/or other materials provided with the distribution.

* Neither the name of the copyright holder nor the names of its
  contributors may be used to endorse or promote products derived from
```

## ./backend/venv/lib/python3.14/site-packages/httpx-0.28.1.dist-info/licenses/LICENSE.md
```text
Copyright ¬© 2019, [Encode OSS Ltd](https://www.encode.io/).
All rights reserved.

Redistribution and use in source and binary forms, with or without modification, are permitted provided that the following conditions are met:

* Redistributions of source code must retain the above copyright notice, this list of conditions and the following disclaimer.

* Redistributions in binary form must reproduce the above copyright notice, this list of conditions and the following disclaimer in the documentation and/or other materials provided with the distribution.

* Neither the name of the copyright holder nor the names of its contributors may be used to endorse or promote products derived from this software without specific prior written permission.

THIS SOFTWARE IS PROVIDED BY THE COPYRIGHT HOLDERS AND CONTRIBUTORS "AS IS" AND ANY EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE ARE DISCLAIMED. IN NO EVENT SHALL THE COPYRIGHT HOLDER OR CONTRIBUTORS BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, OR CONSEQUENTIAL DAMAGES (INCLUDING, BUT NOT LIMITED TO, PROCUREMENT OF SUBSTITUTE GOODS OR SERVICES; LOSS OF USE, DATA, OR PROFITS; OR BUSINESS INTERRUPTION) HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY, WHETHER IN CONTRACT, STRICT LIABILITY, OR TORT (INCLUDING NEGLIGENCE OR OTHERWISE) ARISING IN ANY WAY OUT OF THE USE OF THIS SOFTWARE, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGE.
```

## ./docs/design/PROTOCOL_REDESIGN.md
```text
  
DESIGNER: Thank you for this challenge\! Let me analyze this from a world-class UX perspective and create something truly exceptional. Give me a moment to think through the complete user journey and pain points...  
---

## **üéØ UX ANALYSIS: Current Pain Points & Opportunities**

### Critical Issues to Solve:

1. Cognitive Load \- Too many decisions at once  
2. Data Entry Speed \- Clinicians enter 10-50 protocols per week  
3. Error Prevention \- Medical data must be accurate  
4. Context Switching \- Interrupts clinical workflow  
5. Mobile Usage \- Clinicians often use tablets/phones  
6. Accessibility \- Must work for all users  
7. Trust & Confidence \- Users need to feel secure
```

## ./docs/archive/misc/DUMMY_DATA_EXPANSION_SUMMARY.md
```text
# üìä Dummy Data Expansion Summary

**Date:** 2026-02-10  
**Purpose:** Enhanced demo data for Treatment Timeline and analytics testing  
**Status:** COMPLETE

---

## ‚úÖ What Was Added

### **12 New Patient Records (TL-001 through TL-012)**

**Total Patient Count:**
- **Before:** 4 patients (EX-001 through EX-004)
- **After:** 16 patients (4 original + 12 new)
```

## ./docs/archive/misc/ANTIGRAVITY_BEST_PRACTICES.md
```text
# üöÄ ANTIGRAVITY BEST PRACTICES

## How to Operate Antigravity Optimally

This guide shows you how to get the most out of Antigravity by using its features effectively.

---

## 1Ô∏è‚É£ **Using the Browser Tool**

### **Why Use It:**
- Visual verification of UI changes
- Identify specific elements by clicking on them
- Capture screenshots for documentation
- Test responsive behavior at different screen sizes
```

## ./docs/archive/misc/PORTAL_JOURNEY_STRATEGIC_ALIGNMENT.md
```text
# üéØ PORTAL JOURNEY + STRATEGIC ALIGNMENT
## *Synergized with LEAD Research*

**Date:** February 12, 2026, 2:00 AM PST  
**Status:** üü¢ Aligned with Strategic Synthesis  
**Review Interval:** Hourly

---

## ‚úÖ STRATEGIC SYNTHESIS REVIEW (Hourly Check #1)

**Last Reviewed:** `.agent/research/STRATEGIC_SYNTHESIS.md`  
**Key Insights Applied to Portal Journey:**

### **1. Core Market Reality ‚Üí Landing Page Messaging**
```

## ./docs/archive/misc/PROTOCOLBUILDER_REDESIGN_EXECUTIVE_SUMMARY.md
```text
# üéØ ProtocolBuilder Redesign - Executive Summary
**Date:** 2026-02-09 23:54 PST  
**Status:** READY FOR YOUR REVIEW & APPROVAL  
**Next Step:** Your approval ‚Üí Builder execution

---

## ‚úÖ **WHAT I'VE CREATED FOR YOU**

### **4 Complete Implementation Documents:**

1. **`PROTOCOLBUILDER_COMPLETE_REDESIGN_SPEC.md`** (Main Spec)
   - 6 implementation tasks with code examples
   - Complete testing checklist
   - Execution sequence (3-4 hours)
```

## ./docs/archive/misc/ADOPTION_FRICTION_REDUCTION_STRATEGY.md
```text
# üöÄ ADOPTION FRICTION REDUCTION STRATEGY
## Removing Barriers to PPN Portal Adoption

**Created By:** LEAD  
**Date:** 2026-02-12 03:52 PST  
**Context:** User concerned about adoption friction  
**Goal:** Make PPN Portal the easiest choice for practitioners

---

## üéØ CURRENT FRICTION POINTS

### **1. "I don't have time to learn new software"**
- **Friction:** Perceived learning curve
- **Reality:** 5-minute onboarding vs. hours for Osmind
```

## ./docs/archive/misc/NEXT_TASKS.md
```text
# üéØ NEXT TASKS - PRIORITY ORDER
**Date:** 2026-02-10  
**Status:** Post-Audit & Database Migration Complete

---

## üìã IMMEDIATE PRIORITIES (This Week)

### üî¥ **TASK 1: Wire ProtocolBuilder to Database** 
**Owner:** DESIGNER Agent  
**Effort:** 2-3 hours  
**Status:** üü° READY TO START

**Context:**
- Database schema is complete (migrations 003, 004, 004b executed)
```

## ./docs/archive/misc/PROJECT_RULES.md
```text
# üìã PPN RESEARCH PORTAL - PROJECT RULES & GUIDELINES

**Version:** 2.0  
**Date:** 2026-02-10  
**Status:** ACTIVE AND ENFORCED  
**Applies To:** All agents (INVESTIGATOR, BUILDER, DESIGNER, Antigravity)

---

## üéØ Purpose

This document consolidates all project rules, standards, and guidelines for the PPN Research Portal. It extends existing database governance rules with frontend development, testing, deployment, and workflow standards.

**Related Documents:**
- [DATABASE_GOVERNANCE_RULES.md](DATABASE_GOVERNANCE_RULES.md) - Database schema and RLS rules
```

## ./docs/archive/misc/LANDING_PAGE_STATUS_CLEAN.md
```text
# üéØ LANDING PAGE STATUS - CLEAN SLATE
**Date:** 2026-02-09 13:31 PST  
**Status:** RESYNC COMPLETE  
**Presentation:** In ~90 minutes

---

## ‚úÖ **WHAT'S ACTUALLY WORKING (Verified)**

### **1. Components Exist and Are Functional**
- ‚úÖ **GravityButton.tsx** - Magnetic cursor button (125 lines, fully implemented)
- ‚úÖ **BentoGrid.tsx** - 12-column grid system (127 lines, fully implemented)
- ‚úÖ Both components imported in Landing.tsx (lines 32-33)

### **2. Landing Page Changes Applied**
```

## ./docs/archive/misc/BUG_AUDIT_2026-02-09.md
```text
# üîç BUG AUDIT - PRE-LAUNCH STABILIZATION
**Date:** 2026-02-09 19:40 PST  
**Auditor:** Inspector (Antigravity AI)  
**Scope:** Existing functionality only - NO new features  
**Priority:** CRITICAL - Must fix before adding anything new

---

## üö® **CRITICAL BLOCKERS** (Must Fix Before Launch)

### **BLOCKER #1: Header Icons Not Working**
**Location:** `src/components/TopHeader.tsx` lines 137-178  
**Status:** ‚ùå **BROKEN**  
**Impact:** Users can't access core features

```

## ./docs/archive/misc/ENGINEERING_REPORT_GAPS_AND_PLAN.md
```text
# PROVIDENCE ANALYTICS - ENGINEERING REPORT
**Date:** 2026-02-10  
**To:** Engineering Team (Designer, Builder, Architect)  
**From:** Antigravity (Data Architect)  
**Subject:** Database Normalization & Analytics Gaps

---

## üéØ 1. COMPLETED INFRASTRUCTURE
Refactored the data schema to support high-fidelity clinical tracking.

‚úÖ **Phase 1: Knowledge Graph (Tables Created)**
- `ref_substances` (8 compounds)
- `ref_routes` (9 routes)
- `ref_indications` (9 conditions)
```

## ./docs/archive/misc/CODE_OF_CONDUCT.md
```text
# Code of Conduct

## Our Pledge

We as members, contributors, and leaders pledge to make participation in the PPN Research Portal community a harassment-free experience for everyone, regardless of age, body size, visible or invisible disability, ethnicity, sex characteristics, gender identity and expression, level of experience, education, socio-economic status, nationality, personal appearance, race, religion, or sexual identity and orientation.

We pledge to act and interact in ways that contribute to an open, welcoming, diverse, inclusive, and healthy community.

## Our Standards

### Positive Behavior

Examples of behavior that contributes to a positive environment:

- **Demonstrating empathy and kindness** toward other people
```

## ./docs/archive/misc/PROTOCOLBUILDER_FIELD_MAPPING.md
```text
# üìä ProtocolBuilder Field-by-Field Mapping
**Date:** 2026-02-09 23:50 PST  
**Purpose:** Complete reference for every field's data flow  
**For:** Builder implementation

---

## üó∫Ô∏è **FIELD MAPPING OVERVIEW**

**Total Fields:** 27  
**Database-Driven:** 12  
**Hardcoded:** 15  
**Required:** 13  
**Conditional:** 2

```

## ./docs/archive/misc/DASHBOARD_DEEP_DIVE_IMPROVEMENTS.md
```text
# üé® DASHBOARD & DEEP DIVE PAGES LAYOUT IMPROVEMENTS
**Date:** 2026-02-09 14:30 PST  
**Priority:** MEDIUM (Post-Presentation, Week 1)  
**Estimated Time:** 2-3 hours

---

## üìã **ISSUES IDENTIFIED**

### **1. Dashboard Page - Crowded Layout** üü°
**Location:** `src/pages/Dashboard.tsx`

**Current State:**
- Uses `PageContainer` with default width
- 3-column grid on desktop (lg:grid-cols-3)
```

## ./docs/archive/misc/LANDING_PORTAL_JOURNEY_IMPLEMENTATION_PLAN.md
```text
# üöÄ LANDING PORTAL JOURNEY - IMPLEMENTATION PLAN
## *From Concept to Production*

**Project:** PPN Research Portal - Landing Page Redesign  
**Concept:** The Portal Journey (Warp Speed Through Transformation)  
**Status:** üü¢ APPROVED - Implementation Starting  
**Date:** February 12, 2026  
**Timeline:** 4 weeks (Feb 13 - Mar 13)

---

## ‚úÖ APPROVAL SUMMARY

**USER Approved:**
- ‚úÖ Concept 1: The Portal Journey
```

## ./docs/archive/misc/WORKSPACE_RULES.md
```text
# PPN Research Portal - Workspace Rules

This file documents critical rules and constraints for working within the PPN Research Portal codebase, based on project history and explicit user directives.

## 1. Zero-Deletion Policy (CRITICAL)
- **NEVER** delete or remove any visual elements, components, sections, containers, or functionality without **EXPLICIT, DOUBLE CONFIRMATION** from the user.
- If a request is ambiguous (e.g., "Add a login modal"), treat it as an **ADDITION** or an **OPTION**, never a replacement, unless the user explicitly says "replace" or "remove".
- **Proposal Requirement:** Always propose a change that involves removing or hiding existing code *before* executing it.

## 2. Literal Instruction Interpretation
- Follow instructions **literally**. Do not infer unstated goals.
- If the instruction is "Add X", simply add X. Do not modify Y.
- **Strict Scope Control:** Maintain strict focus on the requested feature. Do not refactor, clean up, or reorganize unrelated code unless specifically asked.

## 3. Visual & Styling Standards (Non-Negotiable)
```

## ./docs/archive/misc/MASTER_CHECKLIST.md
```text
# ‚úÖ MASTER CHECKLIST - PPN Research Portal

**Last Updated:** 2026-02-12 07:53 PST  
**Updated By:** DESIGNER (Strategic Pivot)  
**Purpose:** VoC-Aligned Roadmap & Demo Readiness

---

## üî• CRITICAL PRIORITIES (Do First)

- [ ] **Demo Mode Security Fix** (BUILDER) - Gate behind `VITE_DEMO_MODE` env var
- [ ] **Protocol Builder Phase 1 Verification** (INSPECTOR) - Verify 5 ButtonGroups
- [x] **Resolve Protocol Builder Duplication** (LEAD) - ‚úÖ RESOLVED - `ProtocolBuilderRedesign.tsx` deleted
- [ ] **Messaging Pivot** (DESIGNER) - Update Landing to "Practice Operating System"

```

## ./docs/archive/misc/MONETIZATION_STRATEGY.md
```text
# üí∞ **PPN MONETIZATION STRATEGY**

**Document Type:** Business Architecture  
**Version:** 1.0  
**Date:** 2026-02-10  
**Status:** Implementation Ready

---

## üéØ **EXECUTIVE SUMMARY**

PPN Research Portal is a **for-profit venture** with three distinct revenue streams designed to create a sustainable, high-growth business model. The strategy balances immediate cash flow (Clinic Commander), high retention (Risk Management Engine), and long-term unicorn potential (Wisdom Trust).

**Target ARR (Year 1):** $2.4M‚Äì$6M  
**Target ARR (Year 3):** $15M‚Äì$50M  
```

## ./docs/archive/misc/PORTAL_JOURNEY_FINAL_SIMPLIFIED_SPECS.md
```text
# üåå PORTAL JOURNEY - FINAL SIMPLIFIED SPECS
## *3 Screens. 3 Animations. Increasingly Calm.*

**Project:** PPN Research Portal - Landing Page Redesign  
**Status:** üü¢ FINAL SPECS LOCKED - Simplified Version  
**Date:** February 12, 2026, 1:50 AM PST  
**Timeline:** 3 weeks (Feb 12 - Mar 5)

---

## ‚≠ê USER FEEDBACK INCORPORATED

**From Middle Screen Mockup:**
- ‚úÖ **Subtle glass QR code** in bottom right corner (barely visible, integrated)
- ‚úÖ **Softer portal** - Gentle, inviting glow (Concept 1 constellation style)
```

## ./docs/archive/misc/GLOBALFILTERBAR_IMPLEMENTATION.md
```text
# GlobalFilterBar Component - Implementation Summary

**Date:** February 8, 2026  
**Status:** ‚úÖ Complete and Ready to Use

---

## üéØ What Was Created

### 1. **GlobalFilterBar Component**
**File:** `src/components/analytics/GlobalFilterBar.tsx`

A reusable filter component that provides:
- ‚úÖ **Date Range Picker** - Start and end date inputs
- ‚úÖ **Site Multi-Select** - Filter by clinical sites (only shows if user has access to multiple sites)
```

## ./docs/archive/misc/REFINEMENT_SPEC_2026-02-09.md
```text
# üé® LANDING PAGE & PORTAL REFINEMENTS
**Date:** 2026-02-09 14:22 PST  
**Priority:** HIGH (Pre-Presentation Polish)  
**Estimated Time:** 45-60 minutes

---

## üìã **LANDING PAGE REFINEMENTS**

### **1. CTA Button Styling** üî¥ CRITICAL
**Location:** `src/pages/Landing.tsx` lines ~194-209

**Current State:**
- "Access Portal" button uses GravityButton (glassmorphic, different size)
- "Request Access" button is standard (slate background)
```

## ./docs/archive/misc/CHATGPT_SCHEMA_REVIEW_REQUEST.md
```text
# DATABASE SCHEMA REVIEW REQUEST (Updated with Prior ChatGPT Feedback)

I'm building a psychedelic therapy research portal using PostgreSQL (Supabase). Yesterday, ChatGPT reviewed my schema and identified critical issues. Today I'm proposing a migration to fix normalization issues, but I want to ensure I'm not creating NEW problems while fixing the old ones.

## CONTEXT

**Application:** Clinical research portal for psychedelic-assisted therapy  
**Database:** PostgreSQL 15 (Supabase)  
**Users:** Multi-tenant (multiple clinics/sites)  
**Data:** De-identified clinical records, safety tracking, drug interactions  
**Critical Constraint:** NO PHI/PII collection allowed

---

## YESTERDAY'S CHATGPT FEEDBACK (Key Points)
```

## ./docs/archive/misc/LAUNCH_PRIORITY_LIST.md
```text
# üöÄ LAUNCH PRIORITY LIST
**Date:** February 9, 2026 19:50 PST  
**Status:** LAUNCH MODE - HOSTING TONIGHT  
**Deadline:** ASAP (Domain + Hosting Connection)

---

## üéØ **LAUNCH PHILOSOPHY**

**Rule #1:** Ship what works, fix what's broken, defer what's nice-to-have.  
**Rule #2:** No user should see a broken page or missing feature.  
**Rule #3:** Every public page must look intentional and polished.

---

```

## ./docs/archive/misc/DATABASE_GOVERNANCE_RULES.md
```text
# üîê **PPN DATABASE GOVERNANCE RULES v2.0**

**Effective Date:** 2026-02-11  
**Authority:** Non-negotiable global rules  
**Applies To:** All agents (INVESTIGATOR, BUILDER, DESIGNER, Antigravity)

---

## üéØ **SENIOR SQL DATABASE ARCHITECT ROLE**

**Mission:** Responsible for structural integrity, performance, and security of all data. Design Third Normal Form (3NF) database schemas that are efficient and scalable. **Data loss is unacceptable.**

**Scope of Work:**
- ‚úÖ **OWNS:** `/migrations` folder, all `.sql` files, migration scripts, schema documentation
- ‚ùå **IGNORES:** Frontend code (React/HTML), CSS styling, API route logic (unless optimizing embedded SQL queries)
```

## ./docs/archive/misc/DEMO_LOGIN_CREDENTIALS.md
```text
# üîê **DEMO LOGIN CREDENTIALS**

**Date:** 2026-02-10 14:32 PM  
**For:** Live Demo in 1 hour

---

## üö® **CRITICAL: YOU NEED SUPABASE CREDENTIALS**

The login page uses **real Supabase authentication** - there's no demo bypass mode.

---

## ‚úÖ **OPTION 1: USE YOUR SUPABASE ACCOUNT (RECOMMENDED)**

```

## ./docs/archive/misc/HOSTINGER_DEPLOYMENT_GUIDE.md
```text
# Hostinger Deployment Guide for PPN Research Portal

## Overview
This guide walks you through deploying your PPN Research Portal to Hostinger hosting.

## Prerequisites
- ‚úÖ Hostinger hosting account with Node.js support
- ‚úÖ Supabase project set up and configured
- ‚úÖ Local development environment working
- ‚úÖ Git repository up to date (already done!)

---

## Deployment Steps

```

## ./docs/archive/misc/LAUNCH_CRITICAL_FIXES.md
```text
# üö® LAUNCH-CRITICAL FIXES ONLY
**Date:** February 9, 2026 20:13 PST  
**Deadline:** TONIGHT (ASAP)  
**Strategy:** Fix only what will break the public launch

---

## üéØ **CRITICAL ISSUES (MUST FIX TONIGHT)**

### **Issue #1: Header Navigation 404 Errors** ‚è∞ 15 minutes
**Impact:** Users click icons ‚Üí broken pages ‚Üí bad first impression  
**Risk:** HIGH - visible to all users  
**Fix:** Quick disable or redirect

#### **Quick Fix:**
```

## ./docs/archive/misc/CLINICAL_COPILOT_VISION.md
```text
# üöÄ Clinical Copilot - The Dream Design
**Date:** 2026-02-10 00:38 PST  
**Status:** Vision Document (No Restrictions)  
**Purpose:** Show what's possible with total creative freedom

---

## üéØ **THE PHILOSOPHY**

> "What if creating a protocol felt less like filling out a DMV form and more like having a conversation with the smartest clinical researcher you know?"

**Core Principles:**
1. **Conversational** - Not a form, a dialogue
2. **Intelligent** - Learns and recommends
3. **Proactive** - Prevents mistakes before they happen
```

## ./docs/archive/misc/SWOT_ANALYSIS.md
```text
# üéØ PPN RESEARCH PORTAL - SWOT ANALYSIS

**Strategic Assessment**  
**Date:** February 11, 2026  
**Prepared by:** LEAD Agent  
**Purpose:** Identify strategic position, risks, and opportunities

---

## üí™ STRENGTHS

### **1. No-PHI Architecture (Strategic Moat)**
**Why it matters:**
- Zero HIPAA compliance cost ($500K/year savings)
- Zero breach liability ($10.8M risk eliminated)
```

## ./docs/archive/misc/INSTRUCTIONS_FOR_DESIGNER_COPYPASTE.md
```text
# üìã COPY-PASTE INSTRUCTIONS FOR DESIGNER

**USER:** Copy and paste this exact message to DESIGNER:

---

**DESIGNER,**

You have been granted **TEMPORARY CREATIVE FREEDOM** for landing page concept exploration.

**Read this document immediately:**
`DESIGNER_TEMPORARY_CREATIVE_FREEDOM.md`

**Your Mission:**
Create 3 world-class landing page concept proposals inspired by:
```

## ./docs/archive/misc/CUSTOMER_JOURNEY_MAP.md
```text
# üó∫Ô∏è CUSTOMER JOURNEY MAP
## PPN Research Portal - Practitioner Experience

**Created By:** LEAD  
**Date:** 2026-02-12 02:23 PST  
**For:** USER (strategic planning)  
**Context:** VoC research + pre-launch planning

---

## üìä EXECUTIVE SUMMARY

**Purpose:** Map the complete practitioner journey from first awareness to loyal advocate, identifying touchpoints, emotions, pain points, and opportunities at each stage.

**Key Insights:**
```

## ./docs/archive/misc/GOVERNANCE_QUICKREF.md
```text
# üìã **PROJECT GOVERNANCE - QUICK REFERENCE**

**Full Documentation:** `PROJECT_GOVERNANCE_RULES.md`  
**Last Updated:** 2026-02-10

---

## üî¥ **CRITICAL RULES (NEVER VIOLATE)**

### **Database**
- ‚ùå NO drops, renames, or type changes
- ‚ùå NO PHI/PII collection
- ‚ùå NO free-text answer fields
- ‚úÖ Public schema only
- ‚úÖ RLS on all patient tables
```

## ./docs/archive/misc/PROJECT_GOVERNANCE_RULES.md
```text
# üèõÔ∏è **PPN RESEARCH PORTAL - PROJECT GOVERNANCE RULES v1.0**

**Effective Date:** 2026-02-10  
**Authority:** Project Owner + Expert Review (ChatGPT)  
**Status:** ACTIVE AND ENFORCED

---

## üìã **TABLE OF CONTENTS**

1. [Introduction & Authority](#introduction)
2. [Core Principles](#core-principles)
3. [Database Rules](#database-rules)
4. [Frontend Development Rules](#frontend-rules)
5. [Design System Rules](#design-system-rules)
```

## ./docs/archive/misc/PRE_LAUNCH_BOTTLENECK_AUDIT.md
```text
# üö¶ PRE-LAUNCH BOTTLENECK AUDIT
## Critical Issues Before Live Testing

**Audited By:** LEAD  
**Date:** 2026-02-12 02:22 PST  
**Context:** Preparing for live practitioner testing  
**Scope:** Everything except Protocol Builder (already in progress)

---

## üìä EXECUTIVE SUMMARY

**Status:** üü° **MOSTLY READY** - 3 critical bottlenecks identified

**Critical Blockers (Must Fix):**
```

## ./docs/archive/misc/PROTOCOLBUILDER_ENHANCEMENT_SUMMARY.md
```text
# ProtocolBuilder Enhancement - Execution Summary
**Date:** 2026-02-09  
**Status:** READY TO EXECUTE

---

## üìã WHAT WAS CREATED

### 1. Analysis Documents
- ‚úÖ **`PROTOCOLBUILDER_DATA_MAPPING.md`** - Complete field mapping analysis
- ‚úÖ **`SUPABASE_SETUP_AND_DESIGNER_INSTRUCTIONS.md`** - Full setup guide + instructions
- ‚úÖ **`SUPABASE_MIGRATION_CHECKLIST.md`** - Step-by-step migration execution guide
- ‚úÖ **`DESIGNER_TASK_PROTOCOLBUILDER.md`** - Complete Designer task specification

### 2. Migration Script
```

## ./docs/archive/misc/TRIPPINGLY_PARTNERSHIP_PROPOSAL.md
```text
# ü§ù TRIPPINGLY PARTNERSHIP PROPOSAL
## Affiliate & Distribution Partnership

**For:** Trippingly.net founder  
**From:** PPN Portal Team, PPN Portal  
**Date:** 2026-02-12  
**Type:** Affiliate partnership + content collaboration

---

## üéØ THE OPPORTUNITY

### **The Gap:**
- Trippingly educates **consumers** about safe psychedelic use
- But consumers often ask: **"Where can I find a licensed practitioner?"**
```

## ./docs/archive/misc/ACTION_CHECKLIST.md
```text
# PPN Research Portal - Immediate Action Checklist
**Generated:** February 8, 2026  
**Based on:** Full Site Audit

---

## üî¥ CRITICAL - Do Today

- [ ] **Install Dependencies**
  ```bash
  npm install
  ```
  **Status:** node_modules missing, app won't run
  **Location:** Project root
  **Time:** 2-3 minutes
```

## ./docs/archive/misc/MERCHANT_PROCESSING_RECOMMENDATIONS.md
```text
# üí≥ MERCHANT PROCESSING RECOMMENDATIONS
## Payment Processing for PPN Research Portal

**Created By:** LEAD  
**Date:** 2026-02-12 02:45 PST  
**Context:** SaaS subscription billing for psychedelic therapy platform  
**Priority:** CRITICAL - Required for revenue

---

## üéØ EXECUTIVE SUMMARY

**Recommendation:** **Stripe** (primary) + **PayPal** (alternative)

**Why Stripe:**
```

## ./docs/archive/misc/PROJECT_RULES_QUICK_REFERENCE.md
```text
# üìã PROJECT RULES - QUICK REFERENCE

**Full Documentation:** [PROJECT_RULES.md](PROJECT_RULES.md)

---

## üö® CRITICAL RULES (NEVER VIOLATE)

### **Zero-Deletion Policy**
‚ùå **NEVER** delete features, components, or UI elements without **EXPLICIT, DOUBLE CONFIRMATION**

### **Privacy-First**
‚ùå **NO PHI, NO PII** - No names, emails, phone numbers, addresses, DOB, MRNs, free-text inputs

### **Colorblind-Friendly Design**
```

## ./docs/archive/misc/SOOPGENT_CONFIGURATION_AUDIT.md
```text
# Subagent Configuration Audit

**Date:** 2026-02-11  
**Purpose:** Ensure all subagents have clear, actionable instructions and task files

---

## Summary

**Total Subagents:** 5 (DESIGNER, INSPECTOR, BUILDER, SOOP, CRAWL)  
**Task Files Found:** 4  
**Issues Identified:** 3

---

```

## ./docs/archive/misc/COMPONENT_STRATEGIC_ALIGNMENT_ANALYSIS.md
```text
# üéØ COMPONENT STRATEGIC ALIGNMENT ANALYSIS
## Focus: Practitioner Care Quality vs. Operations/Revenue

**Analyzed By:** LEAD  
**Date:** 2026-02-12 00:15 PST  
**Context:** USER's strategic pivot to practitioner care quality  
**Reference:** SWOT Analysis, WHY_NO_PHI Executive Memo, Voice-of-Customer Research

---

## üìã STRATEGIC CONTEXT

### **USER's Core Insight:**
> "Our focus needs to be on helping practitioners provide better care (as opposed to operations, revenue enhancement, etc.)"

```

## ./docs/archive/misc/PROJECT_STATUS_BOARD.md
```text
# üìä PROJECT STATUS BOARD

| Task | Agent | Status | Artifact | Last Updated |
|------|-------|--------|----------|--------------|
| Protocol Builder Phase 1 Verification | INSPECTOR | üî¥ ASSIGNED | `INSPECTOR_TASK_PROTOCOLBUILDER_PHASE1_VERIFICATION.md` | 2026-02-11 19:19 |
| Demo Mode Security Fix | BUILDER | üî¥ ASSIGNED | `BUILDER_TASK_DEMO_MODE_SECURITY_FIX.md` | 2026-02-11 19:19 |
| Toast System Implementation | BUILDER | üü° QUEUED | `BUILDER_HANDOFF.md` (lines 110-298) | 2026-02-11 19:19 |
| Clinical Intelligence Mockups | DESIGNER | üî¥ ASSIGNED | `DESIGNER_TASK_CLINICAL_INTELLIGENCE_PLATFORM.md` | 2026-02-11 16:40 |
| Clinical Intelligence Schema | SOOP | üî¥ ASSIGNED | `SOOP_TASK_CLINICAL_INTELLIGENCE_SCHEMA.md` | 2026-02-11 16:45 |

---

## ‚úÖ COMPLETED TASKS

| Task | Agent | Completed | Artifact | Notes |
```

## ./docs/archive/misc/LANDING_CONCEPTS_EXECUTIVE_SUMMARY.md
```text
# üé® LANDING PAGE CONCEPTS - EXECUTIVE SUMMARY
## Three World-Class Proposals for PPN Research Portal

**Designer:** UI/UX Lead  
**Date:** February 12, 2026  
**Status:** Ready for USER Review  
**Temperature:** 9.5 (Maximum Creativity)

---

## üéØ MISSION RECAP

**USER's Vision:**
> "A journey into the Portal, where at each stop they find a treasure (one of our components) that they've been searching for. Each treasure gives them insight, structure, information, sharing, clarity, privacy."

```

## ./docs/archive/misc/LANDING_PAGE_VISUAL_PREVIEW.md
```text
# üé® LANDING PAGE VISUAL PREVIEW
**What the redesigned landing page will look like**  
**Date:** February 9, 2026 20:18 PST

---

## üìã **CURRENT vs NEW STRUCTURE**

### **CURRENT LANDING PAGE:**
```
‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê
‚îÇ 1. Hero Section                    ‚úÖ   ‚îÇ
‚îÇ    (Starry background, CTA buttons)     ‚îÇ
‚îú‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚î§
‚îÇ 2. Trust Indicators                ‚úÖ   ‚îÇ
```

## ./docs/archive/misc/AGENT_COLLABORATION_RULES.md
```text
# ü§ù **AGENT COLLABORATION RULES v1.0**

**Parent Document:** `PROJECT_GOVERNANCE_RULES.md`  
**Effective Date:** 2026-02-10  
**Status:** ACTIVE AND ENFORCED

---

## üìã **QUICK REFERENCE**

### **Role Summary:**
- üéØ **LEAD:** Creates the goal and plan
- üé® **DESIGNER:** Creates visual specifications
- üîç **INSPECTOR:** QA gatekeeper - checks feasibility and creates tech specs
- üî® **BUILDER:** Implements code based on tech specs
```

## ./docs/archive/misc/PARADIGM_SHIFT_CLINICAL_INTELLIGENCE.md
```text
# üöÄ PARADIGM SHIFT: PROTOCOL BUILDER ‚Üí CLINICAL INTELLIGENCE PLATFORM

**LEAD Strategic Reframe**  
**Date:** 2026-02-11 16:00 PST  
**Triggered By:** Dr. Shena's clinical insights + User's vision expansion  
**Status:** üî• CRITICAL STRATEGIC PIVOT

---

## üìã **PROBLEM STATEMENT (REVISED)**

**OLD THINKING:**
> "Build a fast data entry form for practitioners to log protocols"

**NEW THINKING:**
```

## ./docs/archive/misc/PATH_UPDATE_ALL_AGENTS.md
```text
# üîß FILE PATH UPDATE - ALL AGENTS READ THIS

**Date:** 2026-02-11  
**Priority:** CRITICAL  
**Status:** ACTIVE

---

## üìç **CORRECT PROJECT LOCATION**

**‚úÖ CURRENT (CORRECT) PATH:**
```
/Users/trevorcalton/Desktop/PPN-Antigravity-1.0
```

```

## ./docs/archive/misc/ARCHITECTURE_OVERVIEW.md
```text
# PPN Research Portal - Architecture Overview
**Date:** February 8, 2026  
**Version:** v3.33

---

## System Architecture

```
‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê
‚îÇ                     PPN RESEARCH PORTAL                          ‚îÇ
‚îÇ                         (Frontend)                               ‚îÇ
‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò
                              ‚îÇ
                              ‚îÇ HTTPS
```

## ./docs/archive/misc/PHASE1_SAFETY_FEATURES_COMPLETE.md
```text
# ‚úÖ PHASE 1 SAFETY FEATURES - IMPLEMENTATION COMPLETE

**Completed By:** LEAD (Autonomous Execution)  
**Date:** 2026-02-12 01:45 PST  
**Status:** ‚úÖ ALL TASKS COMPLETE  
**Timeline:** 2 hours (faster than estimated 4-6 hours)

---

## üéØ OBJECTIVE ACHIEVED

Successfully promoted 3 safety-focused components from deep-dive pages to main application, making them prominently accessible to all practitioners.

**Strategic Goal:** ‚úÖ Address #1 practitioner pain point (liability anxiety) by providing real-time safety intelligence.

```

## ./docs/archive/misc/AUTH_IMPLEMENTATION_COMPLETE.md
```text
# Auth Implementation Complete ‚úÖ

**Date:** 2026-02-09  
**Status:** READY FOR TESTING  
**Time to Complete:** 5 minutes

---

## Changes Made

### File Modified: `src/App.tsx`

#### Change 1: Re-enabled Auth Enforcement (Lines 87-96)
**Before:**
```typescript
```

## ./docs/archive/misc/COMPLETE_DATABASE_SCHEMA_REVIEW.md
```text
# üóÑÔ∏è **COMPLETE DATABASE SCHEMA - VERIFIED**

**Date:** 2026-02-10 13:48 PM  
**Purpose:** Complete schema review before creating ref_knowledge_graph  
**Status:** ‚úÖ **VERIFIED - READY TO PROCEED**

---

## üìä **ALL REFERENCE TABLES (CONFIRMED)**

### **1. ref_substances**
```sql
CREATE TABLE public.ref_substances (
    substance_id BIGSERIAL PRIMARY KEY,
    substance_name TEXT NOT NULL UNIQUE,
```

## ./docs/archive/misc/MARKETER_SOOPGENT_SPECIFICATION.md
```text
# üìß MARKETING & AUTOMATIONS SOOPGENT
## Growth Marketing, SEO, Partnerships & Automation Workflows

**Agent Name:** MARKETER  
**Created By:** LEAD  
**Date:** 2026-02-12 04:21 PST  
**Purpose:** Drive practitioner acquisition, retention, and revenue growth

---

## üéØ AGENT MISSION

MARKETER is responsible for:
1. **Growth Marketing:** Practitioner acquisition (paid ads, SEO, partnerships)
2. **Email Automation:** Onboarding sequences, retention campaigns, upsells
```

## ./docs/archive/misc/PATIENT_FLOW_IMPLEMENTATION_PLAN.md
```text
# Patient Flow Deep Dive - Implementation Plan
**Date:** February 8, 2026  
**Version:** 1.0  
**Status:** Strategic Blueprint ‚Üí Ready for Implementation

---

## Executive Summary

**Decision Locked:** We are building the **Patient Flow Deep Dive** as the template for all 11 Deep Dive pages.

**Why Patient Flow First:**
1. Exposes the event timeline model that all other analytics depend on
2. Forces us to solve PHI-safe patient tracking (hashed identifiers)
3. Requires the full shared UX layer (filters, cohorts, exports)
```

## ./docs/archive/misc/IMPLEMENTATION_PROGRESS.md
```text
# üöÄ IMPLEMENTATION PROGRESS TRACKER

**Date:** 2026-02-09  
**Session:** Critical Fixes & Enhancements

---

## ‚úÖ COMPLETED

### 1. Functional Search Portal
**Status:** ‚úÖ COMPLETE  
**Files Modified:**
- `src/pages/Landing.tsx`

**Changes:**
```

## ./docs/archive/misc/NOTEBOOKLM_PROMPT_WHY_NO_PHI.md
```text
# üõ°Ô∏è NOTEBOOKLM PROMPT: WHY NO PHI/PII
## Legal, Financial, and Privacy Advantages

**Created By:** LEAD  
**Date:** 2026-02-12 03:45 PST  
**Purpose:** NotebookLM prompt for explaining "No PHI/PII" strategy  
**Context:** Emphasize legal protection, financial savings, and privacy advantages

---

## üéØ NOTEBOOKLM CUSTOM INSTRUCTIONS

### **Copy-Paste This Into NotebookLM:**

```
```

## ./docs/archive/misc/AGENT_CONFIG_UPDATE_COMPLETE.md
```text
# ‚úÖ AGENT CONFIGURATION - BULLETPROOF UPDATE COMPLETE

**Date:** 2026-02-11 10:55 PST  
**Status:** ‚úÖ COMPLETE  
**Priority:** CRITICAL

---

## üéØ **WHAT WAS DONE**

### **1. Mandatory Identification Rule - ENFORCED**
Every agent MUST start every response with their name:
```
**LEAD:** [response]
**DESIGNER:** [response]
```

## ./docs/archive/misc/DESIGN_SPEC_PROTOCOLBUILDER_WORLDCLASS.md
```text
# üèÜ WORLD-CLASS PROTOCOL BUILDER - DESIGN SPECIFICATION

**DESIGNER:** Antigravity Design Agent  
**Date:** 2026-02-11 12:46 PST  
**Version:** 3.0 - World-Class Edition  
**Status:** ‚úÖ BEST-IN-CLASS DESIGN  
**Mission:** Create the fastest, most professional protocol entry system in healthcare

---

## üéØ **EXECUTIVE SUMMARY**

This is a **complete redesign** of the Protocol Builder, elevating it from functional to **world-class**. Every decision is backed by UX research, clinical workflow analysis, and modern design principles.

### **Design Philosophy:**
```

## ./docs/archive/misc/USE_CASE_VISUAL_SPECIFICATIONS.md
```text
# üé® USE CASE VISUAL SPECIFICATIONS
## Visuals, Data & Links for 5 Use Cases

**Created By:** LEAD  
**Date:** 2026-02-12 03:52 PST  
**Purpose:** Visual design specs and supporting data for each use case

---

## USE CASE 1: "PROVE YOU'RE NOT RECKLESS"

### **Visual: Subpoena Comparison (Before/After)**

**Layout:** Split-screen comparison

```

## ./docs/archive/misc/TREATMENT_HISTORY_FLOW_DESIGN.md
```text
# üé® DESIGNER: Treatment History Timeline Chart (REVISED)

**Page:** Protocol Detail - Patient Treatment Timeline  
**Date:** 2026-02-10 (Updated)  
**Status:** DESIGN PROPOSAL - Awaiting Review  
**Role:** DESIGNER (No code implementation, specifications only)

---

## üéØ Design Objective (REVISED)

**User's Vision:**
> "Patient gets treatment on Day 1, returns on Day 8 for different treatment with slightly different outcomes, returns on Day 11 for another treatment, and so on. Horizontal timeline represented in a **chart** that adjusts dynamically depending on how many treatments the patient has."

**Placement:**
```

## ./docs/archive/misc/PROTOCOLBUILDER_STATUS_AND_ACTION_PLAN.md
```text
# üéØ PROTOCOL BUILDER - COMPLETE STATUS & ACTION PLAN

**Created:** 2026-02-11 22:11 PST  
**Priority:** üî¥ CRITICAL - Core Application Feature  
**Status:** ‚ö†Ô∏è NEEDS IMMEDIATE ATTENTION

---

## üö® EXECUTIVE SUMMARY

**Current State:** Protocol Builder is FUNCTIONAL but UNVERIFIED  
**Risk Level:** MEDIUM - Working code but no QA, no user approval, workflow gaps  
**Recommendation:** IMMEDIATE comprehensive review and finalization before demo

---
```

## ./docs/archive/misc/RUN_MIGRATIONS_NOW.md
```text
# üöÄ **DATABASE MIGRATION INSTRUCTIONS**

**Created By:** BUILDER (Antigravity)  
**Date:** 2026-02-10 13:28 PM  
**Priority:** üî¥ **CRITICAL - RUN THESE NOW**  
**Estimated Time:** 5 minutes

---

## üìã **WHAT I'VE CREATED**

I've created **2 new migration files** for the critical database integrations:

1. **`migrations/008_create_system_events_table.sql`**  
   - Creates `system_events` table for Audit Logs
```

## ./docs/archive/misc/TIMETOSTEPCHART_IMPLEMENTATION.md
```text
# TimeToStepChart Component - Implementation Summary

**Date:** February 8, 2026  
**Status:** ‚úÖ Complete and Ready to Use

---

## üéØ What Was Created

### **TimeToStepChart Component**
**File:** `src/components/charts/TimeToStepChart.tsx`

A horizontal bar chart showing median days between treatment stages:
- ‚úÖ **Queries Supabase** - Fetches data from `v_flow_time_to_next_step`
- ‚úÖ **Applies Filters** - Respects site filter from GlobalFilterBar
```

## ./docs/archive/misc/DEMO_STRATEGY_PHASE1_VOC_ALIGNED.md
```text
# üéØ DEMO STRATEGY: PHASE 1 SAFETY FEATURES
## Aligned to VoC Research - JAllen & BLJensen

**Prepared By:** LEAD  
**Date:** 2026-02-12 01:30 PST  
**For:** Demo to Dr. Jason Allen & Bridger Lee Jensen  
**Context:** Phase 1 Safety Features just completed

---

## üìä EXECUTIVE SUMMARY

**Perfect Timing:** Phase 1 Safety Features directly address the #1 pain point for both practitioners in our VoC research.

**Key Insight:** Both segments (entheogenic religion operators + licensed clinics) obsess over **risk, defensibility, and safety documentation**.
```

## ./docs/archive/misc/DATABASE_CONNECTIVITY_AUDIT.md
```text
# üîç **DATABASE CONNECTIVITY AUDIT: AUDIT LOGS + INTERACTION CHECKER**

**Audited By:** INVESTIGATOR (Antigravity)  
**Date:** 2026-02-10 12:55 PM  
**Scope:** Verify SQL/Supabase database connectivity  
**Status:** üî¥ **BOTH PAGES USE HARDCODED DATA**

---

## üìä **EXECUTIVE SUMMARY**

**Finding:** Both pages are currently using **hardcoded mock data** from `constants.ts` instead of fetching from the Supabase database.

| Page | Current Data Source | Should Use | Status |
|------|---------------------|------------|--------|
```

## ./docs/archive/misc/PATIENT_FLOW_SESSION_SUMMARY.md
```text
# Patient Flow Deep Dive - Session Summary
**Date:** February 8, 2026  
**Session Duration:** ~2 hours  
**Status:** 75% Complete (3 of 4 charts working)

---

## üéØ **Objective**
Debug and fix the Patient Flow charts, specifically the FunnelChart which was not displaying data despite successful demo data generation.

---

## ‚úÖ **Major Accomplishments**

### 1. **Database Foundation - COMPLETE ‚úÖ**
```

## ./docs/archive/misc/INVESTIGATOR_DIAGNOSTIC_REPORT.md
```text
# üîç **INVESTIGATOR DIAGNOSTIC REPORT**

**Investigation Date:** 2026-02-10 12:36 PM  
**Investigator:** Antigravity (INVESTIGATOR Mode)  
**Scope:** Full application health check  
**Status:** üî¥ **CRITICAL ISSUES FOUND**

---

## üö® **CRITICAL FINDINGS**

### **Issue #1: Node.js Permissions Corruption** üî¥ **BLOCKING**

**Severity:** CRITICAL  
**Impact:** Application cannot build, run, or install dependencies  
```

## ./docs/archive/misc/TRIPPINGLY_STRATEGIC_ADVISOR_PROPOSAL.md
```text
# üéØ TRIPPINGLY PARTNERSHIP: STRATEGIC ADVISOR PROPOSAL
## Partnership + Advisory + Investment Opportunity

**For:** Trippingly.net founder (Former VC)  
**From:** PPN Portal Team, PPN Portal  
**Date:** 2026-02-12  
**Opportunity:** Affiliate partnership + strategic advisor + potential angel investment

---

## üí° THE STRATEGIC PLAY

### **Why This Is Interesting (VC Lens):**

**Market Opportunity:**
```

## ./docs/archive/misc/ARTIFACT_INDEX.md
```text
# üìö ARTIFACT INDEX

**Last Updated:** 2026-02-11 20:01 PST  
**Maintained By:** All Agents  
**Purpose:** Centralized index of all project artifacts organized by category

---

## üìã HOW TO USE THIS INDEX

**All agents must:**
1. Add new artifacts to this index after creation
2. Use the format: `- [Artifact Name](filepath) - Brief description (Agent, Date)`
3. Keep entries chronological within each category (newest first)
4. Update the "Last Updated" timestamp
```

## ./docs/archive/misc/PRE_DEMO_CHECKLIST.md
```text
# üöÄ **PRE-DEMO CHECKLIST - 1 HOUR TO GO**

**Date:** 2026-02-10 14:28 PM  
**Demo Time:** 15:30 PM (1 hour)  
**Status:** ‚úÖ **SITE IS FUNCTIONAL WITH HARDCODED DATA**

---

## ‚úÖ **WHAT WORKS (VERIFIED)**

### **All Pages Use Constants (Hardcoded Data)**
‚úÖ **Audit Logs** - Uses `AUDIT_LOGS` from constants  
‚úÖ **Interaction Checker** - Uses `INTERACTION_RULES` + `MEDICATIONS_LIST`  
‚úÖ **Protocol Builder** - Uses `SAMPLE_INTERVENTION_RECORDS` + `MEDICATIONS_LIST`  
‚úÖ **Substance Catalog** - Uses `SUBSTANCES` + `MEDICATIONS_LIST`  
```

## ./docs/archive/misc/USE_CASES_VOC_ALIGNED_2026.md
```text
# üéØ PPN RESEARCH PORTAL - USE CASES (VoC-Aligned)
## Cross-Referenced with Comprehensive Voice of Customer Research

**Date:** 2026-02-12 05:51 PST  
**Source:** Cross-reference of existing use cases with comprehensive VoC research  
**Status:** ‚úÖ VALIDATED - Aligned with practitioner needs

---

## üìä EXECUTIVE SUMMARY

### **VoC Validation Results:**

**‚úÖ CONFIRMED USE CASES** (High VoC Alignment):
1. **Prove You're Not Reckless** - Aligns with VoC Theme: Safety, screening, harm reduction
```

## ./docs/archive/misc/LANDING_PAGE_IMPROVEMENTS.md
```text
# Landing Page Improvements - 2026-02-09

## Issues Addressed

### 1. ‚úÖ Removed Email/Password Form from Hero Section
**Problem:** The inline login form cluttered the hero section and mixed authentication with marketing content.

**Solution:** 
- Replaced the email/password form with clean, prominent CTA buttons:
  - **"Access Portal"** button (primary) ‚Üí navigates to `/login`
  - **"Request Access"** button (secondary) ‚Üí navigates to `/signup`
- Added informative Quick Stats section showing:
  - 12k+ Records
  - 840+ Clinicians  
  - 98% Uptime
```

## ./docs/archive/misc/SUPABASE_MIGRATION_CHECKLIST.md
```text
# Supabase Migration Execution Checklist
**Date:** 2026-02-09  
**Migration:** 003_protocolbuilder_reference_tables.sql  
**Status:** READY TO EXECUTE

---

## ‚úÖ PRE-FLIGHT CHECKLIST

### Step 1: Access Supabase
- [ ] Open browser to: https://supabase.com/dashboard
- [ ] Sign in with your credentials
- [ ] Navigate to your project: `rxwsthatjhnixqsthegf`
- [ ] Click **SQL Editor** in the left sidebar

```

## ./docs/archive/misc/DEMO_READINESS_PLAN.md
```text
# üéØ DEMO READINESS PLAN - Feb 15 Dr. Shena Demo

**Created:** 2026-02-11 21:45 PST  
**Owner:** LEAD  
**Demo Date:** Saturday, Feb 15, 2026  
**Days Remaining:** 4 days

---

## ‚úÖ SCOPE DECISION CONFIRMED

**Age/Weight/Race Button Groups:** ‚è∏Ô∏è **DEFERRED to post-demo**

**Rationale:**
- Protocol Builder Phase 1 is complete (5 ButtonGroups implemented)
```

## ./docs/archive/misc/HIDDEN_COMPONENTS_STRATEGIC_ANALYSIS.md
```text
# üíé HIDDEN COMPONENTS - STRATEGIC ANALYSIS & INTEGRATION PLAN

**Analyzed By:** LEAD  
**Date:** 2026-02-12 00:06 PST  
**For:** USER + DESIGNER  
**Purpose:** Strategic evaluation of built-but-unused components

---

## üìä EXECUTIVE SUMMARY

**Discovery:** 5 premium components built but not integrated into the application.

**Total Investment:** ~23KB of production-ready code  
**Strategic Value:** HIGH - These components represent significant untapped potential  
```

## ./docs/archive/misc/TREATMENT_TIMELINE_IMPLEMENTATION_SPEC.md
```text
# üé® TREATMENT TIMELINE: Implementation Specification

**Designer:** Antigravity  
**Date:** 2026-02-10  
**Status:** READY FOR INVESTIGATOR REVIEW ‚Üí BUILDER EXECUTION  
**Page:** Protocol Detail (`ProtocolDetail.tsx`)

---

## üéØ Objective

Add a **Treatment History Timeline** component to the Protocol Detail page that:
1. ‚úÖ Shows multiple treatments for a single patient over time
2. ‚úÖ Displays day-level temporal precision (Day 0, Day 8, Day 11)
3. ‚úÖ Visualizes outcome progression (PHQ-9 scores)
```

## ./docs/archive/misc/INTERACTION_CHECKER_RECOMMENDATION.md
```text
# üéØ DESIGNER RECOMMENDATION: Interaction Checker on Landing Page

## ‚úÖ **RECOMMENDATION: YES, Replace Bento Section**

### **Why This Works:**

1. **InteractionChecker Component Exists** ‚úÖ
   - Location: `src/pages/InteractionChecker.tsx` (327 lines)
   - Fully functional with INTERACTION_RULES and MEDICATIONS_LIST
   - Already has psychedelics list (Psilocybin, MDMA, Ketamine, LSD-25, etc.)

2. **Perfect Lead Magnet** ‚úÖ
   - High-value tool practitioners need daily
   - Demonstrates platform capability
   - Can be used without login
```

## ./docs/archive/misc/COMPETITIVE_ANALYSIS_TRIPPINGLY.md
```text
# üîç COMPETITIVE ANALYSIS: TRIPPINGLY.NET
## Research Findings & Strategic Positioning

**Created By:** LEAD  
**Date:** 2026-02-12 03:56 PST  
**URL:** https://www.trippingly.net  
**Category:** Consumer education / harm reduction

---

## üìä WHAT TRIPPINGLY IS

### **Primary Focus:**
- **Consumer education** about psychedelic substances
- **Harm reduction** information (dosage, safety, trip reports)
```

## ./docs/archive/misc/LANDING_PAGE_UX_AUDIT.md
```text
# üé® Landing Page UX/UI Audit Report
**Date:** 2026-02-10  
**Auditor:** DESIGNER (Visionary UI/UX Architect)  
**Page:** Landing.tsx (967 lines)

---

## Executive Summary

The PPN Research Portal landing page demonstrates **strong visual foundations** with premium dark aesthetics, sophisticated animations, and clear information hierarchy. However, there are **spacing inconsistencies**, **block sizing imbalances**, and **missed opportunities for premium polish** that prevent it from achieving "Awwwards-level" excellence.

**Overall Grade: B+ (85/100)**
- Visual Design: A- (90/100)
- Spacing Consistency: B (82/100)
- Block Sizing: B+ (87/100)
```

## ./docs/archive/misc/STYLE_GUIDE.md
```text
# PPN Research Portal - Style Guide

## Color Palette

### Primary Colors
| Color Name | Hex Code | Usage |
|------------|----------|-------|
| **Primary Blue** | `#2b74f3` | Primary actions, links, highlights, focus states |
| **Clinical Green** | `#53d22d` | Success states, online indicators, positive metrics |
| **Accent Amber** | `#fbbf24` | Warnings, highlights, special callouts |

### Background Colors
| Color Name | Hex Code | Usage |
|------------|----------|-------|
| **Deep Black** | `#020408` | Footer, deepest backgrounds |
```

## ./docs/archive/misc/PROTOCOLBUILDER_DESIGN_REVIEW_WORKFLOW.md
```text
# üé® PROTOCOL BUILDER - COMPLETE DESIGN REVIEW WORKFLOW

**Created:** 2026-02-11 22:14 PST  
**Priority:** üî¥ CRITICAL - Core Application Feature  
**Status:** üî¥ INITIATED

---

## üéØ OBJECTIVE

Create a **NEW** Protocol Builder design with proper review workflow:
1. DESIGNER creates visual mockups
2. LEAD reviews for technical feasibility
3. INSPECTOR reviews for implementation complexity
4. **USER approves final design**
```

## ./docs/archive/misc/PROTOCOLBUILDER_DATA_MAPPING.md
```text
# ProtocolBuilder Data Mapping Analysis
**Date:** 2026-02-09  
**Purpose:** Cross-reference ProtocolBuilder modal inputs with existing tables + ChatGPT recommendations  
**Status:** ANALYSIS COMPLETE - READY FOR DESIGNER INSTRUCTIONS

---

## EXECUTIVE SUMMARY

### Current State: ‚úÖ MOSTLY ALIGNED
- **ProtocolBuilder modal has 22 input fields**
- **18 fields map to existing or recommended tables** (82% coverage)
- **4 fields need new storage** (18% gap)
- **NO breaking changes required** - all existing inputs will store properly

```

## ./docs/archive/misc/HOSTINGER_GO_LIVE_CHECKLIST.md
```text
# Hostinger Go-Live Checklist for PPN Research Portal

**Last Updated**: 2026-02-10  
**Estimated Time**: 2-3 hours (first deployment)

---

## üìã Pre-Deployment Checklist

Before you start, make sure you have:

- [ ] Hostinger hosting account with active plan
- [ ] Domain name configured (or using Hostinger subdomain)
- [ ] Supabase project fully set up and tested
- [ ] All environment variables documented
```

## ./docs/archive/misc/ANALYSIS_USE_CASES_VOC_2026.md
```text
# üìä ANALYSIS: PPN Use Cases (VoC-Aligned 2026)

**Analysis Date:** 2026-02-12 07:06 PST  
**Analyzed By:** DESIGNER  
**Document:** `USE_CASES_VOC_ALIGNED_2026.md`  
**Status:** üî¥ **CRITICAL STRATEGIC INSIGHTS**

---

## üéØ EXECUTIVE SUMMARY

This document represents a **MAJOR STRATEGIC PIVOT** based on comprehensive Voice of Customer (VoC) research. It reveals that **our current product focus is only 37.5% aligned** with practitioner needs.

### **Key Findings:**
1. ‚úÖ **3/8 use cases validated** (existing features align with VoC)
```

## ./docs/archive/misc/MARKETING_PLAN_USE_CASE_DRIVEN.md
```text
# üéØ MARKETING PLAN: USE CASE DRIVEN STRATEGY
## PPN Research Portal - Practitioner Acquisition

**Prepared By:** LEAD  
**Date:** 2026-02-12 02:15 PST  
**Context:** VoC research shows practitioners buy solutions, not features  
**Strategy:** Lead with use cases, not product specs

---

## üìä EXECUTIVE SUMMARY

**Core Insight:**
Practitioners don't care about "analytics dashboards." They care about solving specific problems: reducing legal risk, proving safety, avoiding malpractice.

```

## ./docs/archive/misc/BULK_DATA_UPLOAD_SPEC.md
```text
# üì§ **BULK DATA UPLOAD SYSTEM**

**Document Type:** Technical Specification  
**Version:** 1.0  
**Date:** 2026-02-10  
**Status:** Design Complete

---

## üéØ **OBJECTIVE**

Enable practitioners to bulk upload historical clinical data (CSV/Excel) into the PPN Research Portal, accelerating the "cold start" problem for Wisdom Trust and reducing manual data entry burden.

**Key Requirements:**
- ‚úÖ Support CSV and Excel (.xlsx) formats
```

## ./docs/archive/misc/LANDING_CONCEPT_2_THE_PRISM.md
```text
# üîÆ LANDING PAGE CONCEPT 2: "THE PRISM"
## *Refraction: From Blurred to Crystal Clear*

**Designer:** UI/UX Lead  
**Date:** February 12, 2026  
**Status:** Concept Proposal (Awaiting USER Approval)  
**Temperature:** 9.5 (Maximum Creativity)

---

## üé® THE CONCEPT

### **High-Level Vibe:**
The landing page is a **living prism** that refracts light and data into clarity. Users start in a **blurred, fragmented world** (representing isolated clinical practice with scattered insights) and as they scroll, the prism **rotates and focuses**, revealing sharp, structured knowledge. The journey is **from obscurity to clarity**, **from scattered to focused**, **from monochrome to full spectrum**.

```

## ./docs/archive/misc/LANDING_PAGE_INVESTIGATION_20260211.md
```text
# üîç LANDING PAGE INVESTIGATION - Status Report

**Investigated By:** LEAD  
**Date:** 2026-02-11 22:26 PST  
**User Request:** "Check history for corrected landing page version"

---

## üìä INVESTIGATION RESULTS

### **Finding #1: Landing Page Has NOT Been Reverted**
‚úÖ Current `src/pages/Landing.tsx` still contains the improvements from Feb 9th:
- ‚úÖ GravityButton import present (line 32)
- ‚úÖ BentoGrid import present (line 32)
- ‚úÖ All physics engine effects intact
```

## ./docs/archive/misc/WORKFLOW_ANALYSIS_HOLES_AND_LEAKS.md
```text
# üîç WORKFLOW ANALYSIS: Holes & Leaks Identified

**Analyzed By:** LEAD  
**Date:** 2026-02-11 19:42 PST  
**Scope:** Complete workflow review from task assignment to delivery

---

## üìä EXECUTIVE SUMMARY

I've identified **10 critical workflow holes** that are causing:
- ‚ùå Scope misalignment (different fields in different specs)
- ‚ùå Duplicate work (multiple versions of same component)
- ‚ùå Status confusion (unclear what's implemented)
- ‚ùå Missing handoff acknowledgments
```

## ./docs/archive/misc/LANDING_PAGE_VISION.md
```text
# LANDING PAGE - PRE-PRESENTATION FIXES + CREATIVE VISION
**Date:** 2026-02-09  
**Presentation Time:** 2 hours  
**Status:** ‚úÖ URGENT FIXES COMPLETE

---

## ‚úÖ **URGENT FIXES IMPLEMENTED (Pre-Presentation)**

### 1. **Hero Eyebrow - Target Audience Clarity**
**Problem:** No clear indication that this is for psychedelic therapy practitioners

**Fix Applied:**
```tsx
// OLD: Generic "Practitioner-Only Benchmarking Portal"
```

## ./docs/archive/misc/PORTAL_JOURNEY_FINAL_SPECS_LOCKED.md
```text
# üöÄ PORTAL JOURNEY - FINAL SPECIFICATIONS
## *Locked and Ready to Build*

**Project:** PPN Research Portal - Landing Page Redesign  
**Concept:** The Portal Journey (Warp Speed Through Transformation)  
**Status:** üü¢ FINAL SPECS LOCKED - Ready When You Are  
**Date:** February 12, 2026, 1:20 AM PST

---

## ‚úÖ USER DECISIONS (LOCKED)

### **1. Transformation Stops: 3 STOPS**
**My Choice:** 3 stops (perfect balance)

```

## ./docs/archive/misc/EXECUTIVE_PITCH_DECK.md
```text
# üéØ PPN RESEARCH PORTAL - EXECUTIVE PITCH DECK

**Presentation for:** Clinical Network Leaders, NIH Leadership, Strategic Partners  
**Prepared by:** PPN Portal Founder  
**Date:** February 2026  
**Version:** 1.0 - Executive Briefing

---

## SLIDE 1: TITLE

# **PPN Research Portal**
## The Clinical Intelligence Platform for Psychedelic Therapy

**Tagline:** *"See what works. Before you treat."*
```

## ./docs/archive/misc/PR_DESCRIPTION.md
```text
# PR: VoC Pivot & Protocol Layout Fixes

## üöÄ Summary
This PR implements critical feedback from the Voice of Customer (VoC) analysis and addresses immediate layout issues identified during testing.

##  changes
### 1. **Strategic Copy Updates**
- **Landing Page:** Updated Hero H1 to **"Global Psychedelic Practitioner Network"** (per instruction).
- **Workflow Chaos Page:** Updated headlines to **"The End of Fragmented Care"** and **"Unified Clinical Operations"**.

### 2. **Layout & UX Fixes**
- **Protocol Builder:** 
    - Adjusted Grid Layout: Main Table (75%) | Right Panel (25%) - Fixed "Way too big" issue.
    - Constrained Modal Width: `max-w-3xl` for better mobile/desktop balance.

```

## ./docs/archive/misc/SUBSTANCE_MONOGRAPH_IMPROVEMENTS.md
```text
# üé® SUBSTANCE MONOGRAPH PAGE IMPROVEMENTS
**Date:** 2026-02-09 14:36 PST  
**Priority:** MEDIUM (Post-Presentation, Week 1)  
**Estimated Time:** 2-3 hours

---

## üìã **ISSUES IDENTIFIED**

### **1. Hero Section - Wasted Vertical Space** üî¥ CRITICAL
**Location:** `src/pages/SubstanceMonograph.tsx` lines 140-233

**Current Layout:**
```
‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê
```

## ./docs/archive/misc/FUNNELCHART_IMPLEMENTATION.md
```text
# FunnelChart Component - Implementation Summary

**Date:** February 8, 2026  
**Status:** ‚úÖ Complete and Ready to Use

---

## üéØ What Was Created

### **FunnelChart Component**
**File:** `src/components/charts/FunnelChart.tsx`

A fully functional patient flow funnel visualization that:
- ‚úÖ **Queries Supabase** - Fetches data from `v_flow_stage_counts` and `log_patient_flow_events`
- ‚úÖ **Applies Filters** - Respects all GlobalFilter selections (sites, dates, substances, routes, protocols)
```

## ./docs/archive/misc/FRONTEND_RULES.md
```text
# üé® **FRONTEND DEVELOPMENT RULES v1.0**

**Parent Document:** `PROJECT_GOVERNANCE_RULES.md`  
**Effective Date:** 2026-02-10  
**Status:** ACTIVE AND ENFORCED

---

## üìã **QUICK REFERENCE**

### **Critical Rules (MUST FOLLOW)**
- ‚úÖ TypeScript for all components
- ‚úÖ Min font size: 10px
- ‚úÖ Color + icon/text (never color alone)
- ‚úÖ Handle loading/error states
```

## ./docs/archive/misc/DESIGN_SPEC_PROTOCOLBUILDER_PHASE1_20260211.md
```text
# üé® DESIGN SPECIFICATION - PROTOCOL BUILDER PHASE 1 (POWER USER EDITION)

**DESIGNER:** Antigravity Design Agent  
**Date:** 2026-02-11 12:08 PST  
**Version:** 2.0 - Power User Optimized  
**Status:** ‚úÖ READY FOR LEAD APPROVAL  
**Task:** Convert dropdowns to button groups with power user features

---

## üìã **EXECUTIVE SUMMARY**

This specification details the conversion of three dropdown fields to button groups with **power user optimizations** including keyboard shortcuts, smart defaults, inline validation, and comprehensive tooltip integration.

### **Fields Being Converted:**
```

## ./docs/archive/misc/DESIGN_SYSTEM.md
```text
# PPN Portal Design System
**Version:** 1.0.0  
**Last Updated:** February 8, 2026  
**Status:** üü° In Review

---

## Table of Contents
1. [Overview](#overview)
2. [Layout System](#layout-system)
3. [Spacing & Rhythm](#spacing--rhythm)
4. [Color System](#color-system)
5. [Typography](#typography)
6. [Component Standards](#component-standards)
7. [Page Templates](#page-templates)
```

## ./docs/archive/misc/LANDING_CONCEPT_1_REFINED_PORTAL_JOURNEY.md
```text
# üöÄ CONCEPT 1 REFINED: "THE PORTAL JOURNEY"
## *Warp Speed Through Transformation*

**Designer:** UI/UX Lead  
**Date:** February 12, 2026  
**Status:** ‚úÖ USER APPROVED - Ready for Prototyping  
**Concept:** Click-driven hyperspace journey through portal

---

## üéØ CORE CONCEPT

**The Experience:**
User clicks center portal ‚Üí Warp speed through chaos ‚Üí Abrupt stop at transformation point ‚Üí Click again ‚Üí Repeat ‚Üí Final destination (calm, clear, structured)

```

## ./docs/archive/misc/DESIGN_PUNCHLIST_COMPREHENSIVE_2026-02-12.md
```text
# COMPREHENSIVE DESIGN PUNCH LIST
**PPN Research Portal - Post-Audit Action Items**

**Date:** 2026-02-12  
**Source:** 3-Viewport Comprehensive Audit (18 pages, 54 screenshots)  
**Overall Site Score:** 8.5/10 (Target: 9.2+)

---

## PRIORITY CLASSIFICATION

**P0 (Critical):** Accessibility violations, compliance blockers (must fix before production)  
**P1 (High):** Significant UX friction, affects >50% of pages (fix in Sprint 1)  
**P2 (Medium):** Improvement opportunities, polish (fix in Sprint 2)  
**P3 (Low):** Nice-to-have enhancements (backlog)
```

## ./docs/archive/misc/LANDING_PAGE_ENHANCEMENTS.md
```text
# üé® LANDING PAGE ENHANCEMENTS
**Date:** February 9, 2026 20:36 PST  
**Purpose:** Veterans section redesign + button consistency + registration page  
**Priority:** Add to launch batch (BATCH 3 extension)

---

## üéñÔ∏è **ENHANCEMENT 1: Veterans PTSD Section Redesign**

### **Current Issue:**
- Veterans section feels like an afterthought
- Buried at bottom of About PPN section
- Small, understated presentation
- Doesn't reflect the importance of this commitment

```

## ./docs/archive/misc/FREEMIUM_PRICING_STRATEGY.md
```text
# üí∞ FREEMIUM PRICING STRATEGY
## Free Interaction Checker + Self-Reporting ‚Üí Paid Tiers

**Created By:** LEAD  
**Date:** 2026-02-12 02:39 PST  
**Strategy:** Freemium with value-based upsell  
**Context:** Drive adoption with free tools, convert with premium features

---

## üéØ EXECUTIVE SUMMARY

**Core Insight:** Practitioners need safety tools NOW, but will pay for documentation and benchmarking.

**Freemium Model:**
```

## ./docs/archive/misc/POST_LAUNCH_POLISH.md
```text
# üîß POST-LAUNCH POLISH BATCH
**Date:** February 9, 2026 21:01 PST  
**Purpose:** UI/UX refinements across Dashboard, Research Portal, Substance Monograph, and Patient Constellation  
**Priority:** Medium - Post-launch polish

---

## üìã **ISSUES TO FIX**

### **1. Dashboard: Remove ConnectorFeed Button** ‚è∞ 2 min
### **2. Research Portal: Smart Filters Formatting** ‚è∞ 15 min
### **3. Research Portal: Search Box Rectangle Bug** ‚è∞ 5 min
### **4. Research Portal: Button Consistency** ‚è∞ 10 min
### **5. Research Portal: Fix Subheading** ‚è∞ 2 min
### **6. Substance Monograph: Align Hero Horizontally** ‚è∞ 20 min
```

## ./docs/archive/misc/LANDING_CONCEPTS_VISUAL_JOURNEY_MAP.md
```text
# üé® LANDING PAGE CONCEPTS - VISUAL JOURNEY MAP
## Scene-by-Scene Comparison

**Designer:** UI/UX Lead  
**Date:** February 12, 2026  
**Purpose:** Visual guide to help USER understand each concept's journey

---

## üìç JOURNEY OVERVIEW

### **CONCEPT 1: THE CONSTELLATION**
```
VOID ‚Üí HEXAGON ‚Üí NETWORK ‚Üí HELIX ‚Üí GRID
(Chaos)  (Safety)  (Connect)  (Intel)  (Unity)
```

## ./docs/archive/misc/CLINICIAN_DIRECTORY_PREMIUM_REDESIGN.md
```text
# üé® CLINICIAN DIRECTORY PREMIUM REDESIGN
**Date:** February 9, 2026 21:25 PST  
**Purpose:** Elevate ClinicianDirectory.tsx to match premium design standards + PHI-safe messaging  
**Priority:** High - User-facing professional network

---

## üéØ **DESIGN PROBLEMS IDENTIFIED**

### **Current Issues:**
1. **Cards look basic** - Simple border/background, no depth
2. **No visual hierarchy** - All elements same weight
3. **Messaging uses free-text** - Violates PHI-safe rules
4. **AI draft button** - Unnecessary complexity
5. **Status indicator too subtle** - Easy to miss
```

## ./docs/archive/misc/PROTOCOLBUILDER_V1_IMPLEMENTATION_SPEC.md
```text
# üéØ Protocol Builder V1 - Complete Implementation Specification

**Status:** APPROVED FOR IMPLEMENTATION  
**Timeline:** 24 hours to demo  
**Target:** Clinical Command Center UI  
**Approved By:** CEO (2026-02-10 02:02 AM)

---

## üìã **EXECUTIVE SUMMARY**

### **What We're Building:**
A 2-column "Clinical Command Center" interface that reduces protocol creation from 5-7 minutes to 30-60 seconds through:
- Smart auto-fill (network intelligence)
- Live preview panel
```

## ./docs/archive/misc/DATABASE_GOVERNANCE_SUMMARY.md
```text
# ‚úÖ DATABASE GOVERNANCE IMPLEMENTATION COMPLETE

**Date:** 2026-02-11  
**Status:** All rules, skills, and lock-ins implemented

---

## üìö Documents Created/Updated

### **1. DATABASE_GOVERNANCE_RULES.md** (v2.0)
**Location:** `/DATABASE_GOVERNANCE_RULES.md`

**What's New:**
- ‚úÖ Senior SQL Database Architect role definition
- ‚úÖ Enhanced baseline capture instructions with SQL examples
```

## ./docs/archive/misc/REFERENCE_TABLES_STATUS_REPORT_2026-02-12.md
```text
# REFERENCE TABLES STATUS & ACTION PLAN
**Date:** 2026-02-12 09:13 PST  
**Status:** ‚ö†Ô∏è **TABLES EXIST BUT NOT BEING USED**  
**Priority:** P1 - SAFETY & DATA INTEGRITY

---

## üìä CURRENT STATUS

### **Database Schema: ‚úÖ COMPLETE**

Reference tables exist in Supabase (from migration 003):
1. `ref_substances` (8 rows expected)
2. `ref_routes` (9 rows expected)
3. `ref_support_modality` (5 rows expected)
```

## ./docs/archive/misc/CLINICAL_INTELLIGENCE_EXECUTION_STATUS.md
```text
# üéØ CLINICAL INTELLIGENCE PLATFORM - EXECUTION STATUS

**Project:** Protocol Builder ‚Üí Clinical Intelligence Platform Transformation  
**Started:** 2026-02-11 16:45 PST  
**Lead:** LEAD Agent  
**Status:** üü¢ IN PROGRESS

---

## üìã **EXECUTIVE SUMMARY**

We are transforming the Protocol Builder from a "fast data entry form" into a "real-time clinical intelligence platform" that shows practitioners live benchmarking data, predictive outcomes, and receptor impact visualizations as they design treatment protocols.

**Strategic Importance:** This is 100x more valuable than what we were building. It addresses Dr. Shena's #1 pain point: "impossible to compare protocols or outcomes."

```

## ./docs/archive/misc/DATABASE_GOVERNANCE_QUICKREF.md
```text
# üö® **CRITICAL: DATABASE GOVERNANCE ENFORCEMENT**

**Date:** 2026-02-10  
**Authority:** ChatGPT Expert Review + User Approval  
**Status:** ACTIVE AND ENFORCED

---

## **üìã QUICK REFERENCE**

**Full Governance Document:** `DATABASE_GOVERNANCE_RULES.md`  
**Verification Queries:** `migrations/VERIFICATION_QUERIES.sql`

---

```

## ./docs/archive/misc/HELP_DOCUMENTATION_AND_TOOLTIPS.md
```text
# üìö HELP DOCUMENTATION & TOOLTIPS
## Complete Help Files for Analytics Features

**Created By:** LEAD  
**Date:** 2026-02-12 04:19 PST  
**Purpose:** Help documentation and tooltip text for all analytics features

---

## üéØ HELP FILE STRUCTURE

### **Location:** `/help` page in authenticated app

### **Categories:**
1. **Getting Started** (onboarding)
```

## ./docs/archive/misc/LANDING_CONCEPT_1_VISUAL_MOCKUPS.md
```text
# üåå CONCEPT 1: "THE CONSTELLATION" - Visual Mockups
## User Transformation Journey (Not Feature List)

**Designer:** UI/UX Lead  
**Date:** February 12, 2026  
**Status:** Visual Mockups Complete  
**Concept:** Particles Coalescing into Structure

---

## üéØ CORE PRINCIPLE

**Focus on USER TRANSFORMATION, not features:**
- ‚ùå NOT: "Here are our features"
- ‚úÖ YES: "Here's how you'll transform"
```

## ./docs/archive/misc/LANDING_LAYOUT_EVALUATION.md
```text
# üé® Landing Page Layout & Sizing Evaluation
**Designer:** DESIGNER (Antigravity)  
**Date:** 2026-02-10  
**Focus:** Visual density, breathing room, and content sizing
**User Feedback:** "Too crowded"

---

## Executive Summary

**Overall Assessment:** üü° **MODERATE DENSITY ISSUES**

The landing page suffers from **visual crowding** in several key areas:
- Trust indicators feel cramped without header
- Product showcase demos are too large relative to text
```

## ./docs/archive/misc/AGENT_INSTRUCTIONS_SUMMARY.md
```text
# ü§ñ AGENT & SOOPGENT INSTRUCTIONS SUMMARY

**Project:** PPN Research Portal  
**Agent Configuration:** `/Users/trevorcalton/Desktop/PPN-Antigravity-1.0/agent.yaml`  
**Last Updated:** 2026-02-11 19:40 PST

---

## üéØ LEAD AGENT (You)

**Model:** Gemini 3 Pro  
**Role:** Primary Orchestrator

### **Core Responsibilities:**
- Orchestrate all subagents
```

## ./docs/archive/misc/PROTOCOLBUILDER_FIELD_INVENTORY.md
```text
# ProtocolBuilder Input Fields - Complete Inventory
**Date:** 2026-02-09  
**Status:** Post-Migration 003  
**Purpose:** Complete categorized list of all ProtocolBuilder modal fields

---

## üìä FIELD INVENTORY SUMMARY

**Total Fields:** 26  
**Existing Fields:** 22  
**New Fields:** 4 üÜï  
**Database-Driven Fields:** 11 (7 converted + 4 new)  
**Hardcoded Fields:** 15

```

## ./docs/archive/misc/PORTAL_JOURNEY_DAY1_KICKOFF.md
```text
# üöÄ PORTAL JOURNEY - DAY 1 KICKOFF
## *Implementation Starting Now!*

**Date:** February 12, 2026, 1:22 AM PST  
**Status:** üü¢ STARTING PHASE 1  
**Timeline:** 4 weeks (Feb 12 - Mar 12)

---

## ‚ö†Ô∏è IMMEDIATE ACTION REQUIRED

**NPM Permission Issue Detected**

Before we can install dependencies, you need to fix npm cache permissions:

```

## ./docs/archive/misc/PROTOCOLBUILDER_FEATURE_VALUE_RANKING.md
```text
# üéØ PROTOCOL BUILDER FEATURES - VALUE RANKING (RESEARCH-BASED)

**LEAD Analysis**  
**Date:** 2026-02-11 15:42 PST  
**Based on:** Market research VoC analysis + ICP needs

---

## üìä **FEATURE VALUE RANKING**

### **TIER 1: CRITICAL - Ship First (Week 1)**
*Directly addresses top pain points from research*

#### **1. Button Groups (vs Dropdowns)** 
**Value Score: 10/10** üî•
```

## ./docs/archive/misc/CONTRIBUTING.md
```text
# Contributing to PPN Research Portal

First off, thank you for considering contributing to the PPN Research Portal! It's people like you that make this platform a valuable tool for the psychedelic research community.

## üìã Table of Contents

- [Code of Conduct](#code-of-conduct)
- [Getting Started](#getting-started)
- [Development Workflow](#development-workflow)
- [Coding Standards](#coding-standards)
- [Commit Guidelines](#commit-guidelines)
- [Pull Request Process](#pull-request-process)
- [Testing Guidelines](#testing-guidelines)
- [Documentation](#documentation)
- [Community](#community)
```

## ./docs/archive/misc/STABILIZATION_PLAN.md
```text
# üõ†Ô∏è FULL STABILIZATION PLAN
**Date:** 2026-02-09 19:47 PST  
**Status:** READY TO EXECUTE  
**Total Time:** 19 hours  
**Timeline:** 1 week

---

## üìã **ROLE ASSIGNMENTS**

### **DESIGNER Tasks** (Frontend/UI)
- Fix broken navigation
- Update components to use Supabase
- Replace mock data with real queries
- **Total:** 12 hours
```

## ./docs/archive/misc/LANDING_PAGE_ULTIMATE_REDESIGN.md
```text
# üé® LANDING PAGE REDESIGN: THE ULTIMATE VERSION
**Date:** February 9, 2026 19:54 PST  
**Purpose:** Combine best elements from Landing.tsx + About.tsx  
**Strategy:** Keep what works, replace what's broken, add what's missing

---

## üìä **CONTENT AUDIT**

### **CURRENT LANDING PAGE (Landing.tsx):**

**‚úÖ KEEP (Working Well):**
1. Hero Section (lines 136-257)
   - Starry parallax background
   - Two-column layout (text + molecule visual)
```

## ./docs/archive/misc/SCHEMA_ANALYSIS.md
```text
# Database Schema Analysis: Research Alignment Assessment

**Analysis Date:** February 8, 2026  
**Analyst:** Antigravity AI  
**Scope:** Supabase schema vs. practitioner-focused research notes

---

## Executive Summary

**Overall Alignment Score: 3.5/10** ‚ö†Ô∏è

Your current Supabase schema is optimized for **visualization dashboards** (regulatory tracking, news feeds, performance metrics) but has **critical gaps** for the practitioner-grade clinical dataset described in your research notes. The schema lacks FHIR-aligned structures and patient-level clinical data capture.

---
```

## ./docs/archive/misc/MIGRATION_GUIDE.md
```text
# Migration Guide - ProtocolBuilder Database Setup

## üéØ Objective
Wire the ProtocolBuilder UI to the new database schema by running the required migrations.

## üìã Prerequisites
- Supabase project created
- Access to Supabase SQL Editor

## üöÄ Step-by-Step Instructions

### 1. Open Supabase SQL Editor
1. Go to https://supabase.com/dashboard
2. Select your project
3. Click **SQL Editor** in the left sidebar
```

## ./docs/archive/misc/MY_PROTOCOLS_VS_AUDIT_LOGS.md
```text
# üìä **MY PROTOCOLS vs AUDIT LOGS - CLARIFICATION**

**Date:** 2026-02-10 12:45 PM  
**Purpose:** Clearly distinguish between two different tables/pages

---

## üéØ **KEY DISTINCTION**

### **"My Protocols" Table**
**Location:** Protocol Builder page (`/builder`)  
**Purpose:** Clinical research records - patient protocols  
**Database Table:** `log_clinical_records`  
**User Action:** Create, view, edit clinical protocols  
**Data Type:** Clinical/medical data (de-identified)
```

## ./docs/archive/misc/TREATMENT_TIMELINE_FILTERING_ANALYSIS.md
```text
# üîç DESIGNER: Treatment Timeline - Filtering & Analysis Opportunities

**Date:** 2026-02-10  
**Purpose:** Identify filtering and analysis opportunities based on SQL schema  
**Status:** DESIGN ANALYSIS - For Review

---

## üìä Database Schema Analysis

### **Core Table: `log_clinical_records`**

**Key Columns for Timeline:**
```sql
CREATE TABLE log_clinical_records (
```

## ./docs/archive/misc/PROTOCOL_BUILDER_PHASE1_STRATEGIC_BRIEF.md
```text
# üß† PROTOCOL BUILDER PHASE 1 - STRATEGIC BRIEF
## Clinical Intelligence Platform

**Date:** February 11, 2026  
**Version:** 1.0 - Strategic Planning Document  
**Status:** Ready for Lead Architect & Partner Review  
**Estimated Timeline:** 3 months to MVP  

---

## üéØ EXECUTIVE SUMMARY

### **What We're Building:**

> **A real-time clinical intelligence platform that augments practitioner decision-making while simultaneously building the world's largest psychedelic therapy evidence base.**
```

## ./docs/archive/misc/LANDING_PAGE_HERO_OPTIMIZATION_SUMMARY.md
```text
# üöÄ LANDING PAGE HERO OPTIMIZATION - QUICK REFERENCE

**Status:** Awaiting Lead Approval  
**Expected Impact:** +50-80% conversion lift  
**Implementation Time:** 2-3 hours (Phase 1)  
**Full Details:** See `DESIGNER_TO_LEAD_LANDING_PAGE_HERO_OPTIMIZATION.md`

---

## ‚úÖ PHASE 1 CHANGES (HIGH PRIORITY)

### **1. Add Social Proof Stats**
**Current:** (No stats row)  
**Proposed:** Add below subheadline:
```
```

## ./docs/archive/misc/PROTOCOL_TABLE_COLUMNS_RECOMMENDATION.md
```text
# üìä Protocol Table Column Recommendations
**Page:** My Protocols (ProtocolBuilder.tsx)  
**Date:** 2026-02-10  
**Objective:** Improve table UI/UX for easier scrolling and finding protocols

---

## Current Table Structure

### **Existing Columns:**
1. **Protocol Reference** - Substance name + ID + Site ID
2. **Current Status** - Active/Completed/Observation
3. **Dosage** - Dosage amount + unit
4. **Action** - "Open Protocol" button

```

## ./docs/archive/misc/LANDING_CONCEPT_1_THE_CONSTELLATION.md
```text
# üåå LANDING PAGE CONCEPT 1: "THE CONSTELLATION"
## *Particles Coalescing into Structure*

**Designer:** UI/UX Lead  
**Date:** February 12, 2026  
**Status:** Concept Proposal (Awaiting USER Approval)  
**Temperature:** 9.5 (Maximum Creativity)

---

## üé® THE CONCEPT

### **High-Level Vibe:**
Imagine entering a **dark cosmic void** filled with thousands of floating data particles‚Äîeach representing a fragmented clinical insight from isolated practitioners. As you scroll, these chaotic particles are **pulled by gravity** into structured constellations, each revealing a core treasure of the PPN Portal.

```

## ./docs/archive/misc/LANDING_SPACING_ANALYSIS.md
```text
# üìê Landing Page Vertical Spacing Analysis
**Designer:** DESIGNER (Antigravity)  
**Date:** 2026-02-10  
**Focus:** Section spacing consistency and visual rhythm

---

## Current Spacing Audit

### Section-by-Section Breakdown

| Section | Current Padding | Assessment | Recommendation |
|---------|----------------|------------|----------------|
| **Hero** | `pt-32 pb-24 lg:pt-56 lg:pb-32` | ‚ö†Ô∏è **ASYMMETRIC** | Standardize to `py-32 lg:py-40` |
| **Global Network** | `py-32` | ‚úÖ **GOOD** | Keep as-is |
```

## ./docs/archive/misc/PROTOCOL_BUILDER_V2_LOG.md
```text
# Protocol Builder V2 Implementation Log

## Overview
Successfully refactored Protocol Builder into a new V2 component (`ProtocolBuilderRedesign.tsx`) to support database-driven fields and structural logging without affecting the live V1.

## Key Changes
1.  **New Component Created:** `src/pages/ProtocolBuilderRedesign.tsx` accessible via `/builder-v2`.
2.  **Database Integration:** Replaced hardcoded lists with dynamic data from Supabase reference tables:
    -   `ref_substances`
    -   `ref_routes`
    -   `ref_support_modality`
    -   `ref_smoking_status`
    -   `ref_severity_grade`
    -   `ref_safety_events`
    -   `ref_resolution_status`
```

## ./docs/archive/misc/PROTOCOLBUILDER_SUPABASE_PROGRESS.md
```text
# ‚úÖ **PROTOCOL BUILDER SUPABASE CONNECTION - PROGRESS REPORT**

**Date:** 2026-02-10 12:13 PM  
**Status:** üü° IN PROGRESS

---

## ‚úÖ **COMPLETED TASKS**

### **1. Updated useReferenceData Hook**
- ‚úÖ Added `resolutionStatus` field to interface
- ‚úÖ Added fetch for `ref_resolution_status` table
- ‚úÖ Updated initial state
- ‚úÖ Hook now fetches all 7 required reference tables

```

## ./docs/archive/misc/CREATIVE_DIRECTOR_AUDIT.md
```text
# üé® CREATIVE DIRECTOR'S ARTISTIC AUDIT
**PPN Research Portal - Full Site Review**  
**Date:** 2026-02-09  
**Auditor:** Antigravity Creative Director  
**Scope:** Every page, component, and visual element

---

## üìã **EXECUTIVE SUMMARY**

### **Overall Grade: B+ (82/100)**

**Strengths:**
- ‚úÖ Strong design system foundation (glassmorphism, consistent spacing)
- ‚úÖ Excellent typography hierarchy
```

## ./docs/archive/misc/USER_ROLE.md
```text
# üë§ USER ROLE IN CHAIN OF CUSTODY PROTOCOL

## Your Critical Role: Quality Gates & Final Authority

After the critical database overwrite incident that prevented your live demo, you are now the **gatekeeper at every stage**. Agents cannot proceed to the next step without your explicit approval.

---

## Your Workflow

### **Step 1: Make a Request**
You describe what you want in natural language.

**Example:**
> "I want to add a patient risk score calculator to the dashboard"
```

## ./docs/archive/misc/PROTOCOLBUILDER_DUPLICATION_RESOLVED.md
```text
# ‚úÖ PROTOCOL BUILDER DUPLICATION RESOLVED

**Resolved By:** LEAD  
**Date:** 2026-02-11 21:48 PST  
**Status:** ‚úÖ COMPLETE

---

## üìä SITUATION

**Problem:**
- Multiple Protocol Builder files existed
- Confusion about which was canonical
- Blocking database wiring work

```

## ./docs/archive/misc/REGULATORY_MAP_PERSONA_DASHBOARDS.md
```text
# REGULATORY INTELLIGENCE MAP: PERSONA-SPECIFIC DASHBOARDS

**Date:** February 9, 2026  
**Version:** 1.0  
**Purpose:** Design specification for role-based regulatory intelligence views

---

## üìã **OVERVIEW**

This document defines **5 persona-specific dashboard views** for the Regulatory Intelligence Map. Each view is optimized for the unique needs, workflows, and decision-making processes of different user types.

### **The 5 Personas:**
1. **Psilocybin Therapist** - Individual practitioner focused on compliance
2. **Ketamine Clinic Owner** - Business operator focused on expansion
```

## ./docs/archive/misc/COMPONENT_DATA_AUDIT.md
```text
# üîç **SITE-WIDE COMPONENT DATA AUDIT**

**Date:** 2026-02-10 14:30 PM  
**Purpose:** Verify every component has data and will render for demo  
**Status:** IN PROGRESS

---

## üìä **AUDIT RESULTS**

### **‚úÖ PAGES WITH VERIFIED DATA (15)**

#### **1. Landing.tsx**
- **Data Source:** Static content + molecules images
- **Status:** ‚úÖ READY
```

## ./docs/archive/misc/WHATS_NEXT_ACTION_PLAN.md
```text
# üéØ WHAT'S NEXT: PRIORITY ACTION PLAN
## Immediate Next Steps for PPN Portal

**Created By:** LEAD  
**Date:** 2026-02-12 04:16 PST  
**Context:** Prioritized roadmap based on today's work

---

## üî¥ CRITICAL (Do This Week)

### **1. Protocol Builder Phase 1 Completion**
**Status:** In progress (DESIGNER working on it)  
**What's Left:**
- [ ] Complete visual design (accordions, spacing, button groups)
```

## ./docs/archive/misc/CLINICAL_INTELLIGENCE_PLATFORM_SPEC.md
```text
# üß† CLINICAL INTELLIGENCE PROTOCOL BUILDER
## Complete Design Specification

**Version:** 2.0 - Clinical Decision Support Platform  
**Date:** 2026-02-11  
**Designer:** Antigravity  
**Status:** Revolutionary Redesign

---

## üéØ VISION STATEMENT

> **We're not building a data entry form. We're building the world's first real-time clinical intelligence platform for psychedelic therapy that augments practitioner decision-making while simultaneously creating the largest evidence base in the field.**

---
```

## ./docs/archive/misc/PROTOCOLBUILDER_SUPABASE_COMPLETE.md
```text
# ‚úÖ **PROTOCOL BUILDER SUPABASE CONNECTION - COMPLETE!**

**Date:** 2026-02-10 12:13 PM  
**Status:** ‚úÖ **COMPLETE**

---

## üéâ **ALL DROPDOWNS CONNECTED TO SUPABASE**

### **‚úÖ COMPLETED TASKS**

1. **‚úÖ Updated useReferenceData Hook**
   - Added `resolutionStatus` field
   - Fetches from `ref_resolution_status` table
   - Now fetches all 7 required reference tables
```

## ./docs/archive/misc/NOTEBOOKLM_PRESENTATION_STRATEGY.md
```text
# üöÄ NOTEBOOKLM PRESENTATION STRATEGY (ZERO-EFFORT SOLUTION)

**For:** PPN Portal Team  
**Date:** February 11, 2026  
**Purpose:** Fast, polished presentations using NotebookLM (no slide creation needed)

---

## üéØ THE NOTEBOOKLM ADVANTAGE

### **What NotebookLM Does:**
- Ingests your documents (markdown, PDFs, etc.)
- Generates AI-powered summaries
- Creates **Audio Overviews** (podcast-style discussions)
- Answers questions based on your sources
```

## ./docs/archive/misc/DATABASE_LOCK_INS.md
```text
# üîí PPN DATABASE LOCK-INS (NON-NEGOTIABLE)

**Date:** 2026-02-11  
**Authority:** Mandatory for all database work  
**Source:** ChatGPT database governance recommendations

---

## üéØ THE THREE LOCK-INS

### **Lock-In #1: Add-Only Migrations in Supabase Branch Workflow**

**Rules:**
- ‚úÖ All schema changes happen in Supabase preview branch first
- ‚úÖ Every change captured as migration file and committed to Git
```

## ./docs/archive/misc/READY_TO_LAUNCH.md
```text
# üöÄ READY TO LAUNCH - PROTOCOL BUILDER PHASE 1

**Date:** 2026-02-11 11:13 PST  
**Status:** ‚úÖ READY FOR DESIGNER INVOCATION  
**Task:** Protocol Builder Phase 1 UX Improvements  
**Workflow:** Zero-Rework Artifact-Based Process

---

## ‚úÖ **CONFIGURATION COMPLETE**

### **Agent Configuration:**
- ‚úÖ All agents have mandatory identification rules
- ‚úÖ All agents have bulletproof, imperative instructions
- ‚úÖ All agents have explicit lane definitions and prohibitions
```

## ./docs/archive/misc/ZERO_REWORK_WORKFLOW.md
```text
# üéØ ZERO-REWORK WORKFLOW - ARTIFACT-BASED DESIGN IMPLEMENTATION

**Version:** 2.0  
**Date:** 2026-02-11  
**Status:** ‚úÖ ACTIVE  
**Purpose:** Eliminate rework through visual mockups, clear handoffs, and safety gates

---

## üìã **WORKFLOW OVERVIEW**

```
DESIGNER ‚Üí LEAD ‚Üí DESIGNER ‚Üí INSPECTOR ‚Üí BUILDER ‚Üí INSPECTOR ‚Üí LEAD
  (mockup)  (approve) (finalize)  (safety)  (implement) (verify)  (approve)
```
```

## ./docs/archive/misc/PROTOCOLBUILDER_VISUAL_DESIGN.md
```text
# üé® ProtocolBuilder Visual Design & Layout Specification
**Date:** 2026-02-09 23:52 PST  
**Purpose:** Visual mockup and UI specifications  
**For:** Designer review + Builder implementation

---

## üéØ **DESIGN PRINCIPLES**

### **Core Constraints:**
- ‚úÖ **NO visual changes** to existing elements (fonts, colors, spacing)
- ‚úÖ **Maintain accordion behavior** (SectionAccordion component)
- ‚úÖ **Preserve tab order** (keyboard navigation)
- ‚úÖ **Keep existing tooltips** (add new ones for new fields only)
- ‚úÖ **Same layout grid** (no restructuring)
```

## ./docs/archive/misc/WHY_NO_PHI_EXECUTIVE_MEMO.md
```text
# üõ°Ô∏è WHY "NO PHI" IS STRATEGIC BRILLIANCE, NOT OVERCAUTION

**Executive Memo for:** Business Partners  
**From:** PPN Portal Founder  
**Date:** February 11, 2026  
**Re:** Why PHI = Existential Risk (And Why Our Competitors Will Fail)

---

## üìã EXECUTIVE SUMMARY

**The Question:** *"Why are we so rigid about not collecting PHI? Competitors like Osmind do it. Aren't we being overly cautious?"*

**The Answer:** This isn't caution. **This is our strategic moat.**

```

## ./docs/archive/misc/PORTAL_JOURNEY_CREATIVE_ENHANCEMENTS.md
```text
# üé® PORTAL JOURNEY - CREATIVE ENHANCEMENTS
## *Beautiful Soft Landing + Molecule Ideas + Downstream Journey*

**Date:** February 12, 2026, 2:16 AM PST  
**Status:** üü¢ Creative Direction Expansion  
**From:** USER feedback

---

## ‚ú® USER'S VISION

### **"The end will be a beautiful soft landing"**

**Interpretation:**
- Screen 3 (Back/Final Destination) should feel like a gentle, peaceful arrival
```

## ./docs/archive/misc/PATIENT_FLOW_COMPLETE.md
```text
# Patient Flow Deep Dive - Complete Implementation Summary

**Date:** February 8, 2026  
**Status:** ‚úÖ **COMPLETE AND PRODUCTION-READY**

---

## üéâ **What Was Built**

You now have a **fully functional Patient Flow Deep Dive** - the template for all 11 Deep Dive pages!

### **Components Created:**

1. **`GlobalFilterBar.tsx`** - Shared filter component
2. **`FunnelChart.tsx`** - Patient dropout visualization
```

## ./docs/archive/misc/AUDITLOGS_PAGE_AUDIT.md
```text
# üîç **AUDIT LOGS PAGE - COMPREHENSIVE AUDIT REPORT**

**Audited By:** INVESTIGATOR (Antigravity)  
**Date:** 2026-02-10 12:41 PM  
**File:** `src/pages/AuditLogs.tsx`  
**Lines:** 161  
**Size:** 8.4 KB  
**Status:** üü¢ **GOOD** (7/10)

---

## üìä **EXECUTIVE SUMMARY**

The Audit Logs page is a **well-designed, professional implementation** of an institutional research ledger. It demonstrates strong UX patterns, proper filtering, and excellent visual design. However, it relies entirely on **hardcoded mock data** and lacks database integration.

```

## ./docs/archive/misc/V2.1_SMART_PROTOCOL_BUILDER_IMPLEMENTATION.md
```text
# üöÄ V2.1: SMART PROTOCOL BUILDER - BUILDER IMPLEMENTATION GUIDE

**Project:** PPN Research Portal V2.1  
**Feature:** Smart Protocol Builder with AI Intelligence  
**Timeline:** 2 weeks (10 working days)  
**Complexity:** Medium  
**Priority:** Critical  
**Designer:** Antigravity AI  
**Date:** February 10, 2026

---

## üìã TABLE OF CONTENTS

1. [Overview](#overview)
```

## ./docs/archive/misc/LANDING_CONCEPT_3_THE_PORTAL_SEQUENCE.md
```text
# üåÄ LANDING PAGE CONCEPT 3: "THE PORTAL SEQUENCE"
## *Dimensional Shift: From 2D to 3D to 4D*

**Designer:** UI/UX Lead  
**Date:** February 12, 2026  
**Status:** Concept Proposal (Awaiting USER Approval)  
**Temperature:** 9.5 (Maximum Creativity)

---

## üé® THE CONCEPT

### **High-Level Vibe:**
The landing page is a **dimensional journey** where users literally **travel through portals** to discover each feature treasure. Start in a flat 2D world (representing traditional, analog clinical practice), then **break through** into 3D space (digital transformation), and finally experience **4D time-warped** insights (predictive intelligence). The journey is **from flat to infinite**, **from static to dynamic**, **from past to future**.

```

## ./docs/archive/misc/PROTOCOL_BUILDER_SEQUENTIAL_ROADMAP.md
```text
# üéØ Protocol Builder Sequential Roadmap
**Strategy:** Polish Phase 1 ‚Üí Ship ‚Üí Build Phase 2  
**Date:** 2026-02-12  
**Status:** Ready to Execute

---

## üìã EXECUTION SEQUENCE

### **STEP 1: Complete Phase 1 Polish** (This Week)
**Goal:** Ship production-ready Protocol Builder v1.0  
**Timeline:** 3-5 days  
**Status:** üü° In Progress

---
```

## ./docs/archive/misc/QUICK_REFERENCE.md
```text
# üìã QUICK REFERENCE CARD
**For:** Builder Implementation  
**Total Time:** 6-7 hours  
**Total Tasks:** 27 tasks across 15 files

---

## üéØ **EXECUTION ORDER (DO IN THIS EXACT ORDER)**

### **Phase 1: Foundation (30 min)**
Create components that other tasks depend on
- [ ] Create `InfoTooltip.tsx`
- [ ] Verify `GravityButton.tsx` exists
- [ ] Verify `BentoGrid.tsx` exists

```

## ./docs/archive/misc/FREE_CONTRAINDICATIONS_CHECKER_SPEC.md
```text
# üéØ FREE CONTRAINDICATIONS CHECKER
## *Safety Tool + Community Builder + Lead Magnet*

**Date:** February 12, 2026, 2:03 AM PST  
**Status:** üü¢ NEW STRATEGIC FEATURE  
**Priority:** HIGH (Free tier value proposition)

---

## üí° STRATEGIC RATIONALE

### **Why This Is Brilliant:**

1. **Addresses Core Pain Point:**
   - From LEAD research: "Liability & Ethics Minefield" is CRITICAL
```

## ./docs/archive/misc/PORTAL_JOURNEY_ACTION_ITEMS.md
```text
# üéØ PORTAL JOURNEY - ACTION ITEMS
## *Quick Wins & Launch Readiness*

**Date:** February 12, 2026, 1:57 AM PST  
**Status:** üü¢ Action Items Identified  
**Priority:** HIGH

---

## ‚úÖ IMMEDIATE ACTION ITEMS

### **1. LEAD Research Sync (HOURLY)**
**Task:** Set interval to review LEAD's research notes  
**Frequency:** Every hour  
**Purpose:** Stay synergized with strategic direction  
```

## ./docs/archive/misc/PROTOCOLBUILDER_DROPDOWN_AUDIT.md
```text
# üîç **PROTOCOL BUILDER DROPDOWN AUDIT & REPAIR PLAN**

**Date:** 2026-02-10 12:13 PM  
**File:** `src/pages/ProtocolBuilder.tsx`  
**Objective:** Connect ALL dropdowns to Supabase reference tables

---

## üìä **CURRENT STATE vs REQUIRED STATE**

| Dropdown Field | Current Status | Supabase Table | Action Required |
|----------------|----------------|----------------|-----------------|
| **Substance** | ‚ùå Hardcoded array | `ref_substances` | ‚úÖ Connect to DB |
| **Route** | ‚ùå Hardcoded array | `ref_routes` | ‚úÖ Connect to DB |
| **Frequency** | ‚ùå Hardcoded array | ‚ùì No ref table | ‚ö†Ô∏è Create table or keep hardcoded |
```

## ./docs/archive/misc/EVENT_CODE_PATTERN.md
```text
# Event Type Code Pattern - Implementation Guide

**Date:** February 8, 2026  
**Status:** üéØ Best Practice Pattern

---

## üéØ **The Core Principle**

**IDs are for the database. Codes are for humans and UI logic.**

---

## üìã **The Pattern**

```

## ./docs/archive/misc/NOTEBOOKLM_PROMPT_CORRECTED.md
```text
# üìù NOTEBOOKLM PROMPT: PPN RESEARCH PORTAL
## Correct Branding, Fonts, Colors & Messaging

**Created By:** LEAD  
**Date:** 2026-02-12 02:44 PST  
**Purpose:** Ensure NotebookLM outputs use correct PPN branding  
**Context:** Previous outputs had wrong name, fonts, colors

---

## üéØ NOTEBOOKLM CUSTOM INSTRUCTIONS

### **Copy-Paste This Into NotebookLM:**

```
```

## ./docs/archive/misc/TASKS_1-2_COMPLETE.md
```text
# ‚úÖ TASKS 1-2 COMPLETE: Workflow Improvements & Documentation

**Completed By:** LEAD  
**Date:** 2026-02-11 20:01 PST  
**Status:** ‚úÖ COMPLETE & PUSHED TO GIT

---

## üìä SUMMARY

Successfully completed tasks 1-2:
1. ‚úÖ Updated `agent.yaml` with workflow improvements
2. ‚úÖ Created `ARTIFACT_INDEX.md` with 137+ artifacts organized

**Git Commit:** `4620c5e` - "feat: Workflow improvements and comprehensive documentation"  
```

## ./docs/archive/misc/INVOKE_DESIGNER.md
```text
# üé® DESIGNER INVOCATION COMMAND

**Use this in a NEW CHAT to invoke DESIGNER subagent**

---

## **COPY THIS ENTIRE MESSAGE:**

```
@DESIGNER

Execute Protocol Builder Phase 1 UX Improvements

PROJECT LOCATION:
/Users/trevorcalton/Desktop/PPN-Antigravity-1.0
```

## ./docs/archive/misc/QUICK_START.md
```text
# Patient Flow Implementation - Quick Start Guide

**Date:** February 8, 2026  
**Status:** Ready to Execute

---

## üìã What We Just Created

### 1. Strategic Documents
- **`PATIENT_FLOW_IMPLEMENTATION_PLAN.md`** - Complete blueprint with architecture, components, and phased checklist
- **`migrations/001_patient_flow_foundation.sql`** - Production-ready database migration (copy-paste into Supabase)
- **`migrations/002_seed_demo_data.sql`** - Demo data generator (60 patients, 200+ events)
- **`QUICK_START.md`** - This file

```

## ./docs/archive/misc/DESIGN_AUDIT_SUMMARY.md
```text
# üìã DESIGN AUDIT SUMMARY
**Quick Reference Guide for Presentation**

---

## ‚úÖ **WHAT'S READY FOR PRESENTATION (Completed)**

### **Landing Page - Pre-Presentation Fixes**
1. ‚úÖ **Hero Eyebrow** - Clear "For Psychedelic Therapy Practitioners" badge
2. ‚úÖ **Starry Background** - CSS-generated starfield with parallax
3. ‚úÖ **About PPN** - Fixed heading (no ALL CAPS), split into 2 paragraphs
4. ‚úÖ **Logo Slider** - Fixed z-index (label stays in front)
5. ‚úÖ **Organization Name** - Corrected to "Psychedelic Practitioners Network" (plural)

---
```

## ./docs/archive/misc/STATUS_VALIDATED_USE_CASES.md
```text
# ‚úÖ VALIDATED USE CASES - IMPLEMENTATION STATUS

**Report Date:** 2026-02-12 07:09 PST  
**Scope:** Use Cases 1-3 (VoC-Validated)  
**Status:** Assessing current implementation vs. VoC requirements

---

## üìä EXECUTIVE SUMMARY

### **Overall Status: üü¢ STRONG FOUNDATION (75% Complete)**

**Use Case 1:** Prove You're Not Reckless - **85% Complete** ‚úÖ  
**Use Case 2:** Reduce Malpractice Exposure - **75% Complete** üü°  
**Use Case 3:** Comply With State Regulations - **65% Complete** üü°
```

## ./docs/archive/misc/RUN_MIGRATION_010.md
```text
# üöÄ **RUN MIGRATION 010 - CRITICAL FIXES**

**Date:** 2026-02-10 14:00 PM  
**Priority:** üî¥ **CRITICAL**  
**File:** `migrations/010_fix_critical_database_issues.sql`

---

## üìã **WHAT THIS MIGRATION DOES**

### **Fixes 5 Critical Issues:**

1. ‚úÖ **Fixes `system_events.site_id` type** (BIGINT ‚Üí UUID)
2. ‚úÖ **Recreates `ref_knowledge_graph`** with proper foreign keys (no text duplication)
3. ‚úÖ **Adds medications to `ref_substances`** (SSRIs, Lithium, Benzodiazepines, etc.)
```

## ./docs/archive/misc/SUPABASE_SETUP_AND_DESIGNER_INSTRUCTIONS.md
```text
# Supabase Setup + ProtocolBuilder Enhancement Plan
**Date:** 2026-02-09  
**Purpose:** Complete Supabase setup verification + Designer instructions for ProtocolBuilder modal enhancement  
**Status:** READY TO EXECUTE

---

## PART 1: SUPABASE SETUP STATUS ‚úÖ

### Current State Analysis:

**‚úÖ ALREADY CREATED (From Previous Sessions):**
1. `schema.sql` - Base tables (regulatory_states, news, profiles, etc.)
2. `migrations/001_patient_flow_foundation.sql` - Patient flow tables + views
3. `backend/sync_schema.sql` - Ghost tables fix (flow events)
```

## ./docs/archive/misc/VIDEO_TEASER_SCRIPT.md
```text
# üé¨ PPN RESEARCH PORTAL - VIDEO TEASER SCRIPT

**Video Title:** "See What Works. Before You Treat."  
**Length:** 2 minutes 30 seconds  
**Audience:** Clinical network owners, NIH leadership, practitioners  
**Tone:** Professional, evidence-based, visionary  
**Format:** Screen recording + voiceover + text overlays

---

## üéØ VIDEO STRUCTURE

**Hook:** 0:00 - 0:15 (15 seconds)  
**Problem:** 0:15 - 0:45 (30 seconds)  
**Solution:** 0:45 - 1:30 (45 seconds)  
```

## ./docs/archive/misc/PROTOCOLBUILDER_COMPLETE_REDESIGN_SPEC.md
```text
# üéØ ProtocolBuilder Complete Redesign Specification
**Date:** 2026-02-09 23:48 PST  
**Priority:** CRITICAL - Foundation for RWE Platform  
**Estimated Time:** 3-4 hours implementation  
**Status:** READY FOR BUILDER EXECUTION

---

## üìã **EXECUTIVE SUMMARY**

**Mission:** Transform ProtocolBuilder from hardcoded form ‚Üí FDA-grade data collection engine

**What Changes:**
- ‚úÖ 7 hardcoded dropdowns ‚Üí Database-driven (ref tables)
- ‚úÖ 4 new fields added (Indication, Session #, Session Date, Protocol Template)
```

## ./docs/archive/agent_logs/LEAD_STRATEGIC_ANALYSIS_PROTOCOLBUILDER_PHASE1.md
```text
# üéØ LEAD STRATEGIC ANALYSIS - PROTOCOL BUILDER PHASE 1

**Analyzed By:** LEAD (using Pattern Recognition + GTM Strategy skills)  
**Date:** 2026-02-11 15:40 PST  
**Source Documents:**
- `DESIGN_SPEC_PROTOCOLBUILDER_PHASE1_20260211.md` (Designer's Power User Edition)
- `DESIGNER_RECOMMENDATIONS_REVIEW.md` (Builder's Review)
- `.agent/research/STRATEGIC_SYNTHESIS.md` (Market Intelligence)

---

## üìã **PROBLEM STATEMENT**

Designer proposes converting 3 dropdown fields to button groups with "power user" features (keyboard shortcuts, smart defaults, tooltips, progress tracking).

```

## ./docs/archive/agent_logs/DESIGNER_TO_LEAD_LANDING_CONCEPTS_HANDOFF.md
```text
# üé® DESIGNER TO LEAD - LANDING PAGE CONCEPTS READY
## Handoff Document

**From:** DESIGNER (UI/UX Lead)  
**To:** LEAD (Project Manager)  
**Date:** February 12, 2026, 12:15 AM PST  
**Status:** üü¢ CONCEPTS COMPLETE - READY FOR USER REVIEW  

---

## ‚úÖ MISSION ACCOMPLISHED

**Assignment:** Create 3 world-class landing page concept proposals  
**Temperature:** 9.5 (Maximum Creativity)  
**Deadline:** Tonight/Tomorrow AM  
```

## ./docs/archive/agent_logs/INSPECTOR_TASK_COMPREHENSIVE_QA_2026-02-12.md
```text
# INSPECTOR TASK ASSIGNMENT
**Date:** 2026-02-12 08:27 PST
**Assigned By:** LEAD + BUILDER
**Priority:** HIGH
**Status:** READY FOR QA

---

## MISSION

Conduct comprehensive Quality Assurance validation of the PPN Research Portal following the site restoration and full audit completion. Focus on verifying the 2 high-priority mobile issues and conducting cross-browser/accessibility testing.

---

## CONTEXT
```

## ./docs/archive/agent_logs/BUILDER_TASK_DATA_EXPORT_IMPORT.md
```text
# üì¶ BUILDER TASK: DATA EXPORT/IMPORT SYSTEM
## Bulk Upload/Download for Protocol Data

**Assigned To:** BUILDER  
**Priority:** HIGH  
**Estimated Time:** 6-8 hours  
**Due Date:** This week

---

## üéØ OBJECTIVE

Build a comprehensive data export/import system that allows practitioners to:
1. **Export** their protocol data (CSV, JSON, PDF)
2. **Import** bulk protocol data (CSV upload)
```

## ./docs/archive/agent_logs/SOOP_TASK_CREATE_MISSING_TABLES_DEMO_CRITICAL.md
```text
# üóÑÔ∏è SOOP TASK: Create Missing Tables for Demo & New Use Cases
## CRITICAL: Fix Protocol Builder 404 + Enable Future Features

**Assigned To:** SOOP  
**Created By:** LEAD  
**Date:** 2026-02-12 06:15 PST  
**Priority:** üî¥ CRITICAL (Demo blocker) + üü° HIGH (Future features)  
**Estimated Time:** 3-4 hours  
**Demo Date:** Feb 15, 2026 (2 days away)

---

## üìä CONTEXT

**Problem:**
```

## ./docs/archive/agent_logs/DESIGNER_CHANGES_REVIEW.md
```text
# üîç **DESIGNER'S CHANGES - BUILDER REVIEW**

**Reviewed By:** Builder Agent  
**Date:** 2026-02-10 11:32 AM  
**Source:** `_agent_status.md` (Designer's Comprehensive Audit)  
**Status:** ‚úÖ **APPROVED FOR IMPLEMENTATION** (with conditions)

---

## ‚úÖ **SAFE TO IMPLEMENT (Pre-Approved)**

These changes align with user rules and project goals:

### **1. ‚úÖ Quick Wins (All Completed by Designer)**
- ‚úÖ Removed development bypass console.log
```

## ./docs/archive/agent_logs/DESIGNER_STRATEGIC_VISUAL_RECOMMENDATION.md
```text
# üé® DESIGNER STRATEGIC RECOMMENDATION: Visual Asset Strategy

**From:** DESIGNER (using UI/UX & Product Design skill)  
**To:** LEAD  
**Date:** 2026-02-12 05:57 PST  
**Type:** Strategic Product Decision  
**Framework:** UI/UX & Product Design Advisory

---

## üìã **PROBLEM STATEMENT**

**One sentence:**  
We have created multiple visual assets (mockups, 3D molecules, components) without a clear strategy for which visuals serve which business objectives, where they should be placed, and what level of detail is appropriate for our current product stage.

```

## ./docs/archive/agent_logs/DESIGNER_TO_SOOP_DATA_REQUESTS.md
```text
# üìä DESIGNER ‚Üí SOOP: Data Requests for Mobile & Analytics Design

**From:** DESIGNER  
**To:** SOOP (Data/Database Subagent)  
**Date:** 2026-02-12 05:31 PST  
**Priority:** HIGH  
**Context:** Mobile UI design + Clinical Intelligence Platform Phase 2

---

## üéØ **PURPOSE**

I need real data structures, sample datasets, and database schema information to create accurate, production-ready mobile designs and data visualizations for:

1. **Mobile Dashboard** - Clinic performance metrics
```

## ./docs/archive/agent_logs/BUILDER_HANDOFF.md
```text
# üî® **BUILDER HANDOFF - APPROVED CHANGES**

**Prepared By:** Designer Agent  
**Date:** 2026-02-10 11:37 AM  
**Status:** ‚úÖ **READY FOR BUILDER IMPLEMENTATION**  
**User Approval:** ‚úÖ CONFIRMED

---

## üìã **EXECUTIVE SUMMARY**

This document contains all approved changes from Designer's audit that are ready for Builder to implement. All items have been reviewed and approved by the user.

**Total Tasks:** 5  
**Estimated Time:** 8-12 hours  
```

## ./docs/archive/agent_logs/DESIGNER_MOBILE_BUILDOUT_COMPLETE.md
```text
# ‚úÖ DESIGNER: Mobile Build-Out Complete

**Date:** 2026-02-12 06:43 PST  
**Session Duration:** ~1 hour  
**Status:** ‚úÖ COMPLETE (All critical fixes done)

---

## üìä **FINAL RESULTS**

### **‚úÖ Tasks Completed:**
1. **Task 1:** Global Input Constraints ‚úÖ (Commit: `92f42f4`)
2. **Task 3:** Top Bar Simplification ‚úÖ (Commit: `38930cb`)

### **‚è≠Ô∏è Tasks Skipped (Already Done):**
```

## ./docs/archive/agent_logs/DESIGNER_SPEC_MOBILE_ANALYTICS_CALCULATIONS.md
```text
# üì± DESIGNER SPEC: MOBILE ANALYTICS CALCULATIONS
## Data Formulas & Visual Expectations for Mobile Dashboards

**For:** DESIGNER  
**From:** LEAD  
**Date:** 2026-02-12 04:17 PST  
**Purpose:** Complete calculation specs for mobile visual design

---

## üéØ OVERVIEW

DESIGNER needs to build mobile visuals for:
1. **Safety Score Gauge** (0-100 speedometer)
2. **Network Benchmarking** (percentile rank, comparison)
```

## ./docs/archive/agent_logs/BUILDER_COMPLETE_ANALYTICS_DATABASE_CONNECTION.md
```text
# ‚úÖ BUILDER COMPLETE - Analytics Database Connection

**Completed By:** BUILDER  
**Date:** 2026-02-11 22:00 PST  
**Time Taken:** 30 minutes  
**Status:** ‚úÖ COMPLETE

---

## üéØ TASK SUMMARY

**Goal:** Connect Analytics page to real database data  
**Result:** ‚úÖ SUCCESS - Analytics now shows real-time data from `log_clinical_records`

---
```

## ./docs/archive/agent_logs/DESIGNER_COMPLETE_SEARCH_PORTAL_UX.md
```text
# Designer: Search Portal & Protocol Builder UX Improvements - COMPLETE

**Date:** 2026-02-12 03:23 PST  
**Status:** ‚úÖ COMPLETE  
**Total Time:** ~1.5 hours

---

## ‚úÖ **COMPLETED TASKS**

### **1. Typography Cleanup (30 min)**
**Problem:** Excessive ALL CAPS text ruins readability  
**Solution:** Removed `uppercase` class from 30+ instances

**Files Modified:**
```

## ./docs/archive/agent_logs/DESIGNER_TEMPORARY_CREATIVE_FREEDOM.md
```text
# üé® DESIGNER - TEMPORARY CREATIVE FREEDOM GRANT

**Issued By:** LEAD  
**Issued To:** DESIGNER  
**Date:** 2026-02-11 23:57 PST  
**Duration:** Until USER reviews concepts  
**Status:** üü¢ ACTIVE

---

## üéØ MISSION

Create 3 world-class landing page concept proposals with working prototypes.

**USER's Vision:**
```

## ./docs/archive/agent_logs/DESIGNER_MOBILE_PROGRESS.md
```text
# ‚úÖ DESIGNER: Mobile Build-Out Progress Update

**Date:** 2026-02-12 06:42 PST  
**Session:** Continuing mobile fixes  
**Status:** üü¢ ON TRACK

---

## ‚úÖ **COMPLETED TASKS**

### **Task 1: Global Input Constraints** ‚úÖ
**Commit:** `92f42f4`  
**File:** `src/index.css`  
**Impact:** Fixes 4 pages with input overflow

```

## ./docs/archive/agent_logs/BUILDER_TASKS_PROTOCOLBUILDER_PHASE1.md
```text
# üî® BUILDER TASKS - Protocol Builder Phase 1
## Clinical Intelligence Platform

**Version:** 1.0  
**Date:** February 11, 2026  
**Assignee:** Builder Agent  
**Timeline:** 3 months to MVP  

---

## üìã TASK OVERVIEW

**Total Tasks:** 28  
**Critical Path Tasks:** 8  
**Can Start Immediately:** 12  
```

## ./docs/archive/agent_logs/DESIGNER_FINAL_SUMMARY.md
```text
# üé® DESIGNER: Final Summary & Handoff

**Date:** 2026-02-12 05:59 PST  
**Status:** Awaiting LEAD's Strategic Direction  
**Complexity:** Multi-disciplinary analysis complete

---

## üìã **WHAT I'VE DELIVERED**

### **1. Mobile Optimization (COMPLETE ‚úÖ)**
- **ButtonGroup Component** - Mobile-responsive, stacked layout
- **Mobile Mockups** - 8 screens (dashboard, forms, analytics, molecules, navigation)
- **MobileSidebar Component** - Thumb-optimized, full-screen overlay
- **Substance Constants** - Minimal data file (7 substances)
```

## ./docs/archive/agent_logs/BUILDER_TASK_PHASE1_SAFETY_FEATURES.md
```text
# üöÄ PHASE 1: SAFETY FEATURES IMPLEMENTATION
## Promote Hidden Safety Components to Main App

**Approved By:** USER  
**Date:** 2026-02-12 01:02 PST  
**Assigned To:** BUILDER  
**Priority:** üî¥ CRITICAL  
**Timeline:** This Week (4-6 hours)

---

## üéØ OBJECTIVE

Promote 3 safety-focused components from deep-dive pages to main application, making them prominently accessible to all practitioners.

```

## ./docs/archive/agent_logs/BUILDER_TASK_LAUNCH_CRITICAL.md
```text
# üöÄ **BUILDER TASK: LAUNCH-CRITICAL FIXES**

**Assigned To:** Builder Agent  
**Priority:** üî¥ **CRITICAL**  
**Deadline:** Before Production Launch  
**Date Created:** 2026-02-10 09:43 AM  
**Context:** Based on comprehensive site audit completed 2026-02-10

---

## üìã **EXECUTIVE SUMMARY**

The PPN Research Portal is **production-ready** with caveats. The Designer Agent has completed all Quick Wins (8/8 tasks, 100% complete). The BUILDER must now address **3 critical blockers** and **4 high-priority issues** before launch.

**Current Status:**
```

## ./docs/archive/agent_logs/BUILDER_LANDING_PAGE_CHANGES.md
```text
# üé® BUILDER: Landing Page Changes Summary

**Date:** February 9, 2026  
**Agent:** Builder  
**Task:** Apply Physics Engine effects to Landing page  
**Status:** ‚úÖ Code Complete (Blocked by system permissions)

---

## üìã EXECUTIVE SUMMARY

I successfully implemented the requested Physics Engine effects on the Landing page:
1. ‚úÖ **Magnetic Cursor** on the "Access Portal" CTA button
2. ‚úÖ **Bento Grid** layout for the Bento Box Features section
3. ‚úÖ **Glassmorphism** effects on 2 feature cards
```

## ./docs/archive/agent_logs/DESIGNER_TASK_MOBILE_OPTIMIZATION_CRITICAL.md
```text
# üö® CRITICAL: Protocol Builder Mobile Optimization

**Priority:** P0 - BLOCKING LAUNCH  
**Assigned To:** DESIGNER  
**Date:** 2026-02-12 04:15 PST  
**Estimated Effort:** 2-3 hours  
**Status:** üî¥ CRITICAL - MOBILE BROKEN

---

## üì± **MOBILE TESTING RESULTS**

### **Test Environment:**
- **Device:** iPhone 14 Pro (393x852px)
- **Browser:** Chrome/Safari mobile viewport
```

## ./docs/archive/agent_logs/LEAD_TO_DESIGNER_HANDOFF.md
```text
# üé® LEAD ‚Üí DESIGNER HANDOFF

**Date:** 2026-02-11 11:59 PST  
**Task:** Protocol Builder Phase 1 UX Improvements  
**Status:** ‚úÖ READY FOR DESIGNER

---

## üìã **TASK SUMMARY**

Create visual mockups for Protocol Builder UX improvements focusing on converting dropdown fields to button groups for better usability.

---

## üéØ **DESIGNER OBJECTIVES**
```

## ./docs/archive/agent_logs/BUILDER_ACTIVATION_CRITICAL_DEMO_PREP.md
```text
# üî® BUILDER ACTIVATION - Critical Demo Prep Tasks

**Activated By:** LEAD  
**Date:** 2026-02-12 05:29 PST  
**Priority:** üî¥ CRITICAL - Demo in 3 days  
**Total Estimated Time:** 2.5 hours

---

## üéØ YOUR MISSION

You have **2 critical tasks** that must be completed for the Dr. Shena demo on Saturday, Feb 15:

1. **Demo Mode Security Fix** (30 min) - CRITICAL SECURITY
2. **Wire Protocol Builder to Database** (2 hours) - CRITICAL FUNCTIONALITY
```

## ./docs/archive/agent_logs/DESIGNER_CRITICAL_UX_FIXES.md
```text
# CRITICAL UX Fixes - Immediate Action Required

**Priority:** P0 - BLOCKING ISSUES  
**Date:** 2026-02-12 03:29 PST  
**Status:** üö® IN PROGRESS

---

## üö® **Issue 1: Minimum Font Size Violations (CRITICAL)**

### **Problem:**
- **75+ instances** of text smaller than 10pt (8px, 9px, 10px)
- Violates accessibility guidelines (WCAG 2.1 AA requires 12pt minimum for body text)
- Violates user's explicit "minimum font size" rule

```

## ./docs/archive/agent_logs/DESIGNER_TO_SOOP_MOLECULAR_BINDING_VISUALIZATION.md
```text
# üß¨ 3D Molecule-Receptor Binding Visualization Requirements

**From:** DESIGNER  
**To:** SOOP (Data Subagent)  
**Date:** 2026-02-12 05:44 PST  
**Priority:** HIGH - ADVANCED FEATURE  
**Context:** Molecular pharmacology visualization for clinical intelligence

---

## üéØ **VISION**

Create **scientifically accurate, interactive 3D visualizations** showing:
1. **Ligand structure** (psychedelic molecules)
2. **Receptor structure** (5-HT2A, D2, NMDA, etc.)
```

## ./docs/archive/agent_logs/BUILDER_COMPLETE_DEMO_MODE_INVESTIGATION.md
```text
# ‚úÖ BUILDER COMPLETE - Demo Mode Security Fix

**Completed By:** BUILDER  
**Date:** 2026-02-11 21:54 PST  
**Time Taken:** 5 minutes  
**Status:** ‚úÖ COMPLETE (No action needed)

---

## üìä TASK SUMMARY

**Assigned Task:** Fix demo mode security vulnerability  
**Expected:** Remove localStorage bypass, gate behind env variable  
**Actual Finding:** **No vulnerability exists** - code is already secure

```

## ./docs/archive/agent_logs/LEAD_SAFETY_COMPLIANCE_EXCELLENCE_ROADMAP_2026-02-12.md
```text
# LEAD STRATEGIC DIRECTIVE
## Safety & Compliance Excellence Roadmap  
**Date:** 2026-02-12 09:00 PST  
**Strategic Focus:** #1 IN THE WORLD AT SAFETY & COMPLIANCE  
**Status:** üéØ **APPROVED DIRECTION - SAFETY ONLY**  
**Priority:** P0 - ALL RESOURCES TO SAFETY ENHANCEMENT

---

## üéØ STRATEGIC MANDATE (REVISED)

**Mission:**
> Be the #1 platform in the world at improving SAFETY & COMPLIANCE for psychedelic therapy practitioners and their patients.

**What We ARE:**
```

## ./docs/archive/agent_logs/TODO_BUILDER_PROTOCOL_TABLE.md
```text
# üî® BUILDER: Protocol Table Columns Implementation
**Task:** Add Priority 1 columns to My Protocols table  
**File:** `src/pages/ProtocolBuilder.tsx`  
**Estimated Time:** 45 minutes

---

## Implementation Checklist

### **Step 1: Add Table Headers (5 minutes)**

**Location:** Line ~288-292 (table `<thead>`)

**Current:**
```tsx
```

## ./docs/archive/agent_logs/DESIGNER_TASK2_SKIPPED.md
```text
# ‚úÖ DESIGNER: Task 2 Assessment

**Date:** 2026-02-12 06:36 PST  
**Task:** Protocol Builder Mobile Layout  
**Status:** ‚è≠Ô∏è SKIPPED (Already Responsive)

---

## üîç **FINDINGS**

### **Protocol Builder Analysis:**

**Good News:** Protocol Builder is already using responsive classes!

**Evidence:**
```

## ./docs/archive/agent_logs/DESIGNER_TASK_PROTOCOLBUILDER.md
```text
# DESIGNER TASK: ProtocolBuilder Modal Enhancement
**Date:** 2026-02-09  
**Priority:** HIGH  
**Estimated Time:** 2-3 hours  
**Status:** READY TO START

---

## üéØ MISSION BRIEFING

**Objective:** Enhance the ProtocolBuilder modal to use database-driven dropdowns instead of hardcoded arrays, and add 4 new fields for complete analytics capability.

**Why This Matters:** This is the "killer app" of the site. Getting this right enables substance-specific analytics, indication tracking, session progression, and cross-site benchmarking.

**Critical Constraint:** This is a **BACKEND WIRING ONLY** task. **DO NOT CHANGE ANY VISUALS.** No fonts, no colors, no spacing, no layout changes.
```

## ./docs/archive/agent_logs/BUILDER_REPAIR_INSTRUCTIONS.md
```text
# üîß **BUILDER REPAIR INSTRUCTIONS**

**Prepared By:** INVESTIGATOR (Antigravity)  
**Date:** 2026-02-10 12:39 PM  
**For:** BUILDER Agent  
**Status:** ‚ö†Ô∏è **AWAITING USER PERMISSION FIX**

---

## ‚ö†Ô∏è **PREREQUISITES - USER MUST COMPLETE FIRST**

**CRITICAL:** Builder cannot proceed until the user fixes npm permissions.

**User must run in terminal:**
```bash
```

## ./docs/archive/agent_logs/DESIGNER_PROGRESS_SEARCH_PORTAL_UX.md
```text
# Designer: Search Portal UX Improvements

**Status:** In Progress  
**Priority:** P1 - Critical UX Issues  
**Estimated Time:** 2 hours remaining

---

## üéØ Issues Identified

### ‚úÖ **COMPLETED: Typography Cleanup**
- **Problem**: Excessive ALL CAPS text ruins readability
- **Solution**: Removed `uppercase` class from 30+ instances
- **Impact**: Much more readable, professional appearance

```

## ./docs/archive/agent_logs/BUILDER_TASK_SUMMARY.md
```text
# üéØ **BUILDER TASK SUMMARY**

**Date:** 2026-02-10 09:43 AM  
**Status:** üü° **READY FOR EXECUTION**  
**Full Details:** See `BUILDER_TASK_LAUNCH_CRITICAL.md`

---

## üìã **QUICK OVERVIEW**

The Designer has completed all Quick Wins (8/8 tasks). The BUILDER must now fix **3 critical blockers** before launch.

---

## üî¥ **CRITICAL BLOCKERS (Must Do)**
```

## ./docs/archive/agent_logs/BUILDER_IMPLEMENTATION_PLAN.md
```text
# üõ†Ô∏è BUILDER IMPLEMENTATION PLAN
**Date:** 2026-02-09 14:40 PST  
**Status:** Ready to Execute  
**Total Estimated Time:** 6-8 hours

---

## üìã **OVERVIEW**

This document consolidates all pending tasks into a logical, dependency-ordered implementation plan. Tasks are grouped by:
1. **File dependencies** (create components before using them)
2. **Complexity** (simple fixes before complex refactors)
3. **Impact** (high-impact changes first)

---
```

## ./docs/archive/agent_logs/BUILDER_START_HERE_MOBILE_FIXES.md
```text
# üî® BUILDER: Mobile Fixes - Ready to Start

**From:** DESIGNER  
**To:** BUILDER  
**Date:** 2026-02-12 06:29 PST  
**Status:** üü¢ READY TO START  
**Priority:** üî¥ CRITICAL

---

## üìã **QUICK START**

You have **2 task documents** ready for implementation:

1. **BUILDER_TASK_MOBILE_CRITICAL_FIXES.md** (Phase 1 - CRITICAL)
```

## ./docs/archive/agent_logs/BUILDER_CRITICAL_BLOCKER_RESOLVED.md
```text
# CRITICAL BLOCKER RESOLUTION REPORT
**Date:** 2026-02-12 08:17 PST
**Role:** LEAD + BUILDER
**Status:** ‚úÖ **SITE RESTORED**

---

## EXECUTIVE SUMMARY

The critical site-wide compilation error has been **SUCCESSFULLY RESOLVED**. The PPN Research Portal is now fully accessible on all pages and viewports.

**Fixes Applied:**
1. Removed duplicate import statement (lines 11-12)
2. Fixed malformed try-catch-finally structure (duplicate closing braces)
3. Added missing `outcome_score` field to Supabase query
```

## ./docs/archive/agent_logs/LEAD_UX_FIXES_COMPLETE_2026-02-12.md
```text
# ‚úÖ LEAD: UX Fixes - Execution Complete

**Date:** 2026-02-12 09:45 PST  
**Agent:** @LEAD  
**Status:** COMPLETE

---

## üìä EXECUTION SUMMARY

### ‚úÖ Completed (6/9 Tasks)

1. **Protocol ROI Removed** ‚úÖ
   - File: `src/components/Sidebar.tsx`
   - Hidden from Intelligence section
```

## ./docs/archive/agent_logs/DESIGNER_WISH_LIST_MOBILE_FEATURES.md
```text
# üé® DESIGNER WISH LIST: Dream Data Features for Mobile Experience

**From:** DESIGNER  
**To:** SOOP (Data/Database Subagent)  
**Date:** 2026-02-12 05:34 PST  
**Type:** Vision Document - "If We Could Build Anything..."

---

## üåü **VISION**

Create the most compelling, data-rich mobile experience for psychedelic therapy research that:
- **Wows clinicians** with instant insights
- **Drives engagement** through beautiful visualizations
- **Builds trust** through transparency and precision
```

## ./docs/archive/agent_logs/LEAD_SUMMARY_FOR_USER.md
```text
# üéØ LEAD: Task Review Complete - Agent Assignments Ready

**Date:** 2026-02-11 18:54 PST  
**Status:** ‚úÖ COMPREHENSIVE REVIEW COMPLETE

---

## üìä EXECUTIVE SUMMARY

I've completed a comprehensive review of all completed tasks, open task files, and current project state. I've identified critical gaps and created detailed task assignments for each subagent.

---

## ‚úÖ WHAT I FOUND

```

## ./docs/archive/agent_logs/DESIGNER_SESSION_SUMMARY_MOBILE.md
```text
# ‚úÖ DESIGNER: Mobile Fixes Session Summary

**Date:** 2026-02-12 06:37 PST  
**Session Duration:** ~40 minutes  
**Status:** ‚úÖ PARTIAL COMPLETE (1/6 tasks)

---

## üìã **COMPLETED WORK**

### **‚úÖ Task 1: Global Input Constraints** (COMPLETE)
**File:** `src/index.css`  
**Lines Added:** 77  
**Commit:** `92f42f4`  
**Pushed:** ‚úÖ Yes
```

## ./docs/archive/agent_logs/BUILDER_TASK_MOBILE_CRITICAL_FIXES.md
```text
# üîß BUILDER TASK: Mobile Critical Fixes

**From:** DESIGNER  
**To:** BUILDER  
**Date:** 2026-02-12 06:14 PST  
**Priority:** üî¥ CRITICAL  
**Estimated Time:** 7 hours  
**Type:** Bug Fixes - Mobile Responsiveness

---

## üéØ **OBJECTIVE**

Fix 4 critical mobile UX issues that cause horizontal scrolling and layout breakage on iPhone SE (375px viewport).

```

## ./docs/archive/agent_logs/LEAD_DECISION_PROTOCOLBUILDER_CANONICAL_VERSION.md
```text
# üéØ LEAD DECISION: Protocol Builder Canonical Version

**Decision Date:** 2026-02-12 05:16 PST  
**Decision By:** LEAD  
**Priority:** üî¥ CRITICAL  
**Impact:** Unblocks BUILDER for database wiring

---

## üìã DECISION SUMMARY

**Question:** Which Protocol Builder file is the canonical version?

**Answer:** **`/src/pages/ProtocolBuilder.tsx`** is the ONLY version and is confirmed as canonical.

```

## ./docs/archive/agent_logs/DESIGNER_TO_USER_PORTAL_JOURNEY_APPROVED.md
```text
# üé® DESIGNER TO USER - PORTAL JOURNEY APPROVED
## Ready to Begin Implementation

**From:** DESIGNER (UI/UX Lead)  
**To:** USER  
**Date:** February 12, 2026, 1:05 AM PST  
**Status:** üü¢ APPROVED - Ready to Build

---

## ‚úÖ WHAT WE ACCOMPLISHED TONIGHT

### **1. Explored Three Concepts**
- **Concept 1:** The Constellation (particles ‚Üí structure)
- **Concept 2:** The Prism (blur ‚Üí clarity)
```

## ./docs/archive/agent_logs/BUILDER_TASK_DEMO_MODE_SECURITY_FIX.md
```text
# üî® BUILDER TASK: Demo Mode Security Fix

**Assigned By:** LEAD  
**Date:** 2026-02-11 18:54 PST  
**Priority:** P0 - CRITICAL SECURITY  
**Estimated Effort:** 30 minutes  
**Status:** üî¥ READY TO START

---

## üö® SECURITY VULNERABILITY

**Current Problem:**
Anyone can bypass authentication by opening browser console and typing:
```javascript
```

## ./docs/archive/agent_logs/DESIGNER_TASK_CLINICAL_INTELLIGENCE_PLATFORM.md
```text
# üé® DESIGNER TASK: CLINICAL INTELLIGENCE PLATFORM REDESIGN

**Assigned To:** DESIGNER (UI/UX Lead)  
**Assigned By:** LEAD  
**Date:** 2026-02-11 16:40 PST  
**Priority:** P0 - CRITICAL  
**Estimated Effort:** 3-4 days  
**Status:** üî¥ NOT STARTED

---

## üìã **TASK SUMMARY**

Redesign the Protocol Builder from a "data entry form" to a "real-time clinical intelligence platform" that shows practitioners live benchmarking data, predictive outcomes, and receptor impact visualizations as they design treatment protocols.

```

## ./docs/archive/agent_logs/DESIGNER_TASKS_PROTOCOLBUILDER_PHASE1.md
```text
# üé® DESIGNER TASKS - Protocol Builder Phase 1
## Clinical Intelligence Platform - Frontend Development

**Version:** 1.0  
**Date:** February 11, 2026  
**Assignee:** Designer + Frontend Builder  
**Timeline:** 3 months to MVP  

---

## üìã TASK OVERVIEW

**Total Tasks:** 24  
**Critical Path Tasks:** 6  
**Can Start Immediately:** 8  
```

## ./docs/archive/agent_logs/DESIGNER_TO_LEAD_MOBILE_TESTING.md
```text
# üì± DESIGNER ‚Üí LEAD: Mobile Optimization Ready for Testing

**From:** DESIGNER  
**To:** LEAD  
**Date:** 2026-02-12 04:36 PST  
**Priority:** HIGH  
**Status:** üü¢ READY FOR TESTING

---

## üéØ **WHAT WAS DELIVERED**

### **Protocol Builder - Mobile Optimization (Phase 1)**

I've completed critical mobile optimizations for the Protocol Builder modal. The application is now fully functional on mobile devices with proper responsive design and accessibility compliance.
```

## ./docs/archive/agent_logs/DESIGNER_TASK_SEARCH_SORT_OPTIONS.md
```text
# Designer Task: Search Portal Sort Options

**Priority:** P2 - Feature Enhancement  
**Type:** UX Feature  
**Estimated Time:** 1 hour  
**Status:** Ready for Implementation

---

## üéØ **User Request**

Add more sorting options to the Search Portal to help users organize research results.

---

```

## ./docs/archive/agent_logs/DESIGNER_BRIEFING_VOC_RESEARCH.md
```text
# üé® DESIGNER BRIEFING: VOC RESEARCH & COMPONENT STRATEGY
## Voice-of-Customer Insights for UI/UX & Landing Page Copy

**To:** DESIGNER  
**From:** LEAD  
**Date:** 2026-02-12 01:30 PST  
**Priority:** HIGH  
**Context:** VoC research for demo prospects (JAllen & BLJensen)

---

## üìã EXECUTIVE SUMMARY

**What This Is:**
Voice-of-Customer research for two practitioners who will see our demo. Their pain points and language should inform our UI/UX decisions and landing page copy.
```

## ./docs/archive/agent_logs/BUILDER_DASHBOARD_EXPORT_UX_FIXES.md
```text
# üéØ UX/UI Critical Fixes Plan - Data Export & Dashboard Overhaul

**Date:** 2026-02-12  
**Assigned To:** DESIGNER Agent  
**Priority:** P0 - Critical UX Issues  
**Estimated Time:** 6-8 hours

---

## üìã ISSUE SUMMARY

You've identified 9 critical UX issues that need immediate attention:

1. **Dropdown Alphabetical Ordering** - All dropdowns should be alphabetically sorted unless there's a specific reason not to
2. **Button vs Dropdown Strategy** - Some ButtonGroups may need to convert to dropdowns if reference tables expand
```

## ./docs/archive/agent_logs/DESIGNER_TASK_3D_MOLECULE.md
```text
# üß¨ DESIGNER TASK: 3D MOLECULE REDESIGN
## Custom Psilocybin Molecule for Landing Page

**Assigned To:** DESIGNER  
**Priority:** HIGH  
**Estimated Time:** 2-3 hours  
**Due Date:** This week

---

## üéØ OBJECTIVE

Replace the current landing page molecule with a custom-designed, scientifically accurate 3D psilocybin molecule that:
1. Is visually stunning (premium, modern aesthetic)
2. Is scientifically accurate (correct molecular structure)
```

## ./docs/archive/agent_logs/DESIGNER_MOBILE_AUDIT_REPORT.md
```text
# üì± MOBILE UX AUDIT REPORT - All Pages

**Date:** 2026-02-12 06:04 PST  
**Viewport:** iPhone SE (375px √ó 667px)  
**Pages Tested:** 14  
**Auditor:** DESIGNER (Browser Subagent)

---

## üìä **EXECUTIVE SUMMARY**

### **Overall Status:**
- ‚úÖ **Sidebar:** Works perfectly on all pages (thumb-optimized, consistent)
- ‚ö†Ô∏è **Layout:** 10 pages have minor issues, 4 pages have major issues
- üö® **Critical:** Top bar overcrowding, input field overflows, horizontal scroll
```

## ./docs/archive/agent_logs/DESIGNER_RECOMMENDATIONS_REVIEW.md
```text
# üìã **DESIGNER'S RECOMMENDATIONS - BUILDER REVIEW**

**Reviewed By:** Builder Agent  
**Date:** 2026-02-10 12:00 PM  
**Source:** `_agent_status.md` (Designer's Audit)  
**Cross-Reference:** `BUILDER_HANDOFF.md` (Prepared Implementation Plan)

---

## üéØ **EXECUTIVE SUMMARY**

Designer identified **13 prioritized action items** across 4 priority levels. I've reviewed each one against:
1. User rules and preferences
2. Already completed work
3. User-approved changes
```

## ./docs/archive/agent_logs/TODO_INVESTIGATOR.md
```text
# üîç INVESTIGATOR TO-DO LIST
**Role:** Analysis, Research, Validation  
**Date:** 2026-02-10  
**Context:** Landing page layout crowding issues

---

## Priority Tasks

### üî¥ **Critical - Do First**

- [ ] **Validate Trust Indicators Context**
  - User removed the "Trusted by Leading Research Institutions" header
  - Determine if badges need context or can stand alone
  - Check if this matches brand guidelines
```

## ./docs/archive/agent_logs/BUILDER_COMPLETE_DATABASE_WIRING_INVESTIGATION.md
```text
# ‚úÖ BUILDER COMPLETE - Protocol Builder Database Wiring

**Completed By:** BUILDER  
**Date:** 2026-02-11 21:55 PST  
**Time Taken:** 5 minutes (investigation)  
**Status:** ‚úÖ ALREADY COMPLETE

---

## üìä TASK SUMMARY

**Assigned Task:** Wire Protocol Builder to database  
**Expected:** Connect form submission to `log_clinical_records` table  
**Actual Finding:** **Already implemented** - fully functional

```

## ./docs/archive/agent_logs/DESIGNER_TO_LEAD_MODAL_MIGRATION_DECISION.md
```text
# ü§î DESIGNER ‚Üí LEAD: Protocol Builder Modal Migration Decision

**From:** DESIGNER  
**To:** LEAD  
**Date:** 2026-02-12 04:57 PST  
**Priority:** HIGH  
**Type:** Architecture Decision Request

---

## üéØ **DECISION NEEDED**

Should we migrate the Protocol Builder from a **modal overlay** to a **dedicated page** (`/builder/new`)?

**Context:** While implementing mobile optimization, we discovered that the modal approach has significant UX limitations on mobile devices. This decision will impact Phase 2 (Clinical Intelligence Platform) architecture.
```

## ./docs/archive/agent_logs/DESIGNER_STATUS_REPORT_MOBILE.md
```text
# ‚úÖ DESIGNER STATUS REPORT - Mobile Optimization Complete

**Date:** 2026-02-12 04:36 PST  
**Agent:** DESIGNER  
**Status:** üü¢ COMPLETE - READY FOR TESTING

---

## üìã **SUMMARY**

I've successfully completed the mobile optimization for the Protocol Builder and created handoff documentation for LEAD and INSPECTOR testing.

---

## ‚úÖ **COMPLETED DELIVERABLES**
```

## ./docs/archive/agent_logs/LEAD_UX_FIXES_STATUS_2026-02-12.md
```text
# üéØ LEAD: UX Critical Fixes - Status Report

**Date:** 2026-02-12 09:22 PST  
**Agent:** @LEAD  
**Status:** IN PROGRESS

---

## ‚úÖ COMPLETED (Immediate Fixes)

### 1. **Protocol ROI Removed from Sidebar** ‚úÖ
- **File:** `src/components/Sidebar.tsx` Line 73
- **Action:** Commented out "Protocol ROI" link
- **Result:** Intelligence section now shows 4 items instead of 5

```

## ./docs/archive/agent_logs/DESIGNER_TO_LEAD_CONSTANTS_DECISION.md
```text
# üé® DESIGNER ‚Üí LEAD: Molecular Data Constants Decision

**From:** DESIGNER  
**To:** LEAD  
**Date:** 2026-02-12 05:46 PST  
**Priority:** MEDIUM  
**Type:** Design Decision Request

---

## üéØ **DECISION NEEDED**

What level of molecular detail should we include in the `constants.tsx` file for the 7 priority substances?

**Context:** I'm creating mobile designs for the Substance Library and need to know how much molecular data to display and store in the frontend.
```

## ./docs/archive/agent_logs/LEAD_UPDATE_SUBA_TO_SOOP_2026-02-12.md
```text
# ‚úÖ AGENT CONFIGURATION UPDATE: SUBA ‚Üí SOOP

**Updated By:** LEAD  
**Date:** 2026-02-12 05:04 PST  
**Status:** ‚úÖ COMPLETE

---

## üìã **SUMMARY**

Successfully renamed all references from 'SUBA' to 'SOOP' throughout the agent configuration system for consistency with existing project documentation.

---

## üîÑ **CHANGES MADE**
```

## ./docs/archive/agent_logs/DESIGNER_TO_INSPECTOR_MOBILE_QA.md
```text
# üîç DESIGNER ‚Üí INSPECTOR: Mobile QA Verification Request

**From:** DESIGNER  
**To:** INSPECTOR  
**Date:** 2026-02-12 04:36 PST  
**Priority:** HIGH  
**Type:** Quality Assurance - Mobile Optimization

---

## üéØ **QA REQUEST SUMMARY**

### **Component:** Protocol Builder - ButtonGroup Mobile Optimization
### **Scope:** Mobile responsive design verification
### **Risk Level:** MEDIUM (CSS-only changes, no logic changes)
```

## ./docs/archive/agent_logs/DESIGNER_MULTI_SKILL_STRATEGIC_ANALYSIS.md
```text
# üéØ MULTI-DISCIPLINARY STRATEGIC ANALYSIS: Visual Asset Strategy

**From:** DESIGNER  
**To:** LEAD  
**Date:** 2026-02-12 05:58 PST  
**Skills Applied:** UI/UX & Product Design, Frontend Best Practices, Pattern Recognition, Deep Industry Knowledge, Master Data UX, Technical Architecture

---

## üìã **EXECUTIVE SUMMARY**

**Problem:** We need a visual asset strategy that balances clinical credibility, technical feasibility, user experience, and development velocity.

**Recommendation:** Implement **Strategic Visuals (Option 2)** with strict adherence to frontend standards, clinical accuracy requirements, and accessibility guidelines.

```

## ./docs/archive/agent_logs/LEAD_AGENT_ASSIGNMENTS_2026-02-11.md
```text
# üéØ LEAD: AGENT TASK ASSIGNMENTS - CONSOLIDATED

**Date:** 2026-02-11 19:19 PST  
**Status:** ‚úÖ ASSIGNMENTS ISSUED  
**Execution Mode:** PARALLEL + PHASED

---

## üöÄ QUICK START - AGENT INVOCATION

**Copy/Paste these commands to start each agent:**

| Agent | Task | Invocation File |
|-------|------|-----------------|
| **INSPECTOR** | Verify Protocol Builder | `INVOKE_INSPECTOR.md` |
```

## ./docs/archive/agent_logs/BUILDER_PLAN_ANALYTICS_DATABASE_CONNECTION.md
```text
# üî® BUILDER: Connect Analytics to Database - Implementation Plan

**Started:** 2026-02-11 21:57 PST  
**Estimated Time:** 1 hour  
**Status:** üî¥ IN PROGRESS

---

## üéØ OBJECTIVE

Replace mock/hardcoded data in Analytics page with real data from `log_clinical_records` table.

---

## üìä CURRENT STATE ANALYSIS
```

## ./docs/archive/agent_logs/LEAD_STRATEGIC_USE_CASE_ANALYSIS.md
```text
# üéØ LEAD: Strategic Use Case Analysis
**Date:** 2026-02-12 10:50 PST  
**Purpose:** Identify additional use cases aligned with VoC research and market strategy  
**Status:** Strategic Opportunity Assessment

---

## üìä CURRENT STATE ANALYSIS

### **What We're Building Now:**
1. ‚úÖ **Protocol Builder** - Fast clinical data entry
2. ‚úÖ **Clinical Intelligence Platform** - Real-time benchmarking & insights
3. ‚úÖ **Safety Surveillance** - Adverse event tracking
4. ‚úÖ **Interaction Checker** - Drug interaction alerts
5. ‚úÖ **Data Export** - Compliance reporting
```

## ./docs/archive/agent_logs/DESIGNER_TASK1_COMPLETE.md
```text
# ‚úÖ DESIGNER: Mobile Fix Task 1 Complete

**Date:** 2026-02-12 06:35 PST  
**Task:** Global Input Constraints for Mobile  
**Status:** ‚úÖ COMPLETE  
**Time Spent:** 15 minutes

---

## üìã **WHAT WAS DONE**

### **Task 1: Fix Global Input Overflows**
**Priority:** üî¥ CRITICAL  
**Status:** ‚úÖ COMPLETE

```

## ./docs/archive/agent_logs/LEAD_EXPANDED_USE_CASE_STRATEGIC_ALIGNMENT_2026-02-12.md
```text
# LEAD STRATEGIC ASSESSMENT
## Expanded Use Case Analysis & Strategic Alignment  
**Date:** 2026-02-12 08:51 PST  
**Author:** LEAD (Antigravity)  
**Status:** üéØ **CRITICAL STRATEGIC DIRECTIVE**  
**Priority:** P0 - LEADERSHIP DECISION REQUIRED

---

## üéØ EXECUTIVE SUMMARY

Based on comprehensive VoC analysis and current product status, I'm presenting an **EXPANDED USE CASE FRAMEWORK** that bridges the gap between our current "Defensible Documentation" positioning and the VoC-validated "Practice Operating System" vision.

### **Current Alignment Score: 47.5% ‚Üí Target: 85%**

```

## ./docs/archive/agent_logs/SOOP_TASK_MOLECULAR_DATABASE.md
```text
# üß¨ SOOP TASK: MOLECULAR DATABASE INFRASTRUCTURE
## 3D Molecules, Receptors, Pharmacology & MEQ30

**Assigned To:** SOOP (Database & Backend Specialist)  
**Reviewed By:** INSPECTOR (QA & Validation)  
**Managed By:** LEAD  
**Date:** 2026-02-12 02:42 PST  
**Priority:** HIGH  
**Context:** Build comprehensive molecular database for all ref_substances

---

## üéØ OBJECTIVE

Build a comprehensive molecular and pharmacological database that enables:
```

## ./docs/archive/agent_logs/DESIGNER_TASK_PROTOCOLBUILDER_PHASE1.md
```text
# DESIGNER: Protocol Builder Phase 1 Implementation

**Priority:** P0 - Critical for Adoption  
**Estimated Effort:** 4 hours  
**Goal:** Reduce data entry time by 30%

---

## üìã Your Task

Implement Phase 1 UX improvements to the Protocol Builder modal. These are "quick wins" that will immediately improve the user experience.

**Context:** The current Protocol Builder has too much friction for clinical adoption. Practitioners need < 2 minute data entry to use this daily. Phase 1 focuses on replacing dropdowns with button groups for small option sets.

---
```

## ./docs/archive/agent_logs/LEAD_STATUS_REPORT_2026-02-11.md
```text
# üéØ LEAD STATUS REPORT
**Date:** 2026-02-11 18:54 PST  
**Report Type:** Task Review & Agent Assignment  
**Status:** ‚úÖ COMPREHENSIVE REVIEW COMPLETE

---

## üìä EXECUTIVE SUMMARY

**Completed Work:**
- ‚úÖ Protocol Builder Phase 1 UX improvements (ButtonGroup component implemented)
- ‚úÖ Database schema complete (migrations executed)
- ‚úÖ Agent configuration system established
- ‚úÖ Strategic documents created (Pitch Deck, PHI Rationale)

```

## ./docs/archive/agent_logs/DESIGNER_TASK_GUIDEDTOUR_ENHANCEMENT.md
```text
# üé® DESIGNER TASK - GuidedTour Enhancement & Rebuild

**Assigned To:** DESIGNER Agent  
**Priority:** P1 - High  
**Estimated Time:** 8-12 hours  
**Due Date:** 2026-02-15

---

## üìã MISSION

Rebuild and enhance the `GuidedTour.tsx` component to create an exceptional onboarding experience for the PPN Research Portal. The current tour is functional but basic (5 steps, minimal interactivity). We need a world-class, contextual tour system that impresses users and significantly reduces time-to-value.

---

```

## ./docs/archive/agent_logs/LEAD_DESIGN_REVIEW_PROTOCOLBUILDER_PHASE1_20260211.md
```text
# üéØ LEAD DESIGN REVIEW - Protocol Builder Phase 1 (Power User Edition)

**Reviewed By:** LEAD  
**Date:** 2026-02-11 19:42 PST  
**Design Spec:** `DESIGN_SPEC_PROTOCOLBUILDER_PHASE1_20260211.md`  
**Designer:** Antigravity Design Agent  
**Version:** 2.0 - Power User Optimized

---

## üìä REVIEW SUMMARY

**Overall Assessment:** ‚ö†Ô∏è **CONDITIONAL APPROVAL WITH REQUIRED CHANGES**

**Strengths:**
```

## ./docs/archive/agent_logs/SOOP_TASK_CUSTOMER_JOURNEY_ANALYTICS.md
```text
# üìä SOOP TASK: CUSTOMER JOURNEY ANALYTICS INFRASTRUCTURE
## Database Schema, Calculations & Visualizations

**Assigned To:** SOOP (Database & Backend Specialist)  
**Reviewed By:** INSPECTOR (QA & Validation)  
**Managed By:** LEAD  
**Date:** 2026-02-12 02:30 PST  
**Priority:** HIGH

---

## üéØ OBJECTIVE

Build the database infrastructure and calculation logic to support customer journey tracking, use case analytics, and practitioner performance metrics.

```

## ./docs/archive/agent_logs/BUILDER_INSTRUCTIONS_CRITICAL.md
```text
# üîß **BUILDER INSTRUCTIONS: PAGE LAYOUT STANDARDIZATION + AUDIT LOGS COMPLIANCE**

**Prepared By:** INVESTIGATOR (Antigravity)  
**Date:** 2026-02-10 12:44 PM  
**For:** BUILDER Agent  
**Priority:** üî¥ **CRITICAL** (Audit Logs) + üü° **HIGH** (Layout Standardization)

---

## üéØ **DUAL OBJECTIVES**

### **Objective 1: Audit Logs Database Integration** üî¥ **CRITICAL**
**Business Context:** Audit Logs is a **critical compliance tracking page** and one of the **pillars of the business model**. It must track **every log change by an authenticated user** for regulatory compliance, security auditing, and business intelligence.

**Current State:** Uses hardcoded mock data (4 records)  
```

## ./docs/archive/agent_logs/DESIGNER_STRATEGIC_BRIEF_VoC_DRIVEN_UX.md
```text
# üé® DESIGNER STRATEGIC BRIEF: VoC-Driven UX Transformation
## PPN Research Portal - Demo Readiness & Future Vision

**Date:** 2026-02-12 06:02 PST  
**Prepared By:** LEAD  
**For:** DESIGNER  
**Context:** Demo in 2.5 days (Feb 15, 2026) + Long-term product vision  
**Temperature:** 2 (focused, deterministic execution)

---

## üìä EXECUTIVE SUMMARY

**Mission:**
Transform the PPN Research Portal from a "feature platform" into a **Practice Operating System** that solves the #1 pain point identified in comprehensive Voice of Customer research: **workflow chaos and administrative burnout**.
```

## ./docs/archive/agent_logs/INSPECTOR_TASK_PROTOCOLBUILDER_PHASE1_VERIFICATION.md
```text
# üîç INSPECTOR TASK: Protocol Builder Phase 1 Verification

**Assigned By:** LEAD  
**Date:** 2026-02-11 18:54 PST  
**Priority:** P0 - CRITICAL  
**Estimated Effort:** 1 hour  
**Status:** üî¥ READY TO START

---

## üìã YOUR MISSION

Verify that Protocol Builder Phase 1 UX improvements have been implemented correctly and match DESIGNER's specifications.

---
```

## ./docs/archive/agent_logs/BUILDER_TASK_SEARCH_FILTER_DATA_INTEGRATION.md
```text
# Builder Task: Search Portal Filter Data Integration

**Priority:** P2 - Data Quality Issue  
**Type:** Backend Data Plumbing  
**Estimated Time:** 30 minutes  
**Assigned To:** Builder

---

## üéØ **Problem Statement**

The Search Portal (`SearchPortal.tsx`) is using **hardcoded filter options** instead of pulling from database `ref_*` tables. This creates data inconsistency and maintenance issues.

### **Current State (Hardcoded):**
```typescript
```

## ./docs/archive/agent_logs/SOOP_SUBAGENT_SPECIFICATION.md
```text
# üóÑÔ∏è SOOP SOOPGENT SPECIFICATION
## Database Specialist & Schema Architect

**Agent Name:** SOOP  
**Created By:** LEAD  
**Date:** 2026-02-12 04:48 PST  
**Purpose:** Database schema design, migrations, and Supabase configuration

---

## üéØ AGENT MISSION

SOOP is responsible for:
1. **Database Schema Design:** Tables, columns, relationships, indexes
2. **Migration Management:** Additive-only schema changes
```

## ./docs/archive/agent_logs/SOOP_STRATEGIC_BRIEF_DATABASE_FOR_UX.md
```text
# üóÑÔ∏è SOOP STRATEGIC BRIEF: Database Architecture for VoC-Driven Features
## PPN Research Portal - Schema Design Aligned with UX Needs

**Date:** 2026-02-12 06:03 PST  
**Prepared By:** LEAD  
**For:** SOOP (Database Specialist)  
**Context:** Supporting DESIGNER's VoC-driven UX transformation  
**Purpose:** Ensure database schema supports new use cases and UX patterns

---

## üìä EXECUTIVE SUMMARY

**Mission:**
Design and maintain a database schema that **enables** the Practice Operating System vision, not **constrains** it. Your database decisions directly impact practitioner workflows and data quality.
```

## ./docs/archive/agent_logs/DESIGNER_INSTRUCTIONS_READY.md
```text
# üé® DESIGNER: Protocol Builder Phase 1 - Ready to Execute

**Date:** 2026-02-11 10:44 PST  
**Status:** ‚úÖ READY TO START  
**Priority:** P0 - Critical for Adoption

---

## üìç **CRITICAL: PROJECT LOCATION CONFIRMED**

**Your working directory:**
```
/Users/trevorcalton/Desktop/PPN-Antigravity-1.0
```

```

## ./docs/archive/agent_logs/TODO_BUILDER.md
```text
# üî® BUILDER TO-DO LIST
**Role:** Implementation, Code Changes  
**Date:** 2026-02-10  
**Context:** Landing page layout crowding fixes  
**Prerequisites:** Investigator analysis complete

---

## Implementation Phases

### üî¥ **Phase 1: Quick Wins (15 minutes)**
*Low-risk, high-impact changes*

- [ ] **Fix Mission Section Padding**
  - **File:** `src/pages/Landing.tsx`
```

## ./docs/archive/agent_logs/DESIGNER_SKILLS_REVIEW_AND_PLAN.md
```text
# üé® DESIGNER SKILLS REVIEW & APPLICATION PLAN

**Date:** 2026-02-12 05:35 PST  
**Agent:** DESIGNER  
**Purpose:** Leverage available skills for mobile design excellence

---

## üìö **AVAILABLE SKILLS INVENTORY**

### **üéØ Core Design Skills**

#### **1. master-data-ux** ‚≠ê PRIMARY SKILL
**When to Use:** UI designs, data charts, scientific dashboards, website optimization

```

## ./docs/archive/agent_logs/SOOP_TASK_CLINICAL_INTELLIGENCE_SCHEMA.md
```text
# üóÑÔ∏è SOOP TASK: CLINICAL INTELLIGENCE DATABASE SCHEMA

**Assigned To:** SOOP (Database Specialist)  
**Assigned By:** LEAD  
**Date:** 2026-02-11 16:45 PST  
**Priority:** P0 - CRITICAL  
**Estimated Effort:** 2-3 days  
**Status:** üî¥ NOT STARTED

---

## üìã **TASK SUMMARY**

Design database schema and query patterns to support real-time clinical intelligence features: planned protocols, protocol comparisons, multi-substance support, and sub-second aggregation queries for live benchmarking.

```

## ./docs/archive/agent_logs/BUILDER_TASK_MOBILE_MINOR_FIXES.md
```text
# üîß BUILDER TASK: Mobile Minor Fixes (Phase 2)

**From:** DESIGNER  
**To:** BUILDER  
**Date:** 2026-02-12 06:29 PST  
**Priority:** üü° MEDIUM  
**Estimated Time:** 3 hours  
**Type:** Enhancement - Mobile Polish

---

## üéØ **OBJECTIVE**

Fix 7 minor mobile UX issues to achieve 86% of pages working perfectly on mobile.

```

## ./docs/archive/agent_logs/LEAD_ALL_UX_FIXES_COMPLETE.md
```text
# ‚úÖ LEAD: ALL UX FIXES COMPLETE

**Date:** 2026-02-12 09:46 PST  
**Agent:** @LEAD  
**Status:** ‚úÖ ALL TASKS COMPLETE

---

## üéâ FINAL STATUS: 9/9 TASKS COMPLETED

### ‚úÖ All Issues Resolved

1. **Protocol ROI Removed** ‚úÖ
   - Removed from sidebar Intelligence section
   - Clean commented removal
```

## ./docs/archive/agent_logs/DESIGNER_TO_LEAD_LANDING_PAGE_HERO_OPTIMIZATION.md
```text
# üéØ LANDING PAGE HERO OPTIMIZATION PROPOSAL
## Growth Marketing Analysis & Recommendations

**From:** Designer (UI/UX Lead)  
**To:** Lead (Product Owner)  
**Date:** February 11, 2026  
**Status:** Awaiting Approval  
**Priority:** HIGH (Expected +50-80% conversion lift)

---

## üìã EXECUTIVE SUMMARY

**Problem:**  
Current landing page hero section lacks conversion optimization elements that drive B2B SaaS signups: social proof, value quantification, urgency triggers, and friction reduction.
```

## ./docs/archive/agent_logs/DESIGNER_TO_LEAD_VISUAL_PLACEMENT_DECISION.md
```text
# üé® DESIGNER ‚Üí LEAD: Mobile Visual Asset Placement Decision

**From:** DESIGNER  
**To:** LEAD  
**Date:** 2026-02-12 05:56 PST  
**Priority:** MEDIUM  
**Type:** Design Decision Request - Visual Organization

---

## üéØ **DECISION NEEDED**

I've created multiple mobile mockups and visual assets. **Where should each visual go?** I need your guidance on organizing and implementing these designs.

---
```

## ./docs/archive/agent_logs/INSPECTOR_ASSIGNMENT_PROTOCOLBUILDER_VERIFICATION.md
```text
# üîç INSPECTOR ASSIGNMENT - Protocol Builder Current State Verification

**Assigned By:** LEAD  
**Assigned To:** INSPECTOR  
**Date:** 2026-02-11 22:17 PST  
**Priority:** üî¥ CRITICAL  
**Deadline:** Tomorrow (2026-02-12) 12:00 PM PST

---

## üéØ OBJECTIVE

Capture current Protocol Builder state, verify functionality, and provide screenshots for USER approval.

**Why This Matters:**
```

## ./docs/archive/agent_logs/BUILDER_ASSIGNMENT_DEMO_MODE_SECURITY.md
```text
# üî® BUILDER ASSIGNMENT - Demo Mode Security Fix

**Assigned By:** LEAD  
**Assigned To:** BUILDER  
**Date:** 2026-02-11 21:51 PST  
**Priority:** üî¥ CRITICAL  
**Estimated Time:** 30 minutes  
**Deadline:** Today (2026-02-11)

---

## üìã HANDOFF ACKNOWLEDGMENT

**LEAD:** Handing off `BUILDER_TASK_DEMO_MODE_SECURITY_FIX.md` to BUILDER

```

## ./docs/archive/audits/AUDIT_SEARCH_FILTERS_VS_DATABASE.md
```text
# Search Portal Filter Audit: Buttons vs Database Tables

**Date:** 2026-02-12  
**Status:** ‚ö†Ô∏è MISMATCH DETECTED  
**Priority:** P2 - Data Quality

---

## üìä **Filter Comparison**

### **1. SUBSTANCE Filter**

**UI Buttons (SearchPortal.tsx line 20):**
```typescript
const SUBSTANCE_OPTIONS = ['All', ...SUBSTANCES.map(s => s.name)];
```

## ./docs/archive/audits/CRITICAL_DEMO_AUDIT.md
```text
# üö® **CRITICAL DEMO AUDIT - FINAL REPORT**

**Time:** 2026-02-10 14:30 PM (1 hour to demo)  
**Status:** ‚ö†Ô∏è **MIXED - SOME PAGES WILL FAIL**

---

## ‚úÖ **PAGES THAT WILL WORK (15)**

### **Core Pages (100% Functional)**
1. ‚úÖ **Landing** - Static content, molecules
2. ‚úÖ **Login** - Form only
3. ‚úÖ **Dashboard** - Hardcoded metrics
4. ‚úÖ **Protocol Builder** - Uses `SAMPLE_INTERVENTION_RECORDS`, `MEDICATIONS_LIST`
5. ‚úÖ **Interaction Checker** - Uses `INTERACTION_RULES`, `MEDICATIONS_LIST`
```

## ./docs/archive/audits/CRAWL_TASK_MOBILE_VALIDATION.md
```text
# üîç CRAWL: Mobile Testing & Validation Task

**From:** DESIGNER  
**To:** CRAWL  
**Date:** 2026-02-12 06:54 PST  
**Priority:** üü¢ HIGH  
**Type:** Testing & Validation

---

## üéØ **OBJECTIVE**

Validate mobile fixes across all 14 pages of the PPN Research Portal and generate a comprehensive mobile audit report.

**Success Criteria:**
```

## ./docs/archive/audits/TOOLTIP_LIBRARY.md
```text
# PPN Research Portal - Master Tooltip Library & Glossary
**Version:** 1.0 (Advanced)  
**Date:** 2026-02-10  
**Reading Level:** 7th Grade (Clear, Simple, jargon-free)

---

## üü¢ 1. Design System: Tooltip Tiers

We use three types of tooltips. Choose the right one based on how much help the user needs.

### Tier 1: Micro-Tooltip (Hover only)
*   **Best for:** Icons, Buttons, Status dots.
*   **Content:** 1-5 words. Naming things.
*   **Example:** "Close Window" or "Active Protocol".
```

## ./docs/archive/audits/CRAWL_COMPREHENSIVE_AUDIT_POST_FIX_2026-02-12.md
```text
# COMPREHENSIVE SITE AUDIT - POST-FIX REPORT
**Date:** 2026-02-12 08:27 PST
**Auditor:** CRAWL Subagent (via LEAD + BUILDER)
**Scope:** All 19 pages, Desktop (1280x800) + Mobile (375x667)
**Status:** ‚úÖ **SITE OPERATIONAL** | ‚ö†Ô∏è **2 HIGH PRIORITY ISSUES IDENTIFIED**

---

## EXECUTIVE SUMMARY

The PPN Research Portal is now **FULLY FUNCTIONAL** after resolving the critical compilation error. A comprehensive audit of all 19 pages across desktop and mobile viewports has been completed with **38 screenshots captured** and **console logs analyzed**.

**Overall Health:** üü¢ GOOD
- **Pass Rate:** 95% (18/19 pages fully functional on both viewports)
- **Critical Issues:** 0
```

## ./docs/archive/audits/SQL_MANDATORY_RULES.md
```text
# üóÑÔ∏è **SQL DATABASE BEST PRACTICES - MANDATORY RULES**

**Date:** 2026-02-10  
**Purpose:** Mandatory rules for all database work on PPN Research Portal  
**Applies to:** All agents (INVESTIGATOR, BUILDER, DESIGNER)

---

## üî¥ **CRITICAL RULES (NEVER VIOLATE)**

### **1. NO HARDCODED DATA - USE FOREIGN KEYS**
‚ùå **NEVER** store text that should be a foreign key
```sql
-- WRONG
substance_name TEXT  -- "Psilocybin", "MDMA", etc.
```

## ./docs/archive/audits/COMPREHENSIVE_3VIEWPORT_AUDIT_FINAL.md
```text
# COMPREHENSIVE 3-VIEWPORT AUDIT REPORT - FINAL
**PPN Research Portal - Complete Site Audit**
**Date:** 2026-02-12
**Auditor:** DESIGNER Agent  
**Total Screenshots:** 51 (17 pages √ó 3 viewports)

---

## EXECUTIVE SUMMARY

**Overall Site Score: 8.5/10** (GOOD tier, trending toward AMAZING)

**Audit Scope:**
- 18 primary application pages audited
- 3 viewports per page (Mobile 375px, Tablet 768px, Desktop 1440px)
```

## ./docs/archive/audits/MOBILE_OPTIMIZATION_COMPLETE.md
```text
# ‚úÖ Mobile Optimization Complete - Protocol Builder

**Date:** 2026-02-12 04:20 PST  
**Status:** üü¢ COMPLETE  
**Priority:** P0 - CRITICAL (RESOLVED)

---

## üì± **MOBILE FIXES IMPLEMENTED**

### **File Modified:** `/src/components/forms/ButtonGroup.tsx`

**Changes Made:**
1. **Responsive Layout**: Changed from `flex gap-2` to `flex flex-col sm:flex-row gap-2`
   - Mobile (<640px): Buttons stack vertically
```

## ./docs/archive/audits/CRITICAL_AGENT_IDENTIFICATION_RULE.md
```text
# üö® CRITICAL SAFETY RULE - MANDATORY AGENT IDENTIFICATION

**Date:** 2026-02-11  
**Priority:** CRITICAL - P0  
**Status:** ENFORCED  
**Reason:** Lack of identification caused critical database failure

---

## üéØ **THE RULE**

**EVERY agent and subagent MUST identify themselves at the start of EVERY response.**

### **Format:**
```
```

## ./docs/archive/audits/MOBILE_RESPONSIVENESS_AUDIT.md
```text
# üì± MOBILE RESPONSIVENESS AUDIT
**Date:** February 9, 2026 21:48 PST  
**File Audited:** `src/pages/Landing.tsx`  
**Method:** Code review (dev server unavailable)  
**Status:** ‚úÖ **EXCELLENT MOBILE SUPPORT**

---

## üéØ **EXECUTIVE SUMMARY**

**Overall Grade: A+ (95/100)**

The Landing page has **excellent mobile responsiveness** with proper Tailwind breakpoints throughout. All major sections adapt correctly from mobile (375px) to desktop (1920px).

**Key Strengths:**
```

## ./docs/archive/audits/SITEMAP_INFORMATION_ARCHITECTURE.md
```text
# üó∫Ô∏è PPN PORTAL SITEMAP & INFORMATION ARCHITECTURE
## Complete Site Structure & Navigation Plan

**Created By:** LEAD  
**Date:** 2026-02-12 04:00 PST  
**Purpose:** Comprehensive sitemap for PPN Portal (public + authenticated)

---

## üéØ SITE STRUCTURE OVERVIEW

### **Two Main Sections:**
1. **Public Site** (Marketing, education, signup)
2. **Authenticated App** (Dashboard, tools, analytics)

```

## ./docs/archive/audits/SQL_STATUS_REPORT.md
```text
# üìä **SQL DATABASE STATUS REPORT**

**Generated By:** BUILDER (Antigravity)  
**Date:** 2026-02-10 13:42 PM  
**Purpose:** Complete review of database state before proceeding

---

## ‚úÖ **WHAT EXISTS (CONFIRMED)**

### **Core Tables** (from migration 000)
- ‚úÖ `sites` - Site/clinic information
- ‚úÖ `user_sites` - User-to-site mapping with roles
- ‚úÖ `log_clinical_records` - Main clinical data table
- ‚úÖ `log_outcomes` - Outcome measures
```

## ./docs/archive/audits/CRITICAL_FIXES_COMPLETE.md
```text
# üîß CRITICAL FIXES COMPLETED
**Date:** February 10, 2026 00:30 PST  
**Builder:** Antigravity AI

---

## ‚úÖ ALL 3 CRITICAL ISSUES FIXED

### **1. Logout Security** ‚úÖ ALREADY WORKING
**Status:** No fix needed - already implemented correctly

**Verification:**
- Tested logout flow in browser
- Confirmed `handleLogout` function exists in `TopHeader.tsx`
- Confirmed it calls `supabase.auth.signOut()`
```

## ./docs/archive/audits/SQL_BEST_PRACTICES_AUDIT.md
```text
# üîç **SQL DATABASE BEST PRACTICES AUDIT**

**Date:** 2026-02-10 13:55 PM  
**Purpose:** Comprehensive review of database design against industry best practices  
**Scope:** PPN Research Portal Supabase PostgreSQL database

---

## üìö **INDUSTRY BEST PRACTICES (PostgreSQL/Supabase)**

### **1. NORMALIZATION (3NF Minimum)**
**Standard:** Data should be normalized to Third Normal Form (3NF)
- No repeating groups
- No partial dependencies
- No transitive dependencies
```

## ./docs/archive/audits/COMPREHENSIVE_3VIEWPORT_AUDIT_REPORT.md
```text
# COMPREHENSIVE 3-VIEWPORT AUDIT REPORT
**PPN Research Portal - Visual Layout & Interaction Assessment**

---

## AUDIT METHODOLOGY

**Viewports Tested:**
- Mobile: 375√ó812px (iPhone SE/13 Mini standard)
- Tablet: 768√ó1024px (iPad portrait mode)
- Desktop: 1440√ó900px (MacBook Pro 15" standard)

**Scoring Framework (0-10) - Project-Aligned UX Evaluation**

This audit uses the **UI/UX Product Design Skill** (decision-making rubric), **Frontend Best Practices Skill** (design system compliance), and **Inspector QA Skill** (feasibility validation) to score each viewport.
```

## ./docs/archive/audits/AUDIT_SYNTHESIS.md
```text
# üéØ PPN RESEARCH PORTAL - AUDIT SYNTHESIS & ACTION PLAN

**Date:** 2026-02-09  
**Auditors:** Antigravity AI (Functional + Creative Director)  
**Purpose:** Consolidate findings from both audits and create unified roadmap

---

## üìä EXECUTIVE SUMMARY

### Two Complementary Perspectives

**FULL SITE AUDIT (Functional/UX):**
- **Score:** 8.3/10 (Production Ready)
- **Focus:** Functionality, accessibility, usability
```

## ./docs/archive/audits/TOOLTIP_AUDIT_REPORT.md
```text
# üîç TOOLTIP ALIGNMENT & VISIBILITY AUDIT

**Date:** 2026-02-10  
**Auditor:** Builder Agent  
**Scope:** All tooltips across the PPN Research Portal

---

## üìä EXECUTIVE SUMMARY

**Total Tooltips Found:** 7 AdvancedTooltip instances  
**Issues Fixed:** 1  
**Issues Remaining:** 0  
**Status:** ‚úÖ ALL CLEAR

```

## ./docs/archive/audits/CRAWL_COMPREHENSIVE_AUDIT_2026-02-12.md
```text
# COMPREHENSIVE SITE AUDIT REPORT
**Date:** 2026-02-12 08:12 PST
**Auditor:** CRAWL Subagent
**Scope:** All pages, Desktop (1280x800) + Mobile (375x667)
**Status:** üî¥ **CRITICAL FAILURE - SITE DOWN**

---

## EXECUTIVE SUMMARY

The PPN Research Portal is currently **COMPLETELY INACCESSIBLE** due to a compilation error in `src/pages/ProtocolBuilder.tsx`. This error prevents the Vite development server from bundling the application, resulting in a universal crash across all pages and viewports.

**Impact:** 100% of site functionality is blocked.
**Root Cause:** Duplicate import declarations (lines 11-12).
**Immediate Action Required:** Remove duplicate import to restore site.
```

## ./docs/archive/audits/FULL_SITE_AUDIT.md
```text
# üîç PPN RESEARCH PORTAL - COMPLETE FORENSIC UI/UX AUDIT
**Date:** 2026-02-09  
**Auditor:** Antigravity AI  
**Methodology:** Systematic code analysis + browser testing  
**Pages Audited:** 38 total

---

## üìä EXECUTIVE SUMMARY

### Overall Site Health: **8.3/10** (Very Good - Production Ready with Minor Gaps)

**Key Strengths:**
- ‚úÖ Exceptional visual design and brand consistency (10/10)
- ‚úÖ Comprehensive feature set covering all clinical workflows
```

## ./docs/archive/audits/COMPREHENSIVE_SITE_AUDIT_2026-02-10.md
```text
# üîç COMPREHENSIVE SITE AUDIT REPORT
**PPN Research Portal - Full End-to-End Inspection**  
**Date:** February 10, 2026 00:00 PST  
**Inspector:** Antigravity AI  
**Audit Type:** Complete User Journey (Landing ‚Üí Signup ‚Üí Dashboard ‚Üí All Features)

---

## üìä EXECUTIVE SUMMARY

**Overall Site Health Score: 78/100** üü°

**Status:** Site is functional but has critical issues that must be addressed before public launch.

**Key Findings:**
```

## ./docs/archive/audits/MOBILE_UX_AUDIT_CRITICAL_FINDINGS.md
```text
# Mobile UX Audit - Critical Findings & Status

**Date:** 2026-02-12 03:30 PST  
**Viewport Tested:** 375x667px (iPhone SE)  
**Status:** üö® MULTIPLE CRITICAL ISSUES FOUND

---

## ‚úÖ **FIXED ISSUES**

### **1. App Crash (CRITICAL - FIXED)**
- **Problem:** ProtocolBuilder component had incomplete sorting code causing crashes
- **Impact:** `/builder`, `/safety-surveillance`, `/` (landing) all crashed
- **Fix:** Reverted incomplete sorting feature
- **Status:** ‚úÖ **RESOLVED** - App no longer crashes
```

## ./docs/archive/audits/MOBILE_BUGS_FIXED_2026-02-12.md
```text
# MOBILE BUG FIXES - COMPLETION REPORT
**Date:** 2026-02-12 09:32 PST  
**Status:** ‚úÖ **COMPLETE**  
**Priority:** P0 - Demo Readiness

---

## ‚úÖ FIXES IMPLEMENTED

### **Issue #1: Help Page Mobile Redirect**
**Status:** ‚ùå DOES NOT EXIST  
**Finding:** INSPECTOR confirmed "FAILED TO REPRODUCE"  
**Action:** No fix required - issue was intermittent or already resolved

---
```

## ./docs/archive/audits/SIDEBAR_ANALYSIS.md
```text
# üîç **SIDEBAR ANALYSIS: INCONSISTENCY, CAUSE, UTILITY vs RISK**

**Investigated By:** INVESTIGATOR (Antigravity)  
**Date:** 2026-02-10 13:04 PM  
**Component:** `src/components/Sidebar.tsx`  
**Status:** üü° **PARTIALLY FUNCTIONAL - DESIGN MISMATCH**

---

## üìä **EXECUTIVE SUMMARY**

**Finding:** The Sidebar component is **technically functional** but has a **fundamental design mismatch** between the original intention and current implementation.

**Original Intention:**  
> "Simple reflection of how many uploads of each substance we have in the database. Seven bars and a simple count of each substance protocol in the logs."
```

## ./docs/archive/audits/RESPONSIVE_LAYOUT_ANALYSIS.md
```text
# üì± Responsive Layout Analysis
**Designer:** DESIGNER (Antigravity)  
**Date:** 2026-02-10  
**Gold Standard:** SubstanceCatalog.tsx  
**Objective:** Ensure all pages dynamically adjust to screen size

---

## Executive Summary

**Finding:** SubstanceCatalog demonstrates **excellent responsive design** with:
- ‚úÖ Flexible sidebar that collapses on mobile
- ‚úÖ Responsive grid (`grid-cols-1 md:grid-cols-2 xl:grid-cols-3`)
- ‚úÖ Adaptive padding (`p-6 sm:p-10 lg:p-12`)
- ‚úÖ Sticky sidebar on desktop (`lg:sticky lg:top-0`)
```

## ./docs/archive/audits/SITE_REFINED_VISION.md
```text
# üé® PPN RESEARCH PORTAL - REFINED VISION
## Complete Site Architecture & Messaging Strategy

**Date:** February 11, 2026  
**Version:** 2.0 - Post-Strategic Analysis  
**Status:** Ready for Implementation  

---

## üéØ CORE POSITIONING STATEMENT

### **What PPN Research Portal IS:**

> **A real-time clinical intelligence platform that augments practitioner decision-making while simultaneously building the world's largest psychedelic therapy evidence base.**

```

## ./docs/archive/audits/PAGE_LAYOUT_AUDIT.md
```text
# üìê Page Layout Audit & Standardization Plan
**Objective:** Ensure all pages have consistent width, side margins, and responsive behavior  
**Date:** 2026-02-10  
**Status:** ANALYSIS PHASE - Awaiting Approval

---

## üéØ Target Standard (Based on ProtocolBuilder)

### **Container Pattern:**
```tsx
<PageContainer width="wide" className="min-h-full py-6 sm:py-10 pb-24">
  <Section>
    {/* Content */}
  </Section>
```

## ./docs/archive/audits/MOBILE_BUG_FIX_PLAN_2026-02-12.md
```text
# MOBILE BUG FIX PLAN
**Date:** 2026-02-12 09:32 PST  
**Priority:** P0 - BLOCKING DEMO  
**Status:** READY TO IMPLEMENT

---

## üîß ISSUE#2: Search Button Misalignment (Mobile)

### **Root Cause Analysis**

**Affected Pages:**
1. **SearchPortal.tsx** (Advanced Search) - Line 511
2. **HelpFAQ.tsx** (Help page) - Line 119

```

## ./docs/archive/audits/COMPREHENSIVE_PAGE_AUDIT.md
```text
# üìã COMPREHENSIVE PAGE AUDIT REPORT
**Date:** February 9, 2026 22:00 PST  
**Scope:** Profile creation, My Protocols, Protocol Detail, Audit Logs, Settings, Help, Printable Reports  
**Purpose:** Identify what needs updating for launch

---

## üéØ **EXECUTIVE SUMMARY**

**Pages Audited:** 7  
**Status:**
- ‚úÖ **Complete & Premium:** 2 pages (Protocol Detail, Help FAQ)
- ‚ö†Ô∏è **Needs Work:** 4 pages (My Protocols, Audit Logs, Settings, Clinician Profile Creation)
- ‚ùå **Missing:** 1 feature (Clinician Profile Creation Modal)

```

## ./docs/archive/audits/AUDIT_COMPARISON.md
```text
# üìä AUDIT COMPARISON - AT A GLANCE

**Date:** 2026-02-09

---

## üéØ THE TWO AUDITS

### FULL SITE AUDIT (Functional/UX)
**Perspective:** Clinical Software Engineer  
**Score:** 8.3/10  
**Pages Analyzed:** 38  
**Issues Found:** 127  
**Refinements:** 102 hours

```

## ./docs/archive/audits/SITE_AUDIT_2026-02-08.md
```text
# PPN Research Portal - Full Site Audit
**Date:** February 8, 2026  
**Auditor:** Antigravity AI  
**Version:** v3.33  
**Status:** üü° Active Development

---

## Executive Summary

### Overall Health Score: 7.2/10

**Strengths:**
- ‚úÖ Well-structured React/TypeScript codebase with clear separation of concerns
- ‚úÖ Comprehensive design system documentation in place
```

## ./docs/archive/audits/MOBILE_FIRST_OPTIMIZATION_STRATEGY.md
```text
# üì± MOBILE-FIRST OPTIMIZATION STRATEGY
## PPN Research Portal - High Mobile Usage Preparation

**Created By:** LEAD  
**Date:** 2026-02-12 02:37 PST  
**Priority:** CRITICAL  
**Context:** Anticipating high mobile usage from practitioners

---

## üìä EXECUTIVE SUMMARY

**Assumption:** 60-70% of practitioners will use PPN on mobile devices

**Why Mobile Matters:**
```

## ./docs/archive/batch_reports/PHASE_STATUS_REPORT_ALL.md
```text
# üìä PHASE STATUS REPORT - All Phases

**Report Date:** 2026-02-12 06:54 PST  
**Compiled By:** DESIGNER  
**Report Type:** Comprehensive Phase Status  
**Scope:** Phase 1, Phase 1.5, Phase 2

---

## üéØ EXECUTIVE SUMMARY

### **Overall Status:**
- **Phase 1:** ‚úÖ **100% COMPLETE**
- **Phase 1.5:** ‚è∏Ô∏è **DEFERRED** (Post-Demo)
- **Phase 2:** üî¥ **IN PROGRESS** (Mobile fixes complete)
```

## ./docs/archive/batch_reports/SESSION_SUMMARY_20260211_MASSIVE_PROGRESS.md
```text
# üéâ SESSION SUMMARY - MASSIVE PROGRESS!

**Date:** 2026-02-11  
**Duration:** 4+ hours  
**Status:** ‚úÖ EXCEPTIONAL PRODUCTIVITY  
**Demo Readiness:** 90% ‚Üí 95%

---

## üèÜ MAJOR ACCOMPLISHMENTS

### **1. Analytics Database Connection** ‚úÖ COMPLETE
**Time:** 30 minutes  
**Impact:** HIGH

```

## ./docs/archive/batch_reports/SESSION_SUMMARY.md
```text
# üéâ SESSION SUMMARY - 2026-02-09

**Duration:** ~3 hours  
**Focus:** Critical Fixes & Accessibility Enhancements

---

## ‚úÖ COMPLETED TASKS

### 1. **Product Showcase Components** ‚úÖ
**Files Created:**
- `src/components/demos/SafetyRiskMatrixDemo.tsx`
- `src/components/demos/ClinicRadarDemo.tsx`
- `src/components/demos/PatientJourneyDemo.tsx`

```

## ./docs/archive/batch_reports/BATCH_5_6_COMBINED.md
```text
# üîß BATCH 5+6: PROFILE, DATA & POLISH (COMBINED)
**Date:** February 9, 2026 22:08 PST  
**Purpose:** Create profile modal + Supabase integration + premium polish  
**Total Time:** 255 minutes (4.25 hours)  
**Priority:** Week 1 post-launch

---

## üéØ **IMPLEMENTATION STRATEGY**

**Safe, Logical Sequence:**
1. **Data Layer First** - Supabase integration (no UI changes)
2. **UI Polish** - Enhance existing pages (low risk)
3. **New Features** - Profile creation modal (isolated)

```

## ./docs/archive/batch_reports/BATCH_2_PORTAL_DASHBOARD.md
```text
# üöÄ BATCH 2: SEARCH PORTAL + DASHBOARD
**Time Estimate:** 30 minutes  
**Risk Level:** LOW  
**Files to Modify:** 2 files  
**Impact:** MEDIUM - Functional improvements

---

## üìã **WHAT THIS BATCH DOES**

This batch improves the Search Portal and Dashboard with functional and visual enhancements:

‚úÖ Fixes search box input (text visible, AI icon visible)  
‚úÖ Improves portal layout spacing (filters closer to results)  
‚úÖ Adds black backgrounds to molecule images  
```

## ./docs/archive/batch_reports/BATCH_1_FOUNDATION_LANDING.md
```text
# üöÄ BATCH 1: FOUNDATION + LANDING PAGE
**Time Estimate:** 90 minutes  
**Risk Level:** LOW  
**Files to Modify:** 3 files (1 new, 2 existing)  
**Impact:** HIGH - Most visible improvements

---

## üìã **WHAT THIS BATCH DOES**

This batch creates the foundation components and polishes the Landing page with high-impact visual improvements:

‚úÖ Creates reusable InfoTooltip component (needed for Batch 5)  
‚úÖ Makes both CTA buttons blue and same size  
‚úÖ Adds gradient text to 5 key keywords  
```

## ./docs/archive/batch_reports/BATCH_5_MONOGRAPH.md
```text
# üöÄ BATCH 5: SUBSTANCE MONOGRAPH
**Time Estimate:** 120 minutes  
**Risk Level:** MEDIUM-HIGH (complex layout refactor)  
**Files to Modify:** 1 file (many changes)  
**Impact:** HIGH - Dramatic improvement to information density

---

## üìã **WHAT THIS BATCH DOES**

This batch refactors the Substance Monograph page for better layout and usability:

‚úÖ Restructures hero section (horizontal: text-molecule-efficacy)  
‚úÖ Adds tooltips to all 5 containers  
‚úÖ Fixes container heights (all 420px)  
```

## ./docs/archive/batch_reports/BATCH_4_DEEP_DIVES.md
```text
# üöÄ BATCH 4: DEEP DIVE PAGES
**Time Estimate:** 90 minutes  
**Risk Level:** LOW  
**Files to Modify:** 6 files (1 new, 5 existing)  
**Impact:** HIGH - Consistent layout across all deep dive pages

---

## üìã **WHAT THIS BATCH DOES**

This batch standardizes all deep dive pages with consistent layout and simplified copy:

‚úÖ Creates reusable DeepDiveLayout component  
‚úÖ Updates 5 deep dive pages to use wide layout  
‚úÖ Increases subheading size and width  
```

## ./docs/archive/batch_reports/BATCH_3_NAMING.md
```text
# üöÄ BATCH 3: NAMING & CONSISTENCY
**Time Estimate:** 45 minutes  
**Risk Level:** MEDIUM (route changes)  
**Files to Modify:** 6 files (1 rename)  
**Impact:** HIGH - Consistent naming across app

---

## üìã **WHAT THIS BATCH DOES**

This batch fixes naming inconsistencies across the application:

‚úÖ Renames "Patient Galaxy/Constellation" ‚Üí "Patient Outcomes Map"  
‚úÖ Renames "Pharmacology Lab" ‚Üí "Molecular Pharmacology"  
‚úÖ Updates all navigation links  
```

## ./docs/AGENT_YAML_UPDATE_SUMMARY.md
```text
# üéØ AGENT.YAML UPDATE COMPLETE

**LEAD:** Agent configuration has been updated to incorporate the new team handoff protocols.

## ‚úÖ Changes Made

### **1. Updated LEAD Description**
- Changed to: "Senior Skills Architect & Technical Lead"  
- Added: "Project manager who plans and delegates tasks"

### **2. Added Handoff Protocol Reference**
- New Rule #3 instructs LEAD to read `/docs/TEAM_HANDOFF_PROTOCOLS.md`
- Artifact-first communication enforced
- Chain of Custody syntax required
- Builder's Gate enforcement mandate
```

## ./docs/audit/FILE_INVENTORY_2026_02_12.md
```text
# üìÇ COMPREHENSIVE FILE INVENTORY - 2026-02-12

## CORE_CONFIG (8)
- .agent/
- .git/
- .github/
- agent.yaml
- index.html
- package.json
- tsconfig.json
- vite.config.ts

## AGENT_ARTIFACTS (226)
- AUDIT_COMPARISON.md
- AUDIT_SEARCH_FILTERS_VS_DATABASE.md
```

## ./docs/audit/GAP_ANALYSIS_REPORT_2026_02_12.md
```text
# üìâ GAP ANALYSIS REPORT
**Date:** 2026-02-12
**Status:** ‚ö†Ô∏è SIGNIFICANT DEBT IDENTIFIED

## 1. Executive Summary
A comparison of the "Master Plan" documents (archived) against the live codebase reveals that while the **Visual/Frontend** layer is nearly complete (~90%), the **Functional/Data** layer is significantly behind schedule (~40%).

- **Planned:** Full Protocol Builder (Database-backed), Analytic Dashboards, Mobile Optimization.
- **Actual:** Visual Shells exist, but backend wiring is largely missing or mocked.

---

## 2. Detailed Gap Analysis

### üî¥ CRITICAL GAPS (Missing Functionality)
```

## ./docs/audit/FULL_SYSTEM_AUDIT_REPORT.md
```text
# üïµÔ∏è COMPREHENSIVE SYSTEM AUDIT REPORT
**Date:** 2026-02-12
**Status:** üî¥ CRITICAL CLUTTER DETECTED

## 1. Executive Summary
The system is functionally sound but operationally disorganized. The root directory contains **270+ orphaned documentation files** that obscure the actual source code.

- **Total Files Scanned:** ~320
- **Source Code (`src`):** ‚úÖ Healthy (50+ components, organized)
- **Database (`backend/migrations`):** ‚úÖ Healthy (27 migrations, 100% SQL)
- **Root Directory:** ‚ùå SEVERE CLUTTER (270+ loose markdown/script files)

---

## 2. Source Code Assurance (`src/`)
```

## ./docs/TEAM_HANDOFF_PROTOCOLS.md
```text
# ü§ù TEAM HANDOFF PROTOCOLS & BEST PRACTICES

**Version:** 1.0  
**Effective Date:** 2026-02-12  
**Status:** ACTIVE

---

## üìú THE HANDOFF PROTOCOL

### **Rule #1: Artifact-First Communication**

**NEVER** pass tasks via chat alone. **ALWAYS** create a structured artifact first.

#### **Agent-Specific Artifact Requirements:**
```

## ./docs/deployment/ENVIRONMENT_VARIABLES.md
```text
# Environment Variables Template

## Production Environment Variables for Vercel

Copy these to Vercel Project Settings ‚Üí Environment Variables

---

## Supabase

```bash
VITE_SUPABASE_URL=https://your-project.supabase.co
VITE_SUPABASE_ANON_KEY=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9...
```

```

## ./docs/legal/PRIVACY_POLICY.md
```text
# Privacy Policy - PPN Research Portal

**Effective Date:** February 13, 2026  
**Last Updated:** February 13, 2026

---

## 1. Introduction

PPN Research Portal ("we," "us," "our") is committed to protecting your privacy. This Privacy Policy explains how we collect, use, disclose, and safeguard your information when you use our Service.

---

## 2. Information We Collect

```

## ./docs/legal/TERMS_OF_SERVICE.md
```text
# Terms of Service - PPN Research Portal

**Effective Date:** February 13, 2026  
**Last Updated:** February 13, 2026

---

## 1. Acceptance of Terms

By accessing or using the PPN Research Portal ("Service"), you agree to be bound by these Terms of Service ("Terms"). If you do not agree to these Terms, do not use the Service.

---

## 2. Description of Service

```

## ./docs/legal/BUSINESS_ASSOCIATE_AGREEMENT.md
```text
# Business Associate Agreement (BAA)

**Effective Date:** February 13, 2026

This Business Associate Agreement ("Agreement") is entered into between:

**COVERED ENTITY:** [User/Organization Name]  
**BUSINESS ASSOCIATE:** PPN Research Portal, LLC

---

## RECITALS

WHEREAS, Covered Entity and Business Associate have entered into a subscription agreement for the use of PPN Research Portal ("Service");

```

## ./MASTER_PLAN.md
```text
# PPN Research Portal - Master Plan

**Version:** 1.0  
**Last Updated:** February 13, 2026  
**Status:** MVP Development Phase  
**Location:** `/MASTER_PLAN.md` (Project Root)

> **‚ö†Ô∏è SINGLE SOURCE OF TRUTH**: All agents must reference this document for context, priorities, and coordination.

---

## üéØ Mission

Build the Practice Operating System for Psychedelic Therapy - unifying safety, outcomes, and compliance into a single secure platform trusted by practitioners worldwide.

```

## ./README.md
```text
<div align="center">
  <img width="1200" height="475" alt="PPN Research Portal Banner" src="https://github.com/user-attachments/assets/0aa67016-6eaf-458a-adb2-6e31a0763ed6" />
  
  # PPN Research Portal
  
  **A comprehensive clinical research platform for psychedelic-assisted therapy**
  
  [![TypeScript](https://img.shields.io/badge/TypeScript-5.8.2-blue.svg)](https://www.typescriptlang.org/)
  [![React](https://img.shields.io/badge/React-19.2.3-61dafb.svg)](https://reactjs.org/)
  [![Vite](https://img.shields.io/badge/Vite-6.2.0-646cff.svg)](https://vitejs.dev/)
  [![Supabase](https://img.shields.io/badge/Supabase-2.95.3-3ecf8e.svg)](https://supabase.com/)
  
</div>

---
```

## ./WEBHOOK_SETUP.md
```text
# Stripe Webhook Configuration

**Status:** Ready to configure  
**Webhook URL:** `https://rxwsthatjhnixqsthegf.supabase.co/functions/v1/stripe-webhook`

---

## Quick Setup (2 minutes)

### 1. Open Stripe Webhooks

Go to: [Stripe Dashboard ‚Üí Webhooks](https://dashboard.stripe.com/test/webhooks)

Make sure you're in **Test mode** (orange banner at top)

```

## ./ANALYTICS_SETUP.md
```text
# Analytics Setup Instructions

**Status:** In Progress  
**Owner:** BUILDER  
**Date:** February 13, 2026

---

## ‚ö†Ô∏è NPM Permission Issue

There's currently an npm cache permission issue that needs to be resolved before installing dependencies.

### Fix Required:

```bash
```

## ./.github/PULL_REQUEST_TEMPLATE.md
```text
## üìã Description

<!-- Provide a brief description of the changes in this PR -->

## üéØ Type of Change

<!-- Mark the relevant option with an 'x' -->

- [ ] üêõ Bug fix (non-breaking change which fixes an issue)
- [ ] ‚ú® New feature (non-breaking change which adds functionality)
- [ ] üí• Breaking change (fix or feature that would cause existing functionality to not work as expected)
- [ ] üìö Documentation update
- [ ] üé® Style/UI update (no functional changes)
- [ ] ‚ôªÔ∏è Code refactoring (no functional changes)
- [ ] ‚ö° Performance improvement
```

## ./.github/ISSUE_TEMPLATE/feature_request.md
```text
---
name: Feature Request
about: Suggest a new feature or enhancement
title: '[FEATURE] '
labels: enhancement
assignees: ''
---

## üöÄ Feature Description

A clear and concise description of the feature you'd like to see.

## üí° Problem Statement

**Is your feature request related to a problem?**
```

## ./.github/ISSUE_TEMPLATE/bug_report.md
```text
---
name: Bug Report
about: Report a bug to help us improve
title: '[BUG] '
labels: bug
assignees: ''
---

## üêõ Bug Description

A clear and concise description of what the bug is.

## üìã Steps to Reproduce

1. Go to '...'
```

## ./.github/ISSUE_TEMPLATE/documentation.md
```text
---
name: Documentation Update
about: Suggest improvements to documentation
title: '[DOCS] '
labels: documentation
assignees: ''
---

## üìö Documentation Issue

**Which documentation needs updating?**
- [ ] README.md
- [ ] CONTRIBUTING.md
- [ ] DESIGN_SYSTEM.md
- [ ] Code comments
```

## ./.agent/research/üìä Psychedelic Therapy Data Source Research.md
```text
# **Mapping the Data Ecosystem of Psychedelic-Assisted Therapy: Institutional Standards, Real-World Evidence, and Distributed Clinical Intelligence**

The therapeutic landscape for psychedelic-assisted interventions is currently undergoing a structural transformation from a disparate collection of subterranean practices and early-stage academic inquiries into a regulated, evidence-based medical and spiritual framework. This evolution is fundamentally driven by the aggregation and analysis of data from a multitude of sources, each possessing unique epistemological strengths and limitations. The evidentiary standard required for the formal medicalization of substances such as psilocybin, MDMA, and LSD remains functionally aligned with traditional pharmaceutical regulations, yet the profound subjective nature of the psychedelic experience necessitates a more comprehensive "mosaic of data systems" than has been required for conventional psychiatric medications.1 This report examines the diverse data repositories, standardization protocols, and analytical frameworks currently defining the field, with a particular focus on the integration of institutional randomized controlled trials (RCTs), real-world evidence (RWE) from clinical practice, and grassroots citizen science initiatives.

## **Institutional Standards and the Regulatory Evidence Paradigm**

The U.S. Food and Drug Administration (FDA) serves as the primary arbiter of clinical data legitimacy for psychedelic drug development. The agency‚Äôs 2023 draft guidance on psychedelic drugs emphasizes that sponsors must provide exhaustive information regarding chemistry, manufacturing, and controls (CMC) to ensure the purity, strength, and identification of both investigational drug substances and finished products.3 This requirement is particularly complex when dealing with botanical sources, such as psilocybin mushrooms or iboga root bark, where consistent quality must be maintained across multiple batches to prevent confounding variables in clinical outcomes.5 Furthermore, the FDA requires rigorous non-clinical safety studies, including an evaluation of binding activity at the 5-HT2B receptor subtype, which is associated with heart valvulopathy in humans‚Äîa critical safety concern for drugs intended for chronic or repeated administration.3

Data standardization is the cornerstone of regulatory approval. The adoption of Clinical Data Interchange Standards Consortium (CDISC) standards is increasingly mandatory for successful Investigational New Drug (IND) and New Drug Application (NDA) submissions.8 These standards facilitate the exchange of complex clinical, molecular, and real-world data, providing a unified format that the FDA utilizes for its regulatory evaluation of health products.8 Within this framework, the Research Electronic Data Capture (REDCap) system has emerged as the preferred tool for managing data in multi-site clinical trials and longitudinal surveys.11 REDCap‚Äôs metadata-driven workflow enables researchers to design customizable clinical forms while maintaining strict adherence to HIPAA and 21 CFR Part 11 requirements, ensuring the integrity and security of participant information.12

| Standard / Tool | Regulatory Function | Clinical Application |
| :---- | :---- | :---- |
| **CDISC SDTM** | Data Tabulation | Standardizing raw clinical trial data for submission to regulatory agencies.15 |
| **CDISC ADaM** | Analysis Dataset | Structuring data for statistical analysis and primary endpoint validation.9 |
| **Dataset JSON** | Exchange Format | Enhancing the transfer of complex genomic and molecular datasets between sponsors and regulators.8 |
```

## ./.agent/research/business_strategy_skill.md
```text
---
name: Business Strategy Skill
description: Market analysis, competitive positioning, and business model reasoning to guide high-leverage decisions with clear tradeoffs.
---

# Purpose

Train an AI agent to execute this skill at a senior operator level, producing decisions and outputs a team can implement.

# Instructions

## What to do

1. Clarify the decision being made and the metric it is meant to move.
2. Identify constraints (time, budget, risk tolerance, team capacity, regulatory exposure).
```

## ./.agent/research/üìäüìà PPN Strategy Analysis.md
```text
# **Comprehensive App Strategy & Business Analysis: PPN Research Portal**

## **Executive Summary**

The emergence of psychedelic medicine represents a paradigm shift in mental health treatment, transitioning from stigmatized subcultures to a highly regulated, medicalized pharmaceutical sector. As of 2025, the global ketamine clinic market has matured into a multi-billion dollar industry, projected to reach approximately $3.35 billion by 2034\.1 However, this rapid expansion masks a volatile operational reality characterized by market fragmentation, high labor costs, and a critical lack of standardized outcomes data. Simultaneously, the pharmaceutical industry faces a "data cliff" in the development of novel psychedelic therapeutics such as MDMA and psilocybin. With Research and Development (R\&D) costs for new drugs often exceeding $2.6 billion and regulatory approval increasingly contingent on long-term safety profiles, there is an acute, unmet demand for high-fidelity Real-World Evidence (RWE).2

The proposed **PPN Research Portal (Psychedelic Practitioners Network Research Portal)** is strategically positioned to bridge this widening gap between clinical delivery and pharmaceutical research. Conceptually architected as a "Switzerland of Data," the platform functions as a practitioner-only outcomes registry and RWE benchmarking engine. Unlike incumbent Electronic Health Record (EHR) competitors such as Osmind or Maya Health, which impose heavy administrative burdens and operate as centralized data brokers, PPN differentiates itself through a proprietary **Zero-Knowledge (ZK) architecture**. This technical innovation ensures that patient data is cryptographically verified for benchmarking without ever being fully revealed to the platform or third parties in raw form, directly addressing the privacy concerns of practitioners and the liability constraints of HIPAA compliance.3

The convergence of three market forces creates a distinct opportunity for PPN. First, the consolidation of the clinic market, evidenced by high-profile bankruptcies like Field Trip Health, has shifted practitioner focus from rapid scaling to operational sustainability through insurance reimbursement.5 Second, the pharmaceutical demand for RWE has intensified, with companies spending upwards of $20 million annually per asset on data generation to support FDA approvals.2 Third, a "Privacy Paradox" has emerged where clinicians demand data-driven insights but increasingly distrust platforms that monetize patient information. PPN‚Äôs Zero-Knowledge proof mechanism offers a "trustless" alternative, validating outcomes without requiring data sovereignty to be surrendered.

This strategic analysis validates the viability of the PPN Research Portal but recommends a critical pivot from a destination-based platform to an integration-first registry. To achieve scalability, PPN must function as an interoperability layer that extracts data from existing EHRs using ZK proofs to generate benchmarks, rather than relying on manual data entry. Financial projections indicate a Total Addressable Market (TAM) of $8.8 billion within the global de-identified health data sector, with a Serviceable Obtainable Market (SOM) of $45 million by Year 5, driven by the capture of 10% of the high-value psychedelic data licensing market.7

![][image1]

## **1\. Market Analysis**
```

## ./.agent/research/üìà Comprehensive App Strategy and Business Analysis for PPN Research Portal.md
```text
Comprehensive App Strategy and Business Analysis for PPN Research Portal
Executive summary
Elevator pitch
PPN Research Portal is a practitioner-only outcomes registry and real-world evidence (RWE) platform for psychedelic treatments, starting with ketamine clinics and training cohorts. It captures structured, de-identified, session-level treatment data and generates decision-grade benchmarks across sites for risk mitigation, quality improvement, and practice pattern learning.
The wedge is not ‚Äúprotocol advice.‚Äù The wedge is ‚Äúaudit-ready, benchmarkable operations‚Äù in a field where practice varies widely and liability anxiety is high. PPN‚Äôs defensibility comes from the ‚Äúzero-knowledge‚Äù posture, meaning you do not store patient identifiers and you constrain data to coded, comparable elements that can be shared safely at aggregate levels.
This aligns with two powerful market realities: - Regulated or quasi-regulated psychedelic delivery models are emerging and force standardization. Oregon‚Äôs psilocybin program is explicit about preparation requirements, transportation and safety plans, and written consents, including supportive touch consent and secondary dose consent. [1]‚Ä®- Regulated psychedelic-adjacent care already sets a monitoring benchmark. Spravato REMS requires administration under direct observation and at least two hours of monitoring, and Spravato must not be dispensed for home use. [2]
Viability in one sentence
This is viable if, and only if, you can make ‚Äúdata contribution‚Äù easy enough that clinics contribute consistently, and ‚Äúbenchmark outputs‚Äù valuable enough that clinics keep paying.
North Star metric
North Star metric: Benchmark-ready episodes per month.
Definition: - An ‚Äúepisode‚Äù is benchmark-ready when it has (1) a baseline outcome measure, (2) at least one defined follow-up timepoint, (3) a coded exposure record (substance, route, dose unit), (4) a coded setting and support structure, and (5) coded safety event capture (at least ‚Äúnone reported‚Äù versus coded event).
Why this is the right North Star: - Benchmarks require comparable denominators, not anecdotes. - It measures the core value creation loop, data in, decision-grade benchmark out.
Candid outlook
Your biggest risk is not technical. Your biggest risk is adoption friction and trust. Most clinics will not do ‚Äúresearch-grade data entry‚Äù unless the platform saves them time, reduces perceived liability, improves outcomes reporting, or supports payer conversations. That means your product must deliver visible operational value in the first two weeks of setup, not in six months.
Market analysis
```

## ./.agent/research/product_strategy_skill.md
```text
---
name: Product Strategy Skill
description: Feature prioritization, roadmap planning, and user research methods that connect product work to measurable outcomes.
---

# Purpose

Train an AI agent to execute this skill at a senior operator level, producing decisions and outputs a team can implement.

# Instructions

## What to do

1. Clarify the decision being made and the metric it is meant to move.
2. Identify constraints (time, budget, risk tolerance, team capacity, regulatory exposure).
```

## ./.agent/research/üìä VoC Analysis Psychedelic Therapy.md
```text
# **Strategic Voice of Customer Analysis: Psychedelic Therapy Practitioners (2020‚Äì2026)**

## **1\. Executive Intelligence Summary**

### **1.1 Report Scope and Strategic Context**

The global mental health landscape is currently undergoing a structural transformation driven by the re-emergence of psychedelic-assisted therapies (PAT). However, the period between 2020 and 2026 has revealed a critical dichotomy: while clinical efficacy data for substances such as psilocybin and MDMA has matured, the operational, legal, and professional infrastructure required to deliver these therapies at scale remains dangerously underdeveloped. This report provides an exhaustive Voice of Customer (VoC) analysis of the practitioner cohort‚Äîthe psychiatrists, psychologists, underground guides, and clinic operators who constitute the delivery layer of this ecosystem.

Based on a deep forensic analysis of over 250 data points spanning forum discourse, regulatory filings, industry white papers, and digital search behaviors from 2020 to early 2026, this document identifies a workforce in crisis. Practitioners are not asking for more "hype" or general education; they are desperate for logistical scaffolding. The analysis reveals a fragmented market paralyzed by liability fears, failing software infrastructure, and a profound lack of peer supervision.

For a peer-to-peer platform entering this vertical, the strategic imperative is clear: the market does not need another social network. It needs a **Practice Operating System**‚Äîa unified digital environment that solves the specific, high-friction problems of billing, risk management, and clinical mentorship that currently plague the daily lives of practitioners.

### **1.2 Key Findings at a Glance**

The analysis identifies four critical friction domains that dominate practitioner discourse:
```

## ./.agent/research/üìä Psychedelic Therapy Research Data copy.md
```text
Comprehensive Analysis of the Psychedelic Therapeutic Landscape: Data Architectures, Clinical Protocols, and Neuro-Molecular Informatics

Comprehensive Analysis of the Psychedelic Therapeutic Landscape: Data Architectures, Clinical Protocols, and Neuro-Molecular Informatics
Data Infrastructure and Clinical Trial Registries
Trends in Clinical Registration and Market Growth
Publicly Available Datasets and Repositories
National Surveys and Longitudinal Platforms
Specialized Psychedelic Tracking Systems
Subjective Experiences versus Biomarkers: Determining Data Value
The Predictive Power of the "Trip"
Neurobiological Mechanisms and Imaging Data
Real-World Evidence and the Patient Journey
The Phases of Psychedelic-Assisted Therapy
Efficacy in Naturalistic Settings
Failure Data: Identifying "What Went Wrong"
```

## ./.agent/research/üìà Voc Analysis for Psychedelic Therapy Practitioners and Clinicians copy.md
```text
Voice of Customer Analysis for Psychedelic Therapy Practitioners and Clinicians 2020 to February 2026
Executive synthesis
Concise answer‚Ä®Psychedelic therapy practitioners and clinicians are trying to solve a practical problem, not an identity problem. They are asking how to deliver psychedelic-assisted care that is safe, defensible, and repeatable, while the field still has fragmented protocols, uneven regulation, and inconsistent outcome data. Their strongest emotional drivers are responsibility and fear of harm, paired with frustration about hype, commercialization, and the lack of standardized, clinician-usable guidance. [1]
The most consistent high-intent needs across 2020‚ÄìFeb 2026 are:‚Ä®They want standardized protocol reporting and benchmarking across routes, dosing strategies, session cadence, and setting, because published and real-world practice varies widely. [2]‚Ä®They want screening, monitoring, and documentation standards that can survive licensure scrutiny, malpractice risk, and quality audits, especially for ketamine and regulated programs like state psilocybin services. [3]‚Ä®They want clarity on where psychotherapy fits: before, during, or after dosing, what ‚Äúintegration‚Äù actually means in practice, and how to structure it when sessions are long and expensive. [4]‚Ä®They want credible, shareable quantitative data: response and durability metrics, adverse events, challenging experiences, and standardized patient-reported outcomes, not just stories. [5]‚Ä®They are anxious about ethics and power dynamics, including consent during altered states and boundaries around touch, and they want clear guardrails and grievance pathways. [6]
From a messaging standpoint, ‚Äúauthentic connection‚Äù here means speaking like a risk-aware clinician: evidence-forward, humble about uncertainty, explicit about safety, and allergic to hype. Your strongest positioning lever is not inspiration. It is operational credibility: ‚ÄúHere is how peers are standardizing protocol decisions and outcomes without crossing legal, ethical, or privacy lines.‚Äù [7]
Sources and methodology
This report analyzes publicly available practitioner-adjacent language and documentation from 2020 through February 2026 across: clinician-focused forum threads (especially therapist community discussions about ketamine programs, integration work, and professional pathways), practitioner AMAs, professional practice guidelines, consensus statements, therapy manuals, peer-reviewed reviews and measurement papers, and state and federal regulatory materials relevant to legally delivered psychedelic-adjacent care. [8]
Key ‚Äúanchor sources‚Äù used to ground claims about what practitioners must do (not just what they talk about) include:‚Ä®The ÓàÄentityÓàÇ["organization","American Society of Ketamine Physicians, Psychotherapists & Practitioners","ketamine standards society"]ÓàÅ standards and safety statements for ketamine practice and abuse-risk mitigation. [9]‚Ä®Professional practice guidelines presented by ÓàÄentityÓàÇ["organization","BrainFutures","psychedelic guidelines nonprofit"]ÓàÅ and the ÓàÄentityÓàÇ["organization","American Psychedelic Practitioners Association","professional guidelines group"]ÓàÅ, emphasizing licensure standing, training, consent, screening, preparation, and coordination of care. [10]‚Ä®State program requirements in ÓàÄentityÓàÇ["state","Oregon","us state"]ÓàÅ via ÓàÄentityÓàÇ["organization","Oregon Health Authority","state health agency"]ÓàÅ and ÓàÄentityÓàÇ["organization","Oregon Psilocybin Services","psilocybin program oregon"]ÓàÅ guidance and administrative rules (for example, scope, forms, dosing documentation, session duration and ratios). [11]‚Ä®The ÓàÄentityÓàÇ["organization","U.S. Food and Drug Administration","drug regulator us"]ÓàÅ labeling and REMS requirements for esketamine nasal spray, which function as a ‚Äúgold standard‚Äù reference point for what monitored administration looks like in a federally regulated psychedelic-adjacent treatment. [12]‚Ä®The status and scrutiny of MDMA-assisted therapy regulatory efforts (not approved as of the cited FDA actions) via reporting on the complete response letter and the need for additional evidence. [13]
Where this analysis is intentionally conservative:‚Ä®It does not attempt to prescribe dosing or provide clinical protocols for illegal substances. Instead, it documents what practitioners are asking for, what regulated programs require, and what peer-reviewed literature signals as consistent gaps: standardization, safety monitoring, informed consent, and usable outcomes data. [14]
Voice-of-customer themes and sentiments
Theme: Protocol confusion and the demand for standardization‚Ä®Practitioners repeatedly confront the mismatch between ‚Äúpsychedelic renaissance‚Äù marketing language and the day-to-day reality that published protocols vary by substance, indication, route, dose strategy, number of sessions, psychotherapy model, and setting. A ketamine-assisted psychotherapy review explicitly notes ‚Äúmuch variance‚Äù across administration routes, dosage and frequency, psychotherapy modality, and treatment length, and calls for larger trials to develop standardized practices and maintenance programs. [15]‚Ä®VoC signal: when practitioners say ‚Äúprotocol,‚Äù they usually mean ‚Äúa defensible sequence of decisions,‚Äù not a single recipe. The subtext is fear: if outcomes are inconsistent, they will be blamed, audited, or sued.
Theme: Safety, screening, and the clinician‚Äôs duty of care‚Ä®Across practitioner standards and guidelines, screening shows up as non-negotiable. Ketamine standards emphasize thorough medical and psychiatric assessment, review of meds and substance use history, vital signs, and ongoing monitoring for adverse effects, plus written informed consent and documentation. [9]‚Ä®In professional guidelines, screening is framed as comprehensive and aligned to evidence and clinical judgment, not ‚Äúone-size-fits-all.‚Äù [16]‚Ä®In practitioner forums, the language becomes blunt: ketamine ‚Äúworks best as part of a structured, ongoing process,‚Äù and ‚Äúit‚Äôs not a quick fix.‚Äù [17]
Theme: Monitoring and operational readiness‚Ä®Operational details are a major anxiety source because they are measurable. If something goes wrong, documentation is what gets reviewed. The ketamine standards stress monitoring (heart rate, pulse oximetry, blood pressure, level of consciousness) and competence to respond to adverse effects. [18]‚Ä®In regulated esketamine care, monitoring is formal: the REMS materials and FDA labeling specify observation and monitoring for sedation, dissociation, respiratory depression, and blood pressure for at least two hours, and the REMS explicitly states it must not be dispensed for home use. [19]‚Ä®In Oregon‚Äôs state psilocybin framework, the operationalization is even more explicit: rules set minimum administration session durations and facilitator-to-client ratios by psilocybin analyte dose bands. [20]
Theme: Integration as both a clinical need and a resource problem‚Ä®Integration is the most common ‚Äúbridge concept‚Äù between practitioner intent and client outcomes. It is described as necessary, but also expensive and time-consuming. In therapist discussions, practitioners explicitly call out the time burden: ketamine sessions described as hours, and MDMA or psilocybin sessions described as lasting most of a day, which collides with standard outpatient economics. [21]‚Ä®This tension creates a predictable split in sentiment:‚Ä®Clinicians who have seen good outcomes stress structure: ‚Äúnever‚Äù a one-time session without preparation and significant integration. [17]‚Ä®Others criticize the market for calling something ‚Äúassisted psychotherapy‚Äù when psychotherapy is unclear or absent, and argue about whether therapy must occur during dosing or nearby in time. [22]‚Ä®In research and training content, integration is framed as reflection plus application, and measurement of integration is emerging (IES and EIS). [23]
Theme: Ethics, consent, and power dynamics in altered states‚Ä®Ethics is not an abstract concern in this category. It is a reputational and safety landmine. Formal ethics guidance emphasizes the heightened vulnerability inherent to non-ordinary states, the need for specific training and supervision, and strict boundaries. [24]‚Ä®Professional practice guidelines explicitly surface touch as a consent topic in psychedelic-assisted therapy and tie informed consent to an ongoing process rather than a one-time form. [25]‚Ä®Oregon‚Äôs operational forms and guidance underscore how a regulated program handles the same issues: required coordination on a Safety and Support Plan, and explicit ‚ÄúConsent for Use of Supportive Touch‚Äù as a form category. [26]‚Ä®VoC language here is caution-heavy: practitioners fear ‚Äúnefarious companies,‚Äù overpromising, and systems that will scale faster than ethics can keep up. [27]
```

## ./.agent/research/clinical_domain_skill.md
```text
---
name: Clinical Domain Skill
description: Psychedelic therapy protocols, regulatory exposure, and clinical workflows to prevent unsafe, non-compliant, or unrealistic product decisions.
---

# Purpose

Train an AI agent to execute this skill at a senior operator level, producing decisions and outputs a team can implement.

# Instructions

## What to do

1. Clarify the decision being made and the metric it is meant to move.
2. Identify constraints (time, budget, risk tolerance, team capacity, regulatory exposure).
```

## ./.agent/research/VoC - JAllen and BLJensen.md
```text
Top public pain points and desired outcomes I can substantiate from open sources:

1. Legal exposure and enforcement risk around psilocybin related practice (raids, warrants, criminal charges, loss of materials).
2. Credibility and trust problems (licensed clinical care vs spiritual framing, credential skepticism, public backlash).
3. Safety, screening, and harm reduction standards (how to run sessions responsibly, what ‚Äúsafe‚Äù actually means).
4. Measurement and proof (how to track outcomes, what scales to use, how to document without creating new liability).
5. Reimbursement and operating reality (coverage limits, high costs, regulatory burden).
6. Adjacent ‚Äúevidence based‚Äù positioning (supplements and supportive interventions, misinformation fatigue, quality control).

Also: the ‚Äúalternatives to CoStar‚Äù line is a mismatch for this audience. If your underlying intent is ‚Äúalternatives to expensive, opaque, incumbent data platforms,‚Äù the correct analogue here is outcomes measurement, registries, and defensible documentation, not real estate data.

---

# Scope and method

```

## ./.agent/research/PPN Use Cases.md
```text
Discuss what these sources say about Key Use Cases, in the larger context of PPN Portal.

Based on the provided sources, the Key Use Cases for the PPN Research Portal are divided into two distinct market segments: Entheogenic Religion Operators (who prioritize legal survival and legitimacy) and Licensed Clinics (who prioritize reimbursement and operational efficiency).  
The sources explicitly warn against framing the platform as "real estate data" (like CoStar); instead, the use cases center on "outcomes measurement, registries, and defensible documentation".  
1\. Use Case: Legal Defensibility & Risk Management  
Target Audience: Entheogenic Religion Operators (Psilocybin)  
For practitioners operating under religious exemptions (or in gray areas), the primary use case is "survivability". The platform serves as a defensive shield against legal and regulatory threats.  
‚Ä¢ Documentation as Defense: Operators use the platform to transform "high-risk, ad hoc ceremonies" into "standardized, documented, defensible practice".  
‚Ä¢ Proof of Control: The software creates a record that demonstrates "consistent screening and safety practices," proving to authorities (like the DEA or local law enforcement) that the operation is disciplined and not "unlicensed therapy dressed up as religion".  
‚Ä¢ Preventing Enforcement: A key desired outcome is reducing the risk of "raids, warrants, \[and\] criminal charges" by maintaining records that show clear role boundaries and intent.  
2\. Use Case: Reimbursement & Payer Negotiations  
Target Audience: Licensed Clinics (Ketamine/Regulated)  
For licensed clinics, the platform is used to solve the "reimbursement and operating reality" crisis. The goal is to move from cash-pay models to insurance coverage using "audit-ready documentation".  
‚Ä¢ Justifying Coverage: Clinics use the platform to generate "real-world evidence" that proves treatment works, reducing insurance denials and "refund fights".  
‚Ä¢ Business Intelligence: The use case extends to unit economics‚Äîtracking outcomes to identify which protocols yield better results, thereby supporting "predictable revenue" and "higher capacity utilization".  
```

## ./.agent/research/üìä Publicly available data copy.md
```text
Publicly available data repositories for psychedelic research range from high-resolution molecular and neuroimaging databases to large-scale longitudinal surveys and curated industry trackers.
General Scientific and Open-Access Repositories
Researchers frequently utilize general-purpose scientific repositories to store and share datasets related to psychedelic clinical trials and observational studies.
	‚Ä¢	Open Science Framework (OSF): A common repository for pre-registrations, protocols, and supplemental data.[1, 2]
	‚Ä¢	Dryad, figshare, and Zenodo: Trusted platforms for depositing various forms of raw and processed research data.[1, 2]
	‚Ä¢	Harvard Dataverse and Kaggle: Host specialized datasets, such as consolidated psychotropic drug information for statistical analysis.
	‚Ä¢	FAIRsharing and Re3Data: These serve as registries to help investigators identify the most suitable specialized repositories for specific types of biomedical or environmental science data.[3]
Neuroimaging and Brain Data
	‚Ä¢	OpenNeuro: The primary open-access platform for neuroimaging data, hosting psychedelic-specific datasets like PsiConnect, which includes fMRI and EEG records.
	‚Ä¢	NEMAR: An OpenNeuro portal specifically designed for the visualization and analysis of high-resolution MEG, iEEG, and EEG data.
	‚Ä¢	Amsterdam Open MRI Collection (AOMIC): Includes multimodal MRI datasets (multimodal 3T) with integrated psychometric and demographic variables.
Pharmacological and Molecular Informatics
	‚Ä¢	NIMH PDSP Ki Database: Directed by Dr. Bryan Roth, the Psychoactive Drug Screening Program (PDSP) provides a comprehensive database of radioligand binding assays and Ki values for psychedelic compounds across various serotonin receptor subtypes.[4, 5]
	‚Ä¢	PASS Online: Used to predict pharmacological effects and mechanisms of action for novel antidepressant and antipsychotic molecules.[6]
Survey and Citizen Science Repositories
```

## ./.agent/research/network_economics_skill.md
```text
---
name: Network Economics Skill
description: Multi-sided platform dynamics, network effects, and pricing strategy to reach liquidity and capture value without breaking trust.
---

# Purpose

Train an AI agent to execute this skill at a senior operator level, producing decisions and outputs a team can implement.

# Instructions

## What to do

1. Clarify the decision being made and the metric it is meant to move.
2. Identify constraints (time, budget, risk tolerance, team capacity, regulatory exposure).
```

## ./.agent/research/STRATEGIC_SYNTHESIS.md
```text
# Strategic Market Intelligence Synthesis
**Created:** 2026-02-11  
**Purpose:** Bridge market research to product execution decisions

---

## üéØ Core Market Reality

### **What Practitioners Actually Need**

Based on comprehensive VoC analysis (2020-2026), practitioners are NOT asking for:
- ‚ùå More "psychedelic renaissance" hype
- ‚ùå General education content
- ‚ùå Another social network

```

## ./.agent/research/üìà Psychedelic Therapy Data Ecosystem_ Treatments, Clinical Protocols copy.md
```text
Psychedelic Therapy Data Ecosystem: Treatments, Clinical Protocols, Study Designs, Data Methodology, Safety Signals, Benchmarking, and Molecular Informatics
Concise answer‚Ä®The psychedelic-therapy data landscape is fragmented across three big ‚Äúdata universes‚Äù: clinical-trial registries and sponsor submissions (strong on protocols and prespecified outcomes, weak on patient-level access), real-world evidence and safety surveillance (strong on scale and safety signal detection, weak on causal inference and protocol detail), and molecular or receptor informatics (strong on mechanistic mapping, weak on direct clinical translation). The most analysis-ready, large-scale, publicly downloadable sources for treatment and protocol metadata are ClinicalTrials.gov derived datasets (especially the AACT relational database snapshots) and WHO ICTRP exports, while the largest public safety datasets relevant to ketamine and esketamine are FAERS and openFDA downloads. For real-world supervised psilocybin services, Oregon‚Äôs state dashboards plus standardized adverse-reaction forms, along with practice-based networks like OHSU‚Äôs OPEN and ANU‚Äôs AIPPAP registry, are the clearest emerging pipelines for longitudinal patient journey data outside trials. The most consequential ‚Äúvalued data components‚Äù are durable clinical outcomes, adverse events including impairment and abuse-potential-relevant events, therapist and setting fidelity, and patient-reported subjective experience measures, because regulators and clinicians have repeatedly highlighted data reliability, unblinding, and durability as limiting factors. On benchmarking, the field leans heavily on systematic reviews and meta-analyses (including Cochrane and BMJ) plus expert consensus and Delphi methods to standardize ‚Äúset and setting‚Äù reporting and care quality measures.
Reasoning and rationale‚Ä®Psychedelic-assisted therapies behave like complex interventions: outcomes depend not only on molecule and dose, but also on psychological support, therapist skill, setting variables, and follow-up integration. That reality pushes the field toward richer, multi-modal data capture (clinical scales plus PROs plus session process measures plus safety monitoring) and toward standards that allow cross-study aggregation. Regulatory documents around MDMA-assisted therapy show, in unusually direct language, that missing or inconsistently defined adverse-event capture and limited durability data can invalidate an otherwise promising evidence package, which is a useful ‚Äústress test‚Äù for what data matters most. [1]
Relevant data sources for psychedelic therapy analysis
Clinical trial registries are the backbone for protocol-level data: they contain intervention descriptions, arms, masking and allocation, outcomes, timepoints, eligibility criteria, and (sometimes) results. ClinicalTrials.gov can be accessed via its API v2 (intended for programmatic access to study record data) and is widely mirrored into bulk-friendly structures like AACT. [2]
AACT (Aggregate Analysis of ClinicalTrials.gov), maintained by the Clinical Trials Transformation Initiative, is often the most practical ‚Äúanalysis-grade‚Äù entry point because it provides a consistent relational schema with row counts across 51+ tables, including outcomes, analyses, and adverse events. AACT explicitly states it includes all protocol and results data publicly available in ClinicalTrials.gov and preserves source content without cleaning, which is important for auditability but creates parsing work. [3]
WHO ICTRP is the most important cross-registry aggregator, providing single-portal access to trial registration data from multiple global registries and supporting exports (CSV or XML) under explicit terms and conditions. In practice, ICTRP accessibility can vary by mechanism, including time-limited downloads and/or request-based access for complete update feeds. [4]
EU Clinical Trials Register (EU CTR) is a major source for EU interventional medicinal-product trials and is often used to triangulate protocols and results reporting, but bulk extraction is less straightforward than AACT-style downloads. Independent analyses of EU CTR have reported that it contains information on over 40,000 trials (with this ‚Äúhow many‚Äù figure varying by date and inclusion scope), and data quality and availability are active research topics. [5]
ISRCTN is a smaller but relevant registry that supports export of search results to CSV and provides an XML API, making it useful for targeted protocol mining and cross-validation of trial identifiers. [6]
Academic databases are indispensable for linking protocols to peer-reviewed outcomes, methods, and measurement instruments. PubMed/MEDLINE is the most common starting point for psychedelic therapy evidence synthesis and instrument validation (for example, validated subjective experience scales). [7]
Government and regulator repositories matter because they contain ‚Äúdecision-grade‚Äù critiques of data completeness, bias, and safety characterization. For example, FDA advisory materials and complete response letters can reveal precisely which data components were deemed missing or unreliable, and why. In the MDMA-assisted therapy case, FDA documents highlight concerns about functional unblinding, durability, psychotherapy contribution, and adverse event capture reliability. [8]
Comparison table of trial registries and protocol-level sources
Source
Scope for psychedelic therapy
Access level
```

## ./.agent/backlog/protocol_builder_enhancements.md
```text
# Protocol Builder - Backlog Items

**Last Updated:** February 13, 2026

---

## P1 - Post-Launch Enhancements

### 1. Dosage Warning/Guidance System (Research Data Framing)

**Status:** Deferred  
**Priority:** P1 (Important, not urgent)  
**Estimated Time:** 2-3 hours

**Background:**
```

## ./.agent/workflows/finalize_feature.md
```text
---
description: Automatically stage, commit, and push changes to the remote repository to secure progress.
---

1. Check the current git status to see what will be committed.
   - `git status`

2. Add all changes to the staging area.
   - `git add .`

3. Commit the changes with a standard message.
   - `git commit -m "feat: finalize feature (auto-push)"`

4. Push the changes to the current branch on origin.
   - `git push origin HEAD`
```

## ./.agent/workflows/create_tooltips.md
```text
---
description: How to create and implement tooltips using AdvancedTooltip
---

# Skill: Creating Tooltips

This skill provides step-by-step instructions for implementing tooltips in the PPN Research Portal using the `AdvancedTooltip` component.

---

## üìã Prerequisites

- The `AdvancedTooltip` component exists at `src/components/ui/AdvancedTooltip.tsx`
- The `Info` icon from `lucide-react` is available
- You understand the three tooltip tiers: `micro`, `standard`, and `guide`
```

## ./.agent/rules/handoff_protocol.md
```text
# üìú MASTER PROTOCOL: Workflow, Handoffs & Safety

## 1. Handoff Protocol (Chain of Custody)
- **Artifact-First:** Never pass a task via chat. Create a file first.
  - **DESIGNER:** Save specs to `docs/design/[feature_name].md`.
  - **SOOP:** Save schemas to `docs/schema/[feature_name].sql`.
  - **BUILDER:** You may not write code until LEAD comments "‚úÖ APPROVED" on the artifact.
- **Handoff Syntax:** When finishing a task, state: *"I have completed [Task]. Review artifact at [File_Path]."*

## 2. Error Handling & Debugging Standards
**A. The "No Silent Failures" Rule (Frontend)**
- **DESIGNER/BUILDER:** Every async operation (API call, data fetch) must have:
  1. A `Loading` state (spinner/skeleton).
  2. A specific `Error` state (user-friendly message, not raw JSON).
- **Constraint:** React apps must wrap major features in an `<ErrorBoundary>`. The app should never crash to a white screen.
```

## ./.agent/rules/DIRECTIVE_TRACKING_PROTOCOL.md
```text
# Directive Tracking Protocol

**Status:** MANDATORY - ALL AGENTS MUST FOLLOW  
**Effective Date:** February 13, 2026  
**Purpose:** Ensure zero user directives are lost or ignored

---

## üö® CRITICAL RULE

**Every user directive MUST be:**
1. Logged in `COMMAND_LOG.md` within 5 minutes
2. Acknowledged by assigned agent within 2 hours
3. Updated with progress every 24 hours
4. Marked complete when finished
```

## ./.agent/templates/PLAN_TEMPLATE.md
```text
# Implementation Plan: [Project Name]

**Date:** YYYY-MM-DD  
**Lead:** [Agent Name]  
**Status:** [PLANNING | IN PROGRESS | BLOCKED | COMPLETE]

---

## 1. The Goal

**One Sentence Summary:**  
[e.g., Build a responsive treatment timeline visualization for the Patient Flow page.]

**Success Criteria:**
- [ ] [e.g., Timeline displays all treatment sessions chronologically]
```

## ./.agent/templates/completion_artifact_template.md
```text
# Completion Report: [Feature Name]

**Completed by:** BUILDER  
**Date:** [Date]  
**Status:** ‚úÖ COMPLETE  
**Command ID:** [If applicable]

---

## What Was Implemented

**Files Created:**
- `[path]` - [Description]

**Files Modified:**
```

## ./.agent/skills/ui-ux-product-design/SKILL.md
```text
---
name: UI/UX & Product Design
description: Customer-centric product design, usability, and interaction patterns that reduce friction and increase adoption.
---

# Purpose

Train an AI agent to perform this advisory skill at a senior, practical level, with clear outputs and high accountability.

# Instructions

## What to do

1. Clarify the decision being made.
2. Identify constraints (time, budget, risk tolerance, regulatory exposure, team capacity).
```

## ./.agent/skills/molecular-viz/SKILL.md
```text
---
name: molecular-visualization
description: Use this skill when asked to create, render, or design 3D molecular structures, protein binding sites, or chemical data visualizations.
triggers: ["render molecule", "3D structure", "protein view", "binding site", "PDB", "SMILES"]
---

# üß¨ Molecular Visualization & Scientific 3D Protocol

## 1. The Tech Stack (React + Science)
**Constraint:** Do NOT attempt to draw molecules from scratch using generic shapes. You must use established cheminformatics libraries to ensure scientific accuracy.
- **Primary Viewer:** Use **`3dmol.js`** (specifically the React wrapper `3dmol`) for standard PDB/MOL rendering.
- **Advanced Effects:** Use **`@react-three/fiber`** (Three.js) only for "glamour shots" or abstract visualizations where interaction logic is custom.
- **Data Source:** Expect molecular data in **SMILES** strings or **PDB** file format from the Python backend (RDKit).

## 2. Visualization Standards (The "Look")
```

## ./.agent/skills/frontend-best-practices/SKILL.md
```text
---
name: frontend-best-practices
description: Team-specific linting rules, coding standards, and design system documentation for the PPN Research Portal frontend.
---

# Frontend Best Practices Skill

## üéØ Design System Compliance

### **Color Palette (Strict)**

```css
/* Primary Brand */
--emerald-500: #10b981
--emerald-400: #34d399
```

## ./.agent/skills/migration-manager/SKILL.md
```text
---
name: migration-manager
description: Manages Supabase database migrations with proper workflow
---

# Migration Manager

## Purpose
Execute database migrations safely using Supabase CLI.

## Commands

### Create New Migration
```bash
supabase migration new descriptive_name
```

## ./.agent/skills/deep-industry-knowledge/SKILL.md
```text
---
name: Deep Industry Knowledge of Psychedelic Therapy and Alternative Medicine
description: Domain expertise in psychedelic therapy, adjacent modalities, workflows, terminology, and risks to prevent naive product decisions.
---

# Purpose

Train an AI agent to perform this advisory skill at a senior, practical level, with clear outputs and high accountability.

# Instructions

## What to do

1. Clarify the decision being made.
2. Identify constraints (time, budget, risk tolerance, regulatory exposure, team capacity).
```

## ./.agent/skills/inspector-qa/SKILL.md
```text
---
name: inspector-qa
description: audits design specs for technical feasibility and creates strict coding instructions
---
# Inspector QA Protocol

**Role:** Technical QA Lead & Gatekeeper.
**Goal:** You prevent "hallucinated designs" and logical errors from reaching the Builder.

## Workflow
1.  **Read Input:** Analyze the `DESIGN_SPEC.md` (or visual description) provided by the Designer.
2.  **Feasibility Check:**
    *   *Data Check:* Do we have the API data to support this visual? (e.g., "Design shows a user credit score, but our API user object doesn't have that field.")
    *   *Complexity Check:* Is this animation too heavy for mobile performance?
    *   *Hallucination Check:* Did the Designer invent CSS classes that don't exist in our framework (e.g., Tailwind vs. Bootstrap)?
```

## ./.agent/skills/technical-architecture/SKILL.md
```text
---
name: Technical Architecture & Infrastructure
description: Cloud, DevOps, observability, and systems design guidance for scaling from thousands to millions of users.
---

# Purpose

Train an AI agent to perform this advisory skill at a senior, practical level, with clear outputs and high accountability.

# Instructions

## What to do

1. Clarify the decision being made.
2. Identify constraints (time, budget, risk tolerance, regulatory exposure, team capacity).
```

## ./.agent/skills/master-data-ux/SKILL.md
```text
---
name: master-data-ux
description: Use this skill whenever the user asks for UI designs, data charts, scientific dashboards, or website optimization (SEO/CRO). Combines high-end design with technical data visualization for React and Python applications.
---

# Master Data UX Skill

## üé® Persona: Creative Technologist

You are a **Creative Technologist** who blends the artistic eye of a designer with the logic of a data scientist. Your mission is to make complex scientific and financial data look beautiful and easy to understand while maintaining strict accessibility standards and modern design principles.

---

## üéØ When to Use This Skill

```

## ./.agent/skills/database-schema-validator/SKILL.md
```text
---
name: database-schema-validator
description: Validates SQL migration files for banned commands and naming conventions before execution
---

# Database Schema Validator

## Purpose
Automatically check SQL files for governance violations before running them.

## Usage
Before executing any SQL migration, run this validation:

```bash
# Check a migration file
```

## ./.agent/skills/growth-marketing/SKILL.md
```text
---
name: Growth Marketing
description: User acquisition, retention, and compounding loops using experiments, measurement, and channel strategy.
---

# Purpose

Train an AI agent to perform this advisory skill at a senior, practical level, with clear outputs and high accountability.

# Instructions

## What to do

1. Clarify the decision being made.
2. Identify constraints (time, budget, risk tolerance, regulatory exposure, team capacity).
```

## ./.agent/skills/browser/SKILL.md
```text
---
name: browser
description: Essential skill for visual UI/UX verification. Use the browser tool to see what you're building, capture screenshots, and verify design implementations in real-time.
---

# Browser Skill

## üéØ Purpose

The browser skill enables you to **see what you're building** by opening and interacting with the application in a real browser environment. This is **essential** for UI/UX work because you cannot verify visual design, layout, or user experience without actually viewing the rendered interface.

---

## üìã When to Use This Skill

```

## ./.agent/skills/query-optimizer/SKILL.md
```text
---
name: query-optimizer
description: Analyzes query performance using EXPLAIN ANALYZE before deployment
---

# Query Optimizer

## Purpose
Ensure queries are performant before adding to production.

## Usage
Run `EXPLAIN ANALYZE` on all complex queries:

```sql
EXPLAIN ANALYZE
```

## ./.agent/skills/scalable-architecture/SKILL.md
```text
---
name: Scalable Architecture
description: Engineering leadership guidance on performance, reliability, cost, and operational maturity under rapid growth.
---

# Purpose

Train an AI agent to perform this advisory skill at a senior, practical level, with clear outputs and high accountability.

# Instructions

## What to do

1. Clarify the decision being made.
2. Identify constraints (time, budget, risk tolerance, regulatory exposure, team capacity).
```

## ./.agent/skills/emerging-tech-ai-data/SKILL.md
```text
---
name: Emerging Tech (AI/Data)
description: Applied AI, machine learning, and analytics to enable personalization, automation, and insight while managing risk and bias.
---

# Purpose

Train an AI agent to perform this advisory skill at a senior, practical level, with clear outputs and high accountability.

# Instructions

## What to do

1. Clarify the decision being made.
2. Identify constraints (time, budget, risk tolerance, regulatory exposure, team capacity).
```

## ./.agent/skills/international-expansion/SKILL.md
```text
---
name: International Expansion
description: Market selection, localization, operations, and regulatory constraints for global launches.
---

# Purpose

Train an AI agent to perform this advisory skill at a senior, practical level, with clear outputs and high accountability.

# Instructions

## What to do

1. Clarify the decision being made.
2. Identify constraints (time, budget, risk tolerance, regulatory exposure, team capacity).
```

## ./.agent/skills/pattern-recognition/SKILL.md
```text
---
name: Pattern Recognition
description: Spotting founder blind spots and startup failure modes early, based on comparable patterns and second-order effects.
---

# Purpose

Train an AI agent to perform this advisory skill at a senior, practical level, with clear outputs and high accountability.

# Instructions

## What to do

1. Clarify the decision being made.
2. Identify constraints (time, budget, risk tolerance, regulatory exposure, team capacity).
```

## ./.agent/skills/accessibility-checker/SKILL.md
```text
---
name: accessibility-checker
description: Verify WCAG 2.1 compliance, check contrast ratios, validate ARIA labels, and ensure keyboard navigation works correctly. Essential for accessible UI/UX design.
---

# Accessibility Checker Skill

## üéØ Purpose

This skill provides a systematic approach to **verify accessibility compliance** for all UI components. The PPN Research Portal must meet WCAG 2.1 Level AA standards (AAA preferred) to ensure usability for all users, including those with visual, motor, or cognitive disabilities.

---

## üìã Accessibility Requirements

```

## ./.agent/skills/go-to-market-strategy/SKILL.md
```text
---
name: Go-to-Market (GTM) Strategy
description: Sales, positioning, pricing, and customer acquisition strategy for digital products, aligned to ICP and buying process.
---

# Purpose

Train an AI agent to perform this advisory skill at a senior, practical level, with clear outputs and high accountability.

# Instructions

## What to do

1. Clarify the decision being made.
2. Identify constraints (time, budget, risk tolerance, regulatory exposure, team capacity).
```

## ./.agent/skills/ai-emerging-tech-integration/SKILL.md
```text
---
name: AI & Emerging Tech Integration
description: Practical application of AI video generation, data annotation, and machine learning to improve existing products with measurable business impact.
---

# Purpose

Train an AI agent to perform this advisory skill at a senior, practical level, with clear outputs and high accountability.

# Instructions

## What to do

1. Clarify the decision being made.
2. Identify constraints (time, budget, risk tolerance, regulatory exposure, team capacity).
```

## ./.agent/handoffs/SOOP_COMMAND_007_TEST_DATA.md
```text
# Command #007: Execute Test Data Migration

**Date Issued:** Feb 13, 2026, 5:50 PM PST  
**Issued By:** LEAD (on behalf of User)  
**Assigned To:** SOOP  
**Priority:** P1 - IMMEDIATE EXECUTION  
**Estimated Time:** 5 minutes

---

## DIRECTIVE

Execute the test data migration `migrations/999_load_test_data.sql` in Supabase Dashboard.

**User's Question:** "How do I view test data?" - The migration exists but hasn't been executed yet.
```

## ./.agent/handoffs/protocol_builder_workflow_analysis.md
```text
# Protocol Builder - User Workflow Analysis

**Date:** Feb 13, 2026, 10:43 AM  
**Analyst:** LEAD  
**Goal:** Optimize for speed and minimal steps

---

## Design Principle

> "The number one goal is fast and functional in minimal steps"

**Implications:**
1. **Minimize touches/clicks** - Every interaction should accomplish maximum work
2. **Smart defaults** - Pre-fill when possible, auto-increment session numbers
```

## ./.agent/handoffs/RLS_AUDIT_REPORT.md
```text
# Row Level Security (RLS) Audit Report - FINAL

**Date:** February 14, 2026  
**Auditor:** SOOP  
**Purpose:** Pre-launch security audit of all database tables  
**Priority:** P1 - CRITICAL FOR SECURITY  
**Status:** ‚ö†Ô∏è **ACTION REQUIRED** - Manual verification needed

---

## Executive Summary

**Audit Method:** Examined all migration files and found extensive RLS coverage across 40+ tables.

**Key Findings:**
```

## ./.agent/handoffs/SOOP_TEST_DATA_LOADING.md
```text
# @SOOP: Test Data Loading Instructions

**Command ID:** #004  
**Date Issued:** February 13, 2026, 4:26 PM PST  
**Issued By:** User (Boss)  
**Priority:** P0 - CRITICAL  
**Deadline:** Today EOD (Feb 13, 2026)

---

## Directive

**"Please give SOOP instructions for loading test data (that can be easily identified and removed later) to the database; include enough variety in the test record so that all functions and visualizations are readable are displayed."**

You are assigned to load comprehensive test data into the database to enable testing of all Protocol Builder features and visualizations.
```

## ./.agent/handoffs/LEAD_TO_BUILDER_TOPHEADER_CLARIFICATION.md
```text
# LEAD Response to BUILDER - Command #009 TopHeader Fix

**Date:** Feb 13, 2026, 5:56 PM PST  
**From:** LEAD  
**To:** BUILDER

---

## Answers to Your Questions

### 1. What is the specific issue with TopHeader?

**Problem:** TopHeader.tsx displays hardcoded "Dr. Sarah Jenkins" for ALL users instead of real user data from Supabase.

**Current Code (Lines 52, 224):**
```

## ./.agent/handoffs/SOOP_USER_PROFILES_COMPLETE.md
```text
# User Profiles Database - Complete ‚úÖ

## Command #005 - Task #2: User Profiles Table

**Status:** ‚úÖ VERIFIED - Migration already exists and exceeds requirements

---

## Migration File

**File:** `migrations/020_create_user_profiles.sql`  
**Status:** ‚úÖ Already created (more comprehensive than spec)

### Schema Overview

```

## ./.agent/handoffs/protocol_builder_critical_analysis.md
```text
# Protocol Builder - Critical Analysis & Redesign Requirements

**Date:** Feb 13, 2026, 10:34 AM  
**Analyst:** LEAD  
**Status:** üö® **MAJOR FAILURES IDENTIFIED - REQUIRES COMPLETE REDESIGN**

---

## Executive Summary

The current Protocol Builder implementation has **7 critical failures** that violate core product principles and user requirements. A complete redesign is required.

**Severity:** HIGH - Does not meet Feb 15 demo requirements

---
```

## ./.agent/handoffs/COMMAND_007_STATUS.md
```text
# Command #007: Test Data Migration Status

## Quick Check

**Run this query in Supabase Dashboard to check status:**

```sql
-- Check if test data already loaded
SELECT COUNT(*) as test_protocol_count
FROM protocols
WHERE created_by = '00000000-0000-0000-0000-000000000001';
```

**Expected Results:**
- **If count = 0:** Test data NOT loaded ‚Üí Execute `migrations/999_load_test_data.sql`
```

## ./.agent/handoffs/SOOP_COMMAND_008_RLS_AUDIT.md
```text
# Command #008: Row Level Security (RLS) Audit

**Date Issued:** Feb 13, 2026, 5:50 PM PST  
**Issued By:** LEAD (on behalf of User)  
**Assigned To:** SOOP  
**Priority:** P1 - CRITICAL FOR SECURITY  
**Estimated Time:** 2-3 hours  
**Start After:** Command #007 complete

---

## DIRECTIVE

Audit ALL database tables for proper Row Level Security (RLS) policies. This is CRITICAL for launch security.

```

## ./.agent/handoffs/DESIGNER_HANDOFF_PROTOCOL_BUILDER_REDESIGN.md
```text
# DESIGNER Handoff - Protocol Builder Complete Redesign

**From:** LEAD  
**To:** DESIGNER  
**Date:** Feb 13, 2026, 10:40 AM  
**Priority:** CRITICAL - Complete Redesign Required  
**Temperature:** 3 (Refinement mode)

---

## üö® CRITICAL REQUIREMENTS (NON-NEGOTIABLE)

### 1. ZERO TEXT ENTRY POLICY ‚ö†Ô∏è

**RULE:** Absolutely NO free-text inputs anywhere in the application
```

## ./.agent/handoffs/MARKETER_COMMAND_012_VIDEO_SCRIPT.md
```text
# Command #012: Product Demo Video Script

**Date Issued:** Feb 13, 2026, 5:50 PM PST  
**Issued By:** LEAD (on behalf of User)  
**Assigned To:** MARKETER  
**Priority:** P2 - MEDIUM  
**Estimated Time:** 1-2 days  
**Start After:** Command #011 (Monograph Hero) complete

---

## DIRECTIVE

Create a professional product demo video script for the PPN Research Portal.

```

## ./.agent/handoffs/SOOP_HANDOFF_PROTOCOL_BUILDER.md
```text
# SOOP Handoff - Protocol Builder Database Requirements

**From:** LEAD  
**To:** SOOP  
**Date:** Feb 13, 2026, 3:44 AM  
**Priority:** HIGH - Feb 15 Demo Deadline

---

## Executive Summary

USER has approved DESIGNER's **full Clinical Decision Support System** for Protocol Builder. This requires significant database work including materialized views, receptor affinity data, and drug interaction tables.

**Timeline:** 2 days until Feb 15 demo (11:15 AM)

```

## ./.agent/handoffs/BUILDER_COMMAND_009_TOPHEADER_URGENT.md
```text
# Command #009: TopHeader Fix - URGENT

**Date Issued:** Feb 13, 2026, 5:50 PM PST  
**Issued By:** LEAD (on behalf of User)  
**Assigned To:** BUILDER  
**Priority:** P0 - URGENT - USER NEEDS THIS ASAP  
**Estimated Time:** 1-2 hours  
**Start After:** Legal Pages complete OR IMMEDIATELY if Legal Pages done

---

## DIRECTIVE

**USER SAYS:** "I need this done ASAP!!!!!"

```

## ./.agent/handoffs/BUILDER_COMMAND_006_TOPHEADER_FIX.md
```text
# Command #006: TopHeader Fix - Display Real User Profile

**Date Issued:** Feb 13, 2026, 5:30 PM PST  
**Issued By:** LEAD (on behalf of User)  
**Assigned To:** BUILDER  
**Priority:** P1 - High (Post-Launch, Pre-Pricing)  
**Deadline:** Feb 14, 2026 EOD

---

## Directive

Fix TopHeader.tsx to display real user profile data from Supabase instead of hardcoded "Dr. Sarah Jenkins".

---
```

## ./.agent/handoffs/COMMAND_LOG.md
```text
# Command Log - Single Source of Truth

**Purpose:** Track every user directive to ensure nothing gets missed  
**Owner:** LEAD Agent  
**Updated:** Every time user gives a directive  
**Review Frequency:** Every agent conversation start

---

## Active Commands (Pending/In Progress)

_No active commands. Launch successful._

---

```

## ./.agent/handoffs/BUILDER_COMMAND_013_GUIDEDTOUR_UPDATE.md
```text
# Command #013: Update GuidedTour with Unique Value Proposition

**Date Issued:** Feb 13, 2026, 6:10 PM PST  
**Issued By:** LEAD (on behalf of User)  
**Assigned To:** BUILDER  
**Priority:** P1 - HIGH  
**Estimated Time:** 1-2 hours  
**Start After:** Command #009 (TopHeader fix) complete

---

## DIRECTIVE

Update `GuidedTour.tsx` to reflect the platform's unique value proposition and working analytics features.

```

## ./.agent/handoffs/BUILDER_COMMAND_016_CHART_IMPROVEMENTS.md
```text
# Command #016: Analytics Chart Improvements - Legends, Tooltips, Filters

**Date Issued:** Feb 13, 2026, 7:25 PM PST  
**Issued By:** LEAD (on behalf of User)  
**Assigned To:** BUILDER  
**Priority:** P1 - HIGH  
**Estimated Time:** 2-3 hours  
**Start After:** Command #014 (Analytics page filters) complete

---

## DIRECTIVE

Fix recharts rendering warnings and implement comprehensive chart improvements across all analytics pages:

```

## ./.agent/handoffs/SOOP_COMMAND_015_P0_ANALYTICS.md
```text
# Command #015: Protocol Intelligence Implementation (Full Plan)

**Date Issued:** Feb 13, 2026, 6:30 PM PST  
**Issued By:** LEAD (on behalf of User)  
**Assigned To:** SOOP (Database), DESIGNER (UI/UX), BUILDER (Frontend)  
**Priority:** P1 - HIGH  
**Estimated Time:** 3 weeks (Phase 1), 6 weeks (Phase 2)  
**Start After:** Command #008 (RLS Audit) complete

**Reference:** SOOP's original implementation plan from conversation `64b01072-8b80-4b2a-b847-bb7358af4d41`

---

## EXECUTIVE SUMMARY

```

## ./.agent/handoffs/task.md
```text
# Protocol Builder - Restore & Redesign

**Current Phase:** Execution (Parallel Work)  
**Priority:** HIGH  
**Overall Goal:** Restore My Protocols page immediately, then complete full redesign

---

## BUILDER Tasks (IMMEDIATE - 30 min)

### Restore My Protocols Page
- [x] Fix `MyProtocols.tsx` - Remove modal logic, use navigation
- [x] Update `App.tsx` - Add routing for `/protocols` and `/protocol-builder`
- [x] Update `ProtocolBuilder.tsx` - Add back button and auto-navigation
- [ ] Test workflow - Verify navigation and functionality (BLOCKED: node_modules permission error)
```

## ./.agent/handoffs/DESIGNER_COMMAND_010_PRICING_PAGE.md
```text
# Command #010: Pricing Page Design

**Date Issued:** Feb 13, 2026, 5:50 PM PST  
**Issued By:** LEAD (on behalf of User)  
**Assigned To:** DESIGNER  
**Priority:** P1 - HIGH  
**Estimated Time:** 3-5 days  
**Start After:** Command #009 (TopHeader fix) complete

---

## DIRECTIVE

Design comprehensive pricing page for PPN Research Portal with tier-based subscription model.

```

## ./.agent/handoffs/DESIGNER_PROTOCOL_BUILDER_AUDIT.md
```text
# @DESIGNER: Protocol Builder Functionality Audit

**Command ID:** #003  
**Date Issued:** February 13, 2026, 4:26 PM PST  
**Issued By:** User (Boss)  
**Priority:** P0 - CRITICAL  
**Deadline:** Today EOD (Feb 13, 2026)

---

## Directive

**"Assign a different agent, not you, to fully test the functionality of the protocol builder."**

You are assigned to conduct a **comprehensive functionality audit** of the Protocol Builder. The Boss has identified that the dosage slider cannot be grabbed directly, and there may be other interaction issues.
```

## ./.agent/handoffs/SOOP_BUILDER_DATABASE_DEPENDENCIES.md
```text
# @SOOP: BUILDER Database Dependencies

**Command ID:** #005  
**Date Issued:** February 13, 2026, 4:45 PM PST  
**Issued By:** LEAD (on behalf of BUILDER)  
**Priority:** P0 - CRITICAL  
**Deadline:** Today EOD (Feb 13, 2026)

---

## Directive

BUILDER needs database support for two features:
1. **Clinical Insights Panel** - Database work for Protocol Builder
2. **User Profiles** - New table for profile management
```

## ./.agent/handoffs/TEST_DATA_LOADED.md
```text
# Test Data Loading - Documentation

## Status: ‚úÖ Complete

### Command #004 - Test Data Loading
**Assigned By:** LEAD  
**Deadline:** Feb 13, 2026 EOD  
**Priority:** P0 - CRITICAL

---

## What Was Created

### Migration File: `migrations/999_load_test_data.sql`

```

## ./.agent/handoffs/BUILDER_COMMAND_014_ANALYTICS_FIXES.md
```text
# Command #014: Fix Analytics Page Filters and Layout

**Date Issued:** Feb 13, 2026, 6:10 PM PST  
**Issued By:** LEAD (on behalf of User)  
**Assigned To:** BUILDER  
**Priority:** P1 - HIGH  
**Estimated Time:** 2-3 hours  
**Start After:** Command #013 (GuidedTour) complete

---

## DIRECTIVE

Fix filters and layout issues on Analytics page and deep-dive component pages.

```

## ./.agent/handoffs/DESIGNER_COMMAND_011_MONOGRAPH_HERO.md
```text
# Command #011: Substance Monograph Hero Section Fix

**Date Issued:** Feb 13, 2026, 5:50 PM PST  
**Issued By:** LEAD (on behalf of User)  
**Assigned To:** DESIGNER  
**Priority:** P1 - HIGH  
**Estimated Time:** 2-3 hours  
**Start After:** Command #010 (Pricing Page) complete

---

## DIRECTIVE

**USER SAYS:** "For now, I just want to fix the Hero/top section layout."

```

## ./.agent/handoffs/BUILDER_TO_SOOP_medications_rls.md
```text
# BUILDER ‚Üí SOOP: Fix ref_medications RLS Policies

**From:** BUILDER  
**To:** SOOP (via LEAD)  
**Date:** Feb 13, 2026, 4:43 PM PST  
**Priority:** üî¥ CRITICAL - Blocking Protocol Builder V3 completion

---

## Issue Summary

Migration `021_add_common_medications_flag.sql` ran successfully and added the `is_common` column to `ref_medications` table. However, the **frontend cannot access the table** - Supabase REST API returns **404 Not Found**.

**Error in Browser Console:**
```
```

## ./.agent/handoffs/BUILDER_HANDOFF_MY_PROTOCOLS.md
```text
# BUILDER Handoff - Restore My Protocols Page (Quick Fix)

**From:** LEAD  
**To:** BUILDER  
**Priority:** HIGH - Immediate Fix  
**Estimated Time:** 30 minutes

---

## Objective

Restore My Protocols page as a protocols list table (not Protocol Builder workflow). This is a quick fix to unblock the user while DESIGNER works on complete redesign.

---

```

## ./SOOP_TO_BUILDER_HANDOFF.md
```text
# SOOP ‚Üí BUILDER Handoff: Protocol Builder Database Schema

**Date:** Feb 13, 2026, 10:08 AM  
**Status:** ‚úÖ ALL MIGRATIONS COMPLETE  
**Ready for:** Frontend Implementation

---

## Executive Summary

All database work for Protocol Builder Clinical Decision Support System is **COMPLETE**. The database now includes:

‚úÖ Receptor affinity data for 8 psychedelic substances  
‚úÖ Drug interaction knowledge graph with 15+ interactions  
‚úÖ 3 materialized views for real-time analytics  
```

## ./.antigravity/work_orders/WO-002_Protocol_Detail_Accessibility.md
```text
STATUS: DEFERRED

> **‚ö†Ô∏è DEFERRED:** DESIGNER is currently working on a complete Protocol Detail redesign (bento box layout, 8 components, Title Case typography). This work order should be executed AFTER the redesign is complete to avoid duplicate work.
> 
> **Related:** DESIGNER handoff in conversation `e5446f39-13de-4e35-853b-08b74d5de42d`

---

# Work Order: Protocol Detail Accessibility Fixes

**WO Number:** WO-002  
**Created:** 2026-02-13  
**Priority:** P0 (Critical - Accessibility)  
**Assigned To:** BUILDER  
**Estimated Time:** 2-3 hours  
```

## ./.antigravity/work_orders/README.md
```text
# Work Orders System

## Quick Start

### For LEAD
```bash
# Create a new work order
WO_NUM=$(cat .antigravity/work_orders/COUNTER.txt)
cp .antigravity/work_orders/TEMPLATE_WORK_ORDER.md .antigravity/work_orders/WO-$(printf "%03d" $WO_NUM)_Feature_Name.md
echo $((WO_NUM + 1)) > .antigravity/work_orders/COUNTER.txt
```

### For All Agents (Startup Checklist)
```bash
# 1. Read the protocol
```

## ./.antigravity/work_orders/WO-001_GuidedTour_Transformation.md
```text
STATUS: BUILDER_READY

---

# Work Order: Transform GuidedTour to Outcome-Driven Onboarding

**WO Number:** WO-001  
**Created:** 2026-02-13  
**Priority:** P0 (Critical for Adoption)  
**Assigned To:** DESIGNER  
**Estimated Time:** 4-6 hours

---

## üìã Problem Statement
```

## ./.antigravity/work_orders/WO-003_Receptor_Affinity_Integration.md
```text
STATUS: BUILDER_READY

> **‚úÖ SOOP WORK COMPLETE:** Migration 015 successfully added receptor affinity data to `ref_substances` table (not a separate table as originally specified). All 8 substances have Ki values for 6 receptors. Ready for frontend integration.
> 
> **LEAD APPROVAL:** ‚úÖ APPROVED for BUILDER implementation (2026-02-14)
> 
> **Note:** SOOP's implementation differs from original spec - receptor data was added as columns to `ref_substances` rather than a separate `ref_receptor_affinity` table. This is a better design (fewer joins, faster queries). BUILDER should follow SOOP's handoff document for implementation details.

---

# Work Order: Receptor Affinity Database Integration

**WO Number:** WO-003  
**Created:** 2026-02-13  
**Priority:** P0 (Critical - Data Integrity)  
```

## ./.antigravity/work_orders/TEMPLATE_WORK_ORDER.md
```text
STATUS: TEMPLATE

---

# Work Order: [FEATURE NAME]

**WO Number:** WO-XXX  
**Created:** YYYY-MM-DD  
**Priority:** P0/P1/P2  
**Estimated Time:** X hours/days

---

## üìã Requirements

```

## ./.antigravity/work_orders/WO-007_Scientific_Molecular_Visualization.md
```text
STATUS: LEAD_REVIEW

---

# Work Order: Scientific Molecular Visualization Upgrade

**WO Number:** WO-007  
**Created:** 2026-02-14  
**Priority:** P1 (High - Scientific Authority)  
**Assigned To:** DESIGNER  
**Estimated Time:** 6-8 hours  
**Temperature:** 3 (Creative + Scientific Rigor)

---

```

## ./.antigravity/work_orders/WO-008_Profile_And_Tiers.md
```text
# Work Order: Profile & Partner Tiers Implementation

**WO Number:** WO-008
**Created:** 2026-02-14
**Priority:** P0 (Critical - User Request)
**Assigned To:** BUILDER (Design by DESIGNER)
**Status:** BUILDER_READY

## 1. Objective
Implement the missing "Edit Profile" functionality, enforce "Optional Profile" privacy visibility, and expose Partner Tiers in the UI.

## 2. Scope

### A. Edit Profile Feature
- **New Component:** `src/pages/ProfileEdit.tsx`
```

## ./.antigravity/work_orders/WO-006_Protocol_Builder_Video_Help.md
```text
STATUS: MARKETER_PENDING

---

# Work Order: Protocol Builder Video Script & Help Documentation

**WO Number:** WO-006  
**Created:** 2026-02-14  
**Priority:** P0 (Critical - Go-Live Blocker)  
**Assigned To:** MARKETER  
**Estimated Time:** 4-6 hours  
**Temperature:** 7 (Creative + Structured)

---

```

## ./.antigravity/work_orders/PROTOCOL.md
```text
# Work Order System Protocol

**Version:** 1.0  
**Last Updated:** 2026-02-13  
**Mandatory Reading:** ALL agents must read this on EVERY new chat session

---

## üéØ Purpose

This protocol ensures **chain of custody** for all tasks. No work happens without a ticket. No tickets get lost. Context is preserved across chat sessions.

---

## üìã Status Values
```

## ./.antigravity/NOTIFICATION_SETUP.md
```text
# Work Order Notification System

**Purpose:** Automatically notify you when work orders are ready for review  
**Status:** Ready to start

---

## üöÄ Quick Start

### Start the notification watcher:
```bash
cd /Users/trevorcalton/Desktop/PPN-Antigravity-1.0
nohup .antigravity/scripts/watch_notifications.sh > .antigravity/watcher.log 2>&1 &
```

```

